This is a Validated Antibody Database (VAD) review about rat occludin, based on 488 published articles (read how Labome selects the articles), using occludin antibody in all methods. It is aimed to help Labome visitors find the most suited occludin antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
occludin synonym: occludin

Knockout validation
Invitrogen
mouse monoclonal (OC-3F10)
  • western blot knockout validation; human; fig 1
In order to determine the contribution of occludin to hepatitis C virus infection, Invitrogen occludin antibody (Thermo Fisher, noca) was used in western blot knockout validation on human samples (fig 1). Biol Pharm Bull (2016) ncbi
Invitrogen
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; loading ...; fig 2d
Invitrogen occludin antibody (Abcam, 33-1500) was used in immunohistochemistry on mouse samples (fig 2d). Cell Mol Gastroenterol Hepatol (2019) ncbi
rabbit polyclonal
  • western blot; rat; fig 2a
Invitrogen occludin antibody (Zymed Laboratories, 71-1500) was used in western blot on rat samples (fig 2a). J Neurosci (2018) ncbi
rabbit polyclonal
  • western blot; mouse; loading ...; fig s2g
Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples (fig s2g). J Clin Invest (2017) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:100; fig 5l
In order to study the effect of angiocrine factors on retinal pigment epithelium basement membrane and barrier function, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry on human samples at 1:100 (fig 5l). Nat Commun (2017) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 5g
In order to study the effect of angiocrine factors on retinal pigment epithelium basement membrane and barrier function, Invitrogen occludin antibody (Thermo Fisher Scientific, 71-1500) was used in western blot on human samples at 1:1000 (fig 5g). Nat Commun (2017) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; 1:2000; loading ...; fig 3b
In order to describe a role for sphingosine 1-phosphate receptor-1 in regulating blood brain barrier permeability, Invitrogen occludin antibody (Invitrogen, 331500) was used in western blot on mouse samples at 1:2000 (fig 3b). Proc Natl Acad Sci U S A (2017) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; 1:200; loading ...; fig 7d
  • western blot; dog; loading ...; fig 7e
In order to find and characterize the interaction between Eps15 and pS227-FIP2, Invitrogen occludin antibody (BD Biosciences, 71-1500) was used in immunocytochemistry on dog samples at 1:200 (fig 7d) and in western blot on dog samples (fig 7e). Mol Biol Cell (2017) ncbi
rabbit polyclonal
  • western blot; mouse; loading ...; fig 4f
In order to study meiotic germ cell antigens, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples (fig 4f). J Clin Invest (2017) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; fig 2b
In order to investigate the role of nuclear factor erythroid 2-related factor in cigarette smoking-induced cerebrobvascular/blood brain barrier impairments, Invitrogen occludin antibody (Life Technologies, 331500) was used in western blot on mouse samples (fig 2b). Redox Biol (2017) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; loading ...; fig 2a
In order to explore the responses of occludin to stimulation by TNFalpha, IL-1beta and LPS in an immortalized human cerebral endothelial cell line, Invitrogen occludin antibody (Thermo Fisher Scientific, OC-3F10) was used in western blot on human samples (fig 2a). PLoS ONE (2017) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; loading ...; fig 5a
In order to study the role of P-Glycoprotein in the tight junctions using MCDK cells., Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on dog samples (fig 5a). IEEE Trans Nanobioscience (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; loading ...; fig 4b
  • western blot; human; 1:1000; loading ...; tbl 3
In order to report the presence of PIWI-like proteins in somatic cells and the possible role of HIWI2 in preserving the functional integrity of epithelial cells, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig 4b) and in western blot on human samples at 1:1000 (tbl 3). Mol Cell Biochem (2017) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:150; fig 6a
  • western blot; rat; 1:300; fig 6g
In order to elucidate how particulate matter impairs male reproduction, Invitrogen occludin antibody (Invitrogen, 40-4700) was used in immunohistochemistry - paraffin section on rat samples at 1:150 (fig 6a) and in western blot on rat samples at 1:300 (fig 6g). Toxicol Lett (2017) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; 1:50; loading ...; fig 7a
In order to assess changes in the cell and luminal volumes of type II Madin-Darby canine kidney cells grown in response to drugs or to changes in the composition of the basal extracellular fluid, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on dog samples at 1:50 (fig 7a). Can J Physiol Pharmacol (2017) ncbi
rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 4
In order to test if A2A receptor signaling governs the blood-brain barrier dynamics in sleep-restricted rats, Invitrogen occludin antibody (Invitrogen, 40-4700) was used in western blot on rat samples at 1:1000 (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:1000; loading ...; fig 2a
  • western blot; mouse; 1:1000; loading ...; fig 6a
In order to examine the role of Salmonella AvrA during infection, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on human samples at 1:1000 (fig 2a) and in western blot on mouse samples at 1:1000 (fig 6a). J Biol Chem (2016) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rabbit; 1:1000; loading ...; fig 6b
In order to investigate the role of TRPV4 in a corneal epithelial cell model, Invitrogen occludin antibody (Thermo Fisher, 33-1511) was used in western blot on rabbit samples at 1:1000 (fig 6b). J Cell Physiol (2017) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 7c
In order to report the effects of peroxisome proliferator-activated receptor beta/delta agonist on the acute phase response after brain injury, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples at 1:1000 (fig 7c). Transl Res (2017) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; loading ...; fig 1.1
In order to study how iron-depleted, iron-saturated, and manganese-saturated forms of lactoferrin govern intestinal barrier function, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunohistochemistry on human samples (fig 1.1). Biometals (2016) ncbi
rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 5a
In order to assess the contribution of mutated prostasin in dextran sodium sulfate-induced colitis, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:1000 (fig 5a). Inflamm Bowel Dis (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; rat; 1:100; loading ...; fig 3c
In order to assess the effects of PEGylation on the toxicity of nanoparticles in rat brains, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on rat samples at 1:100 (fig 3c). Mol Pharm (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 2.5 ug/ml; loading ...; fig 3d
In order to demonstrate a novel mechanism by which HIV-1 invades ocular tissues and promotes translocation or invasion by additional pathogens, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples at 2.5 ug/ml (fig 3d). J Biol Chem (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; dog; 1:200; loading ...; fig 4a
  • western blot; dog; 1:1000; loading ...; fig 3d
In order to measure tight junction protein expression in canine duodenum, lung, liver, and kidney, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on dog samples at 1:200 (fig 4a) and in western blot on dog samples at 1:1000 (fig 3d). Mol Med Rep (2016) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 7 ug/ml; loading ...; tbl s5
  • western blot; mouse; 3 ug/ml; loading ...; tbl s5
In order to explore the effects of mild chronic psychological stress on metabolic, inflammatory, and behavioral profiles in a mouse model of diet-induced obesity, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry on mouse samples at 7 ug/ml (tbl s5) and in western blot on mouse samples at 3 ug/ml (tbl s5). Brain Behav Immun (2017) ncbi
rabbit polyclonal
  • western blot; rat; 1:250; loading ...; tbl 1
In order to examine the organization of actin microfilaments in Sertoli cell at the blood testis barrier, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:250 (tbl 1). Spermatogenesis (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3a
In order to study the role of TLR4 in irinotecan-induced diarrhea, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3a). Mol Cancer Ther (2016) ncbi
rabbit polyclonal
  • western blot; mouse; 1:400; loading ...; fig 4l
In order to study the role of TLR4 in irinotecan-induced diarrhea, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples at 1:400 (fig 4l). Mol Cancer Ther (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dog; 1:200; fig 5
  • western blot; dog; 1:1000; fig 8a
In order to investigate how serine proteases increase transepithelial electrical resistance, Invitrogen occludin antibody (Invitrogen, 331500) was used in immunocytochemistry on dog samples at 1:200 (fig 5) and in western blot on dog samples at 1:1000 (fig 8a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 1
  • western blot; rat; 1:1000; fig 1
  • western blot; mouse; 1:1000; fig 1
In order to examine claudin-11 localization in testis of patients with normal and impaired spermatogenesis, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on human samples at 1:1000 (fig 1), in western blot on rat samples at 1:1000 (fig 1) and in western blot on mouse samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:100; loading ...
In order to propose using an integrated insert in a dynamic microfluidic platform for toxicological testing, Invitrogen occludin antibody (Thermo Fisher, 33-1500) was used in immunocytochemistry on rat samples at 1:100. J Appl Toxicol (2017) ncbi
rabbit polyclonal
  • western blot; rat; 1:250; fig 2
In order to characterize overexpression of gap junction protein connexin 43 by rescue of perfluorooctanesulfonate (PFOS)-mediated sertoli cell injury, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:250 (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; fig 3a
In order to test if hypoxia inducible factor-1 activation contributes to hyperglycemia-aggravated blood brain barrier disruption in an ischemic stroke model, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on mouse samples (fig 3a). Neurobiol Dis (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 2f
In order to examine trafficking of cancer-targeting alkylphosphocholine analogues across the blood brain barrier, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples at 1:200 (fig 2f). Mol Pharm (2016) ncbi
rabbit polyclonal
  • western blot; rat; 1:250; fig 5
In order to report that crumbs homolog 3 is an actin microfilament regulator, Invitrogen occludin antibody (Invitrogen, Life Technologies, 71-1500) was used in western blot on rat samples at 1:250 (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; rat; 1:100; fig 2
In order to report that crumbs homolog 3 is an actin microfilament regulator, Invitrogen occludin antibody (Invitrogen, Life Technologies, 33-1500) was used in immunohistochemistry - frozen section on rat samples at 1:100 (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:100; fig s8
In order to analyze preservation of epithelial polarity and epithelial barrier by alix-mediated assembly of the actomyosin-tight junction polarity complex, Invitrogen occludin antibody (Life Technologies, 331588) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig s8). Nat Commun (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 2
In order to analyze how to cease the inflammatory effects of HIV-1 infection in vitro by electro-magnetic nano-particle bound beclin1 siRNA that crosses the blood-brain barrier, Invitrogen occludin antibody (Thermo Scientific, 331588) was used in immunocytochemistry on human samples (fig 2). J Neuroimmune Pharmacol (2017) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; fig 4
In order to study the intestinal barrier function using Arhgap17-deficient mice, Invitrogen occludin antibody (Life Technologies, 711500) was used in immunohistochemistry on mouse samples (fig 4). Sci Rep (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 3
  • immunohistochemistry - paraffin section; mouse; fig 3
In order to characterize and identify a novel tissue barrier in tendon blood vessels, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on human samples (fig 3) and in immunohistochemistry - paraffin section on mouse samples (fig 3). Eur Cell Mater (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; rat; 2.5 ug/ml; fig 5
  • immunoprecipitation; rat; 3 ug/ml; fig 5
  • western blot; rat; 0.5 ug/ml; fig 5
In order to study the increase of nectin-3 in the cell junctions of the uterine epithelium at implantation, Invitrogen occludin antibody (Life Technologies Australia Pty, 33-1500) was used in immunohistochemistry - frozen section on rat samples at 2.5 ug/ml (fig 5), in immunoprecipitation on rat samples at 3 ug/ml (fig 5) and in western blot on rat samples at 0.5 ug/ml (fig 5). Reprod Sci (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; rat; 1:100; fig 4
  • western blot; rat; 1:500; fig 2
In order to analyze hyperoxia-induced pulmonary epithelial barrier breakdown and how caveolin-1 regulates the expression of tight junction proteins, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on rat samples at 1:100 (fig 4) and in western blot on rat samples at 1:500 (fig 2). Respir Res (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 2
In order to elucidate regulation of E-cadherin and CD24 by determination of cell fate transition and impeding tumor initiation and progression in breast cancer via HOXA5, Invitrogen occludin antibody (Thermo Fisher Scientific, 71-1500) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 2). Oncogene (2016) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; fig s6
In order to identify transcription factors involved in pancreatic ductal adenocarcinoma pathogenesis, Invitrogen occludin antibody (Life Technologies, 711500) was used in immunohistochemistry on mouse samples (fig s6). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; mouse; fig 1
In order to characterize induction of lactation-specific tight junctions concurrent with beta-casein expression in mammary epithelial cells due to prolactin and glucocorticoid signaling, Invitrogen occludin antibody (Life Technologies, 33-1500) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Biochim Biophys Acta (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 3
  • western blot; pig; 1:1000; fig 3
In order to determine expression of epithelial as well as mesenchymal cell adhesion molecules in 293 cells, Invitrogen occludin antibody (Zymed, 71-1500) was used in western blot on human samples at 1:1000 (fig 3) and in western blot on pig samples at 1:1000 (fig 3). Int J Mol Med (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; mouse; 1:300; fig 4
  • western blot; mouse; 1:3000; fig 4
In order to study recruitment of PDZD11 to adherens junctions to stabilize nectins via PLEKHA7, Invitrogen occludin antibody (Zymed Laboratories, 33-1500) was used in immunocytochemistry on mouse samples at 1:300 (fig 4) and in western blot on mouse samples at 1:3000 (fig 4). J Biol Chem (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; pig; 1:100; fig 3
In order to characterize cell junction assembly in early porcine embryo development by ADAM10, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on pig samples at 1:100 (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 4
In order to utilize a unique in vitro platform to learn about development of Toll-like receptor 4-targeted therapeutic options and the study of SN38-induced mucosal damage, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples (fig 4). Exp Biol Med (Maywood) (2016) ncbi
rabbit polyclonal
  • western blot; rat; 1:1000; fig 2
In order to study the reduction of paracellular permeability of rat brain endothelial cells exposed to ischemia-like conditions by adropin, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:1000 (fig 2). Peptides (2016) ncbi
rabbit polyclonal
  • western blot; rat; 1:250; fig 3
In order to determine regulation of ectoplasmic specialization dynamics via its effects on actin microfilaments in the testes of male rats by planar cell polarity (PCP) protein Vangl2, Invitrogen occludin antibody (Invitrogen, 711500) was used in western blot on rat samples at 1:250 (fig 3). Endocrinology (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 2
In order to analyze tight junction protein expression in mal de Meleda by use of immunohistological studies, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on human samples (fig 2). Ultrastruct Pathol (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 2
In order to utilize human alveolar epithelial cells expressing tight junctions as an air-blood barrier model, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples at 1:200 (fig 2). ALTEX (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig s2
In order to utilize a novel mouse model with retinal detachment caused by a disruption of protein kinase C, theta, to study retinal pigment epithelium atrophy 1 (rpea1), Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on mouse samples (fig s2). Invest Ophthalmol Vis Sci (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; fig 8
In order to study enhancing mucosal inflammation by chronic ethanol feeding that promotes azoxymethane and dextran sulfate sodium-induced colonic tumorigenesis, Invitrogen occludin antibody (Invitrogen, 331500) was used in immunohistochemistry - frozen section on mouse samples (fig 8). BMC Cancer (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; 1:1000; fig 1
In order to study a reconstituted choroid plexus epithelium to show T-lymphocytes traffic into the brain across the blood-CSF barrier, Invitrogen occludin antibody (Life Technologies, 71-1500) was used in immunocytochemistry on mouse samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; sheep; 1:50; fig 4
In order to determine if monitoring of fetal intestinal inflammation by heart rate variability analysis can signal incipient necrotizing enterocolitis of the neonate, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry - paraffin section on sheep samples at 1:50 (fig 4). Pediatr Crit Care Med (2016) ncbi
mouse monoclonal (OC-3F10)
  • western blot knockout validation; human; fig 1
In order to determine the contribution of occludin to hepatitis C virus infection, Invitrogen occludin antibody (Thermo Fisher, noca) was used in western blot knockout validation on human samples (fig 1). Biol Pharm Bull (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 6
  • immunohistochemistry; mouse; 1:200; fig 5
In order to study disruption of retinal pigment epithelial structure and function with features of age-related macular degeneration caused by hyperhomocysteinemia, Invitrogen occludin antibody (Invitrogen, 331500) was used in immunocytochemistry on human samples at 1:200 (fig 6) and in immunohistochemistry on mouse samples at 1:200 (fig 5). Oncotarget (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 6
In order to study disruption of retinal pigment epithelial structure and function with features of age-related macular degeneration caused by hyperhomocysteinemia, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - free floating section; rat; 1:100; fig 4
In order to evaluate the blood-brain barrier in adult rats and morphological changes due to restraint stress-induction, Invitrogen occludin antibody (Thermo Fisher Scientific, 71-1500) was used in immunohistochemistry - free floating section on rat samples at 1:100 (fig 4). Front Mol Neurosci (2015) ncbi
rabbit polyclonal
  • western blot; dog; fig 3
  • western blot; mouse; fig 3
In order to study the effects of glycogen storage in cells from the seminiferous tubules, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on dog samples (fig 3) and in western blot on mouse samples (fig 3). J Cell Physiol (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig 3
In order to study the impact of Faecalibacterium prausnitzii in a mouse model of irritable bowel syndrome, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:50; fig 3
In order to assess purinergic receptor P2RY12-dependent microglial closure to blood-brain barrier injuries, Invitrogen occludin antibody (Life Technologies, 33-1500) was used in immunohistochemistry on mouse samples at 1:50 (fig 3). Proc Natl Acad Sci U S A (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; rat; 1:50; tbl 2
In order to test if overexpression of Connexin 43 in adjudin-treated rats reseals the disrupted blood-testis barrier and reinitiates spermatogenesis, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - frozen section on rat samples at 1:50 (tbl 2). FASEB J (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 4c
  • western blot; mouse; 1:2000; loading ...; fig 4b
In order to test if vitamin D signaling ameliorates lipopolysaccharide-induced acute lung injury by altering barrier integrity, Invitrogen occludin antibody (Cell Signaling, 331500) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 4c) and in western blot on mouse samples at 1:2000 (fig 4b). Mol Med Rep (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; dog; 1:600; fig 1
In order to investigate how tight junctions regulate allergen penetration in atopic dermatitis, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on dog samples at 1:600 (fig 1). Vet Dermatol (2016) ncbi
rabbit polyclonal
  • western blot; cow; fig 3
In order to study two bovine mammary epithelial cell lines in 2D and 3D models for functional and phenotypic characterization, Invitrogen occludin antibody (Zymed, 71-1500) was used in western blot on cow samples (fig 3). Am J Physiol Cell Physiol (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to establish and characterize long-term, stable 3D organoid cultures derived from human fallopian tubes, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1
In order to assess the capacity of primary synovial fibroblasts to support hepatitis C virus propagation, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; fig s2
  • ELISA; human; 1:50; fig s2
  • western blot; human; fig s2
In order to analyze control of HIV transcription in brain pericytes by occludin via regulation of SIRT-1 activation, Invitrogen occludin antibody (Thermo Scientific, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig s2), in ELISA on human samples at 1:50 (fig s2) and in western blot on human samples (fig s2). FASEB J (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; rat; 2500 ng/ml; fig 4
  • western blot; rat; 1:125; fig 3
In order to study sertoli cell tight junction function in vitro and the role of Claudin-11 and occludin as major contributors, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on rat samples at 2500 ng/ml (fig 4) and in western blot on rat samples at 1:125 (fig 3). Asian J Androl (2016) ncbi
rabbit polyclonal
  • immunohistochemistry; tiger salamander; 1:500; fig 1
In order to characterize axolotl spinal cord regeneration and how induction of neural stem cell expansion occurs by planar cell polarity-mediation, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry on tiger salamander samples at 1:500 (fig 1). elife (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 2
In order to describe methods to differentiate and characterize hPSC-derived brain microvascular endothelial cells, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples at 1:200 (fig 2). Methods (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:200; fig 2
In order to study the transmigration of neuroblastoma cells across the blood-cerebrospinal fluid barrier in vitro, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on human samples at 1:200 (fig 2). Cancer Cell Int (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:100; fig 5
In order to create and characterize a model for kidney disease using CRISPR-mutants, Invitrogen occludin antibody (Thermo Fisher Scientific, 71-1500) was used in immunocytochemistry on human samples at 1:100 (fig 5). Nat Commun (2015) ncbi
rabbit polyclonal
  • western blot; rat
In order to examine the effect of advanced glycation end products on the retina, Invitrogen occludin antibody (Invitrogen Life Technologies, 711500) was used in western blot on rat samples . Mol Med Rep (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 1c
In order to elucidate the contribution of SPRY2 to colon cancer, Invitrogen occludin antibody (Life Technologies, 71-1500) was used in western blot on human samples (fig 1c). Oncogene (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:100; fig 2b
  • western blot; human; 1:1000; fig 2a
In order to characterize two clones from triple negative breast MDA-MB-231 cancer cells, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on human samples at 1:100 (fig 2b) and in western blot on human samples at 1:1000 (fig 2a). Exp Cell Res (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1,2,3
In order to research pancreatic epithelial cells and a possible sensor system through the hippo pathway co-localizing with occludin, Invitrogen occludin antibody (Invitrogen, 33-C1500) was used in western blot on human samples (fig 1,2,3). Tissue Barriers (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 5 ug/ml
In order to assess epithelial tight junctions, cytokine production, and matrix metalloproteinase profiles in patients undergoing chemotherapy, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry on human samples at 5 ug/ml. Support Care Cancer (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 4
In order to study the use of microfluidics in temporal monitoring of differentiated human airway epithelial cells, Invitrogen occludin antibody (Life Technologies, OC-3F10) was used in immunocytochemistry on human samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; fig 2b
In order to propose that IL-17-producing gammadelta T cells help to maintain and protect the intestinal mucosa, Invitrogen occludin antibody (Life Technologies, OC-3F10) was used in immunohistochemistry - frozen section on mouse samples (fig 2b). Immunity (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 2b
In order to study the contribution of neutrophil peptides 1 to HIV transmission, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples at 1:200 (fig 2b). Viral Immunol (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:100
  • western blot; mouse; 1:250
In order to study the effects of Abeta on the functionality of the blood-CSF barrier, Invitrogen occludin antibody (Life Technologies, 33-1500) was used in immunohistochemistry on mouse samples at 1:100 and in western blot on mouse samples at 1:250. J Neurosci (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:50
  • western blot; human; 1:200
In order to elucidate the effects and mechanism of miR-18a on the permeability of the blood-tumor barrier, Invitrogen occludin antibody (Life Technologies, 33-1500) was used in immunocytochemistry on human samples at 1:50 and in western blot on human samples at 1:200. J Neurosci Res (2015) ncbi
rabbit polyclonal
  • western blot; dog
In order to examine the role of occludin in H2O2-mediated renal epithelial cell monolayer permeability, Invitrogen occludin antibody (Life Technologies, 404700) was used in western blot on dog samples . J Cell Biochem (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; dog
In order to examine the role of occludin in H2O2-mediated renal epithelial cell monolayer permeability, Invitrogen occludin antibody (Life Technologies, 71-1500) was used in immunocytochemistry on dog samples . J Cell Biochem (2016) ncbi
rabbit polyclonal
  • western blot; chicken; 1:1000
In order to test if rapamycin-sensitive target of rapamycin complex 1 pathway is involved in intestinal barrier integrity, Invitrogen occludin antibody (Beyotime, 71-1500) was used in western blot on chicken samples at 1:1000. J Anim Physiol Anim Nutr (Berl) (2016) ncbi
rabbit polyclonal
  • western blot; rat; 1:1000
In order to test if 2,3,5,6-tetramethylpyrazine protects the blood brain barries integrity in ischemia/reperfusion injury, Invitrogen occludin antibody (Invitrogen Life Technologies, 71-1500) was used in western blot on rat samples at 1:1000. Exp Ther Med (2015) ncbi
rabbit polyclonal
  • western blot; human
In order to examine what proteins are produced when carbohydrate-fed healthy humans receive enteral delivery of proteins, Invitrogen occludin antibody (Life Technologies, 71-1500) was used in western blot on human samples . Am J Clin Nutr (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:250; fig s8
In order to study modulation of the composition of the gut microbiota by ganoderma lucidum that reduces obesity in mice, Invitrogen occludin antibody (Invitrogen, 71-1,500) was used in western blot on mouse samples at 1:250 (fig s8). Nat Commun (2015) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; baboons; 1:100
  • western blot; baboons; 1:2000
In order to study the choroid plexus in the fetus, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on baboons samples at 1:100 and in western blot on baboons samples at 1:2000. Reprod Toxicol (2015) ncbi
rabbit polyclonal
  • western blot; rat; 1:250
In order to study the role of plastin 3 in ectoplasmic specialization dynamics during spermatogenesis in the rat testis, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:250. FASEB J (2015) ncbi
rabbit polyclonal
  • western blot; mouse
In order to determine the role of the HGF/c-Met pathway in regulating oval cell migratory and invasive properties, Invitrogen occludin antibody (Invitrogen, 711500) was used in western blot on mouse samples . Biochim Biophys Acta (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:100; fig 3b
In order to compare the effects of two excipients applied to emerged reconstructed human epidermis, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunohistochemistry on human samples at 1:100 (fig 3b). Exp Dermatol (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000
In order to determine effects of low-dose-rate chronic radiation on male fertility, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples at 1:1000. Radiat Prot Dosimetry (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:500; loading ...; fig 3c
  • western blot; rat; 1:500; loading ...; fig 2a
In order to propose that claudin-4 is required for mAChR-modulated paracellular permeability of epithelial cells and investigate the mechanism, Invitrogen occludin antibody (Life Technologies, 331500) was used in immunocytochemistry on rat samples at 1:500 (fig 3c) and in western blot on rat samples at 1:500 (fig 2a). J Cell Sci (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse
In order to investigate the role of claudin-1/claudin-5 in epithelial/endothelial barriers, Invitrogen occludin antibody (Life Technologies, 71-1500) was used in immunocytochemistry on mouse samples . Biomaterials (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 2.5 ug/ml
In order to investigate the role of claudin-1/claudin-5 in epithelial/endothelial barriers, Invitrogen occludin antibody (Life Technologies, 33-1500) was used in immunocytochemistry on human samples at 2.5 ug/ml. Biomaterials (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse
In order to investigate the deficiency of intestine and microbiome in an amyotrophic lateral sclerosis mouse model, Invitrogen occludin antibody (Zymed, 33-1500) was used in western blot on mouse samples . Physiol Rep (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:200
In order to discuss the contribution of epithelial barrier dysfunction to mucosal diseases, including asthma, chronic rhinosinusitis, and eosinophilic esophagitis, Invitrogen occludin antibody (Life Technologies, 71-1500) was used in immunocytochemistry on human samples at 1:200. J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; Rhesus monkey; fig s1b
In order to identify cellular determinants of interspecies hepatitis C virus transmission and establish an immunocompetent model system, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in western blot on Rhesus monkey samples (fig s1b). Hepatology (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 5
In order to study the impairment of human brain endothelial barrier integrity via integrin alpha-4 transduced outside-in signaling due to soluble VCAM-1, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples (fig 5). Acta Neuropathol (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; fig 6
In order to elucidate the contributions of cell-cell adhesion proteins to intercellular force and epithelial tissue dynamics, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry on human samples (fig 6). Nat Cell Biol (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000
In order to investigate the effect of prostacyclin on pericyte loss and demyelination induced by lysophosphatidylcholine in the central nervous system, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples at 1:1000. J Biol Chem (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dog; fig 6
  • western blot; dog; fig 3
In order to identify the members of the tight junction proteome, Invitrogen occludin antibody (Life Technologies, 33-1500) was used in immunocytochemistry on dog samples (fig 6) and in western blot on dog samples (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human
Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunohistochemistry on human samples . PLoS ONE (2015) ncbi
rabbit polyclonal
  • western blot; rat; 1:1000; fig 1
In order to determine the effect of 17beta-estradiol on blood-spinal cord barrier breakdown, hemorrhage, and subsequent inflammation after spinal cord injury, Invitrogen occludin antibody (Invitrogen, 40-4700) was used in western blot on rat samples at 1:1000 (fig 1). Endocrinology (2015) ncbi
rabbit polyclonal
  • western blot; human; 1:1000
In order to generate a new line of conditionally immortalized human brain microvascular endothelial cells to study blood brain barrier function, Invitrogen occludin antibody (Zymed Laboratories, 71-1500) was used in western blot on human samples at 1:1000. Fluids Barriers CNS (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:500
In order to study the role of astroglial cx43 in immune quiescence of the brain, Invitrogen occludin antibody (Life Technologies, 71-1500) was used in western blot on mouse samples at 1:500. J Neurosci (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse
In order to investigate the role of LSR/angulin-1 in blood-brain barrier formation, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry - frozen section on mouse samples . J Cell Biol (2015) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; mouse
In order to investigate the role of LSR/angulin-1 in blood-brain barrier formation, Invitrogen occludin antibody (Invitrogen, 40-4700) was used in immunohistochemistry - frozen section on mouse samples . J Cell Biol (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:200
In order to study the role of Musashi-1 in blood-testis barrier structure during spermatogenesis, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples at 1:200. Mol Biol Cell (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human
In order to test if foreskin tissue samples from asymptomatic HSV-2 seropositive men had signs of inflammation at the molecular level, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunohistochemistry - frozen section on human samples . BMJ Open (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 6
In order to study human breast cancer cell lines and how Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration, Invitrogen occludin antibody (Invitrogen, OC-F10) was used in western blot on human samples (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:50
In order to investigate the role of opioid receptor delta in skin differentiation and barrier function repair, Invitrogen occludin antibody (Life technologies, 33-1500) was used in immunohistochemistry on human samples at 1:50. Int J Cosmet Sci (2015) ncbi
rabbit polyclonal
  • western blot; rat; 1:200; fig 5
In order to assess changes to the blood-brain barriers and regional cerebral blood flow in a neonatal model of hypoxic-ischemic encephalopathy, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:200 (fig 5). J Cereb Blood Flow Metab (2015) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse
  • immunocytochemistry; mouse
In order to examine the role of the mammalian acid sphingomyelinase/ceramide system in the development of lung edema caused by S. aureus, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on mouse samples and in immunocytochemistry on mouse samples . J Mol Med (Berl) (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:100; fig 5
  • western blot; human; 1:250; fig 2
In order to test if azithromycin attenuates cigarette smoke extract-induced A549 cell oxidative stress injury, Invitrogen occludin antibody (Invitrogen Life Technologies, 71-1500) was used in immunocytochemistry on human samples at 1:100 (fig 5) and in western blot on human samples at 1:250 (fig 2). Mol Med Rep (2015) ncbi
rabbit polyclonal
  • immunoprecipitation; rat; 1:300
  • western blot; rat; 1:500
In order to report the signaling mechanisms by which PKC-zeta activation affects EMAP-II-induced BTB hyperpermeability, Invitrogen occludin antibody (Invitrogen, 71-C1500) was used in immunoprecipitation on rat samples at 1:300 and in western blot on rat samples at 1:500. Exp Cell Res (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; Domestic guinea pig
In order to characterize transcription factor AP-2gamma in early embryonic development of porcine parthenotes, Invitrogen occludin antibody (ZYMED, 33-1500) was used in immunohistochemistry on Domestic guinea pig samples . Reprod Fertil Dev (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:20
In order to assess the effects of different cell culturing conditions on the Calu-3 epithelial cell model, Invitrogen occludin antibody (Zymed-Life Technologies, 71-1500) was used in immunocytochemistry on human samples at 1:20. Eur J Pharm Sci (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100
  • western blot; human
Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:100 and in western blot on human samples . Infect Immun (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:1000
In order to study how DLC2 regulates cell junction maintenance and planar spindle positioning, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples at 1:1000. Nat Commun (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human
  • western blot; human
In order to investigate the effect of homoharringtonine on intestinal epithelial permeability and its mechanism, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples and in western blot on human samples . Eur J Pharm Biopharm (2015) ncbi
rabbit polyclonal
  • western blot; mouse
In order to test if ERalpha modulates blood-brain barrier integrity and/or neuroinflammation in lupus-prone mice, Invitrogen occludin antibody (Invitrogen, 40-4700) was used in western blot on mouse samples . J Neuroinflammation (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; mouse; 1:500; fig 3
In order to study the contribution of ZO-1, -2, and -3 on collecting duct cell proliferation, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunocytochemistry on mouse samples at 1:500 (fig 3). Cell Cycle (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; mouse
In order to evaluate a model of cerebral malaria pathogenesis and its effect on the blood brain barrier, Invitrogen occludin antibody (Invitrogen, 40-4700) was used in immunohistochemistry - frozen section on mouse samples . PLoS Pathog (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; 5 ug/ml
  • western blot; mouse; 2 ug/ml
In order to assess the neuroprotective features of acetyl-L-carnitine in methamphetamine-induced damage, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on mouse samples at 5 ug/ml and in western blot on mouse samples at 2 ug/ml. Mol Neurobiol (2016) ncbi
rabbit polyclonal
  • western blot; rat; 1:300
In order to study the role of EB1 in tubulin and actin cytoskeletal networks at the sertoli cell blood-testis barrier, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:300. Endocrinology (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:1000; loading ...; fig 6b
In order to develop an efficient system to culture hepatitis C virus, Invitrogen occludin antibody (Life Technologies, OC-3F10) was used in western blot on human samples at 1:1000 (fig 6b). Jpn J Infect Dis (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; common platanna; fig 3
In order to investigate matrix metalloproteinase expression in the Xenopus laevis corneal epithelium, Invitrogen occludin antibody (Invitrogen, 331500) was used in immunohistochemistry - frozen section on common platanna samples (fig 3). PLoS ONE (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; common platanna; fig 3
In order to investigate matrix metalloproteinase expression in the Xenopus laevis corneal epithelium, Invitrogen occludin antibody (Invitrogen, 711500) was used in immunohistochemistry - frozen section on common platanna samples (fig 3). PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:300; fig 4
  • western blot; mouse; 1:1000
In order to study the blood-brain barrier function in germ free mice, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry on mouse samples at 1:300 (fig 4) and in western blot on mouse samples at 1:1000. Sci Transl Med (2014) ncbi
rabbit polyclonal
In order to examine the role of perforin and CD8 T cells in immune-mediated blood-brain barrier disruption, Invitrogen occludin antibody (Invitrogen, 71-C1500) was used . PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:1000; fig 3
In order to demonstrate that emodin attenuates LPS- and hypoxia/reoxygenation-induced intestinal epithelial barrier dysfunction by inhibiting the HIF-1alpha and NF-kappaB signaling pathways, which regulate tight junctions, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on human samples at 1:1000 (fig 3). Int J Mol Med (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
In order to analyze cancer cell plasticity autonomous stimulation by human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells, Invitrogen occludin antibody (Invitrogen, Z-T22) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human
In order to study tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on human samples . Surg Obes Relat Dis (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; sheep; 1:500
In order to study the effect of a high-concentrate diet on colonic epithelial barrier and cell apoptosis in lactating goats, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on sheep samples at 1:500. BMC Vet Res (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to research aggravation of murine caerulein-induced acute pancreatitis and the favoring of acinar keratin granule formation due to epiplakin deficiency, Invitrogen occludin antibody (Life Technologies, OC-3F10) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). PLoS ONE (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:100
  • western blot; rat; 1:125
In order to investigate the role of rpS6 in blood-testis barrier function, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on rat samples at 1:100 and in western blot on rat samples at 1:125. J Cell Sci (2014) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human
Invitrogen occludin antibody (Zymed laboratories, OC-3F10) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; Rhesus monkey; 1:400
In order to examine the localization of epithelial junctions in relation to paracellular permeability and intestinal adhesion, Invitrogen occludin antibody (Life Technologies, 33-1500) was used in immunohistochemistry - paraffin section on Rhesus monkey samples at 1:400. Exp Toxicol Pathol (2014) ncbi
rabbit polyclonal
  • western blot; rat; 1:1000; fig 6
In order to study the role of vascular endothelial growth factor A in ovarian hyperstimulation syndrome, Invitrogen occludin antibody (Invitrogen Corp., 71-1500) was used in western blot on rat samples at 1:1000 (fig 6). J Steroid Biochem Mol Biol (2014) ncbi
rabbit polyclonal
  • immunohistochemistry; rat; 1:50
  • western blot; rat; 1:250
In order to investigate their role of angiopoietin 1 in regulating the blood-spinal cord barrier, Invitrogen occludin antibody (Zymed/Invitrogen, 71-1500) was used in immunohistochemistry on rat samples at 1:50 and in western blot on rat samples at 1:250. Exp Cell Res (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; human
In order to study using RPMI 2650 cells to create an in vitro model of the nasal mucosa, Invitrogen occludin antibody (Zymed-Life Technologies, 71-1500) was used in immunocytochemistry on human samples . Pharm Res (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:1000; loading ...; fig 1c
In order to examine the roles of scavenger receptor class B type I, CD81, claudin 1, and occludin in Hepatitis C virus infection, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples at 1:1000 (fig 1c). J Virol (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; 1:50; fig s5
In order to analyze the barrier properties of mouse brain endothelial cells and stabilizing adherens junctions due to heparan sulfate proteoglycan agrin, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on mouse samples at 1:50 (fig s5). Cell Tissue Res (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 3
In order to assess the role of Toll-like receptor 2 in maintaining the integrity of the airway epithelial barrier, Invitrogen occludin antibody (InvitrogenAG, 33-1500) was used in immunocytochemistry on human samples (fig 3). Tissue Barriers (2014) ncbi
rabbit polyclonal
  • western blot; human; fig 1
In order to investigate the mechanisms of hepatitis C virus entry into multiple permissive human hepatocyte-derived cells, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on human samples (fig 1). J Gen Virol (2014) ncbi
rabbit polyclonal
  • western blot; human
In order to investigate the localization of POF1B in desmosomes and its role in human intestinal and keratinocyte cell lines, Invitrogen occludin antibody (Zymed Laboratories, 71-1500) was used in western blot on human samples . J Invest Dermatol (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:200
In order to evaluate the cystathionine-beta-synthase heterozygous mice as a model of mild to moderate hyperhomocysteinemia, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry on mouse samples at 1:200. Am J Pathol (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; 1:250
In order to study the role of tight junction alterations in cavernous malformations, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry - frozen section on human samples at 1:250. J Neurosurg (2014) ncbi
rabbit polyclonal
  • western blot; dog
In order to study the role of ZO proteins in the regulation of transcription factor DbpA/ZONAB, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on dog samples . J Biol Chem (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 4
In order to demonstrate that ceramide accumulates in cystic fibrosis lungs and mediates increased cell death, susceptibility to infections, and inflammation, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4). Cell Physiol Biochem (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:100
  • western blot; mouse; 1:250
In order to elucidate N-wasp and its role in structural integrity of the blood-testis barrier, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - frozen section on mouse samples at 1:100 and in western blot on mouse samples at 1:250. PLoS Genet (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; human
In order to determine the effect of ablating HAI-1 and HAI-2 on endogenous matriptase expression, subcellular localization, and activation in polarized intestinal epithelial cells, Invitrogen occludin antibody (Zymed Laboratories, 71-1500) was used in immunocytochemistry on human samples . J Biol Chem (2014) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 1
In order to assess the contribution of enteropathogenic Escherichia coli EspG-mediated microtubule disruption to tight junction perturbation, Invitrogen occludin antibody (Life Technologies, 71-1500) was used in western blot on human samples at 1:1000 (fig 1). Cell Microbiol (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:3000
In order to investigate the effect of peanut allergens on intestinal barrier permeability and tight junction localisation in Caco-2 cell cultures, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on human samples at 1:3000. Cell Physiol Biochem (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig 5b
In order to study the role of TH9 cells in ulcerative colitis, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 5b). Nat Immunol (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:100
  • western blot; rat; 1:3500
In order to test if chlorogenic acid improves the intestinal barrier integrity of weaned rats treated with lipopolysaccharide, Invitrogen occludin antibody (invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on rat samples at 1:100 and in western blot on rat samples at 1:3500. PLoS ONE (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; human; 1:200
In order to examine the origin of crescent forming cells in human glomerulonephritis, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - frozen section on human samples at 1:200. Int J Nephrol (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; human
In order to evaluate an in vitro blood-brain barrier model, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on human samples . J Neurosci Methods (2014) ncbi
rabbit polyclonal
  • western blot; human; fig s13
In order to determine the effect of HGF on the function of tight junctions in human prostate epithelial, prostate stem cell-like, and prostate cancer cell lines, Invitrogen occludin antibody (Zymed, 71-1500) was used in western blot on human samples (fig s13). Oncol Rep (2014) ncbi
rabbit polyclonal
  • western blot; mouse; 1:250
In order to study the circadian control of ccludin and claudin-1 expression in the mouse large intestine, Invitrogen occludin antibody (Applied Biosystems, 71-1500) was used in western blot on mouse samples at 1:250. PLoS ONE (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; 1:50; fig 3c
In order to test whether PLEKHA7 protein modulates epithelial tight junction barrier function, Invitrogen occludin antibody (Zymed, 71?C1500) was used in immunocytochemistry on dog samples at 1:50 (fig 3c). Tissue Barriers (2014) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; 1:1000
In order to characterize transmural intestinal wall permeability in severe ischemia after enteral protease inhibition, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on rat samples at 1:1000. PLoS ONE (2014) ncbi
rabbit polyclonal
  • immunohistochemistry; human; 1:30
  • western blot; human; 1:200
In order to investigate chorioamnionitis, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry on human samples at 1:30 and in western blot on human samples at 1:200. Placenta (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:200
  • western blot; rat; 1:200
In order to study hepatocyte polarity and various claudins that are expressed in tight junctions of cell lines, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on rat samples at 1:200 and in western blot on rat samples at 1:200. Tissue Barriers (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human
In order to investigate the role of lipolysis stimulated lipoprotein receptor in aggressive breast cancer behavior, Invitrogen occludin antibody (Zymed, 33-1500) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; loading ...; fig s5
In order to identify a cell line that supports the entire life cycle of hepatitis B and hepatitis C viruses, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples (fig s5). Proc Natl Acad Sci U S A (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; human
  • western blot; human
In order to determine the quantity, distribution and function of tight junction proteins in patients undergoing dialysis treatments, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on human samples and in western blot on human samples . Perit Dial Int (2015) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:500; fig 2
  • western blot; mouse; 1:1000; fig 2
In order to find that astrocytic laminin maintains the blood brain barrier by regulating pericyte differentiation, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry on mouse samples at 1:500 (fig 2) and in western blot on mouse samples at 1:1000 (fig 2). Nat Commun (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; Domestic guinea pig; 1:250
  • western blot; Domestic guinea pig; 1:500
In order to study the effect of retinoic acid on the tight junctions of the retinal pigment epithelium-choroid complex of guinea pigs, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry on Domestic guinea pig samples at 1:250 and in western blot on Domestic guinea pig samples at 1:500. Int J Mol Med (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:150
  • western blot; mouse; 1:200
In order to examine how glutamate modulates intestinal epithelial cell growth and epithelial barrier function during total parenteral nutrition, Invitrogen occludin antibody (Life Technologies, 331500) was used in immunohistochemistry - frozen section on mouse samples at 1:150 and in western blot on mouse samples at 1:200. FASEB J (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
  • western blot; human; 1:500
In order to study the expression of zonula occludens-1 and occludin in the bladder urothelium of patients with interstitial cystitis/painful bladder syndrome, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on human samples at 1:100, in immunocytochemistry on human samples at 1:100 and in western blot on human samples at 1:500. J Formos Med Assoc (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100
  • western blot; human
In order to study the effect of Shigella species and its vaccine candidates on small intestinal barrier function and immune response, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples at 1:100 and in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100
In order to study cord blood as a source of circulating endothelial progenitor cells that can be directed towards specialized endothelial phenotypes, Invitrogen occludin antibody (Invitrogen, 33?C1500) was used in immunocytochemistry on human samples at 1:100. PLoS ONE (2014) ncbi
rabbit polyclonal
  • western blot; rat; 1:500; fig 3
In order to test if proteins involved in forming the junctions decrease and if this alters the ability of the blood-testis barrier to protect the germ cells as rats age, Invitrogen occludin antibody (Invitrogen, 711500) was used in western blot on rat samples at 1:500 (fig 3). PLoS ONE (2013) ncbi
rabbit polyclonal
  • western blot; human; 0.5 ug/ml
In order to study the role of ENaC in the mechanism by which cholera toxin mediates increased human mammary epithelial sodium uptake, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on human samples at 0.5 ug/ml. Am J Physiol Cell Physiol (2014) ncbi
rabbit polyclonal
  • immunohistochemistry; rat; 1:200; fig 2
In order to examine the structural and molecular alterations of the outer blood retinal barrier in diabetes samples, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunohistochemistry on rat samples at 1:200 (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; 1:1000
In order to investigate the effect of intestinal contents on hemorrhagic shock, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on rat samples at 1:1000. Physiol Rep (2013) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; 1:50
  • western blot; mouse; 1:1000
In order to study the effect of activity-based anorexia on intestinal barrier function in mice, Invitrogen occludin antibody (Zymed Laboratories, 71-1500) was used in immunocytochemistry on mouse samples at 1:50 and in western blot on mouse samples at 1:1000. Clin Nutr (2014) ncbi
mouse monoclonal (OC-3F10)
  • western blot; pig; 1:500
In order to investigate the effect of intraluminal acid on esophageal nodose C fibers after mast cell activation, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on pig samples at 1:500. Am J Physiol Gastrointest Liver Physiol (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; fig 3
  • western blot; dog; fig 7
In order to study the molecular mechanisms underlying the reversible effects of capsaicin on tight junction permeability, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on dog samples (fig 3) and in western blot on dog samples (fig 7). PLoS ONE (2013) ncbi
rabbit polyclonal
  • western blot; rat; 1:1000
In order to evaluate the neuroprotective effect of the lipoxin A4 receptor agonist, BML-111, in a rat model of ischemic stroke, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:1000. J Neurochem (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; mouse
  • western blot; mouse
In order to characterize tight junctions in the digestive tract of cystic fibrosis mice, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - frozen section on mouse samples and in western blot on mouse samples . Cell Tissue Res (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; mouse
In order to study the role of Crumbs3 in proper epithelial development and viability, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - frozen section on mouse samples . Mol Cell Biol (2014) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:500; fig s4
In order to demonstrate that PC-1 regulates correct tubular diameter during nephron development, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry on mouse samples at 1:500 (fig s4). Nat Commun (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dog
  • western blot; dog
In order to investigate the effect of ouabain on endocytosis and degradation of tight junction proteins, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on dog samples and in western blot on dog samples . Exp Cell Res (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:1000; fig 3
In order to analyze the influence of SCFAs and AMP-activated protein kinase on ethanol-induced barrier dysfunction, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on human samples at 1:1000 (fig 3). J Nutr (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; mouse; 1:100; fig 2
In order to study the role of Cldn6 in epithelial differentiation, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunocytochemistry on mouse samples at 1:100 (fig 2). PLoS ONE (2013) ncbi
rabbit polyclonal
  • western blot; human; fig 7
In order to test the apoptotic activity of the proteinases secreted Pseudomonas aeruginosa, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on human samples (fig 7). PLoS ONE (2013) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:100; fig 4
In order to study how Rab11 inhibits the barrier-disrupting effects of CtxA, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on human samples at 1:100 (fig 4). Cell Host Microbe (2013) ncbi
rabbit polyclonal
  • western blot; mouse; fig 4
In order to study the role of ClC-2 in epithelial barrier function and recovery in the event of epithelial injury, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples (fig 4). Inflamm Bowel Dis (2013) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1500; fig 1
In order to investigate the expression of the tight junction proteins occludin, claudin-1 and ZO-2 in the epidermis of female mice, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples at 1:1500 (fig 1). Exp Cell Res (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 2
In order to investigate the expression of the tight junction proteins occludin, claudin-1 and ZO-2 in the epidermis of female mice, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2). Exp Cell Res (2013) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000
In order to study the effect of endotoxemia on the progression of encephalopathy in relation to BBB permeability during acute liver failure, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples at 1:1000. Liver Int (2014) ncbi
rabbit polyclonal
  • western blot; rat; 1:200; tbl 1
In order to study how Sertoli cell blood-testis +C309:C312 barrier dynamics are regulated by the NC1 domain of collagen alpha3(IV) derived from the basement membrane, Invitrogen occludin antibody (Life Technologies, 71-1500) was used in western blot on rat samples at 1:200 (tbl 1). Spermatogenesis (2013) ncbi
rabbit polyclonal
  • western blot; mouse; 1:150
In order to evaluate the protective effect of the poly(ADP-ribose)polymerase inhibitor PJ34 against vascular toxicity, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples at 1:150. Exp Neurol (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 3
In order to study collective cell movement, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples (fig 3). Biol Open (2013) ncbi
rabbit polyclonal
  • western blot; human; 1:1000
In order to investigate the regulation of ZO-1 by p38delta mitogen-activated protein kinase in differentiating human epidermal keratinocytes, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on human samples at 1:1000. Arch Dermatol Res (2014) ncbi
rabbit polyclonal
  • western blot; rat; 1.25 ug/ml; fig 4
In order to study the cellular and molecular basis of retinoid actions upon Sertoli cell differentiation, Invitrogen occludin antibody (Zymed, 71-1500) was used in western blot on rat samples at 1.25 ug/ml (fig 4). Mol Cell Endocrinol (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; fig 2
  • immunohistochemistry; human; 1:100; fig 1
In order to report that tight junctions are physiological regulated by sex hormones during the menstrual cycle, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig 2) and in immunohistochemistry on human samples at 1:100 (fig 1). Cell Tissue Res (2013) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
In order to assess the role of the Scribble polarity module, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). J Cell Sci (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; mouse; fig 5
In order to optimize a scaffold needed to generate an artificial salivary gland, Invitrogen occludin antibody (Life Technologies, 33-1500) was used in immunocytochemistry on mouse samples (fig 5). Biomaterials (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat
In order to evaluate protocols for the isolation and culture of endothelial cells from rate brain and spinal cord, Invitrogen occludin antibody (Life Technologies, 33-1500) was used in immunocytochemistry on rat samples . BMC Neurosci (2013) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 4
In order to investigate how TLR signaling in the choroid plexus contributes to systemic inflammation, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4). Transl Stroke Res (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 2.5 ug/ml; fig 5
  • western blot; human; 2 ug/ml; fig 5
In order to study the mechanisms underlying cell-cell contact-mediated HCV transfer and infection, Invitrogen occludin antibody (Zymed/Invitrogen, 33-1500) was used in immunocytochemistry on human samples at 2.5 ug/ml (fig 5) and in western blot on human samples at 2 ug/ml (fig 5). J Virol (2013) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; human; 1:200
In order to identify the functional tight junction barrier in human epidermis, Invitrogen occludin antibody (Invitrogen, 40-4700) was used in immunohistochemistry - frozen section on human samples at 1:200. J Dermatol Sci (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to elucidate the anti-viral effect of amiodarone on HCV life cycle, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 2). Clin Sci (Lond) (2013) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000
  • immunocytochemistry; rat; 1:100
In order to evaluate an in vitro model of blood brain barrier, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples at 1:1000 and in immunocytochemistry on rat samples at 1:100. PLoS ONE (2013) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; 1:100
In order to identify the mechanism for the vascular permeability syndrome and respiratory distress in severe dengue, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on dog samples at 1:100. J Virol (2013) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:75; fig 2
In order to determine the level of tight junction proteins and blood-testes barrier permeability in Sox8(-/-) adult testes, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on mouse samples at 1:75 (fig 2). Biol Reprod (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; sheep; 1:5000; fig 2
In order to examine the photoperiodically different concentration of polychlorinated biphenyls in the cerebrospinal fluid in sheep, Invitrogen occludin antibody (Invitrogen, OC-3 F10) was used in western blot on sheep samples at 1:5000 (fig 2). Neurotoxicol Teratol (2013) ncbi
rabbit polyclonal
  • western blot; rat; 1:250
In order to report that Rai14 regulates actin filaments organization in Sertoli cells during the epithelial cycle, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:250. PLoS ONE (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 4
In order to investigate the role of occludin in hepatitis C virus cell entry, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in western blot on human samples (fig 4). PLoS Pathog (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human
In order to demonstrate the effect of HIV-1 Tat C on miRNA-101 expression in human brain microvascular endothelial cells, Invitrogen occludin antibody (Invitrogen, 33-1520) was used in western blot on human samples . J Neurosci (2013) ncbi
rabbit polyclonal
  • western blot; human; 1:500; fig 3
In order to discuss the role of WDR66 in esophageal squamous cell carcinoma, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on human samples at 1:500 (fig 3). BMC Cancer (2013) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; fig s3
In order to show that epithelial-derived breast cancer cells use signaling molecules that normally facilitate cellular migration and invasion of mesenchymal cells, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples at 1:1000 (fig s3). J Cell Sci (2013) ncbi
rabbit polyclonal
  • western blot; human; fig 3
In order to identify the mechanisms responsible for the disruption of the blood brain barrier after exposure to advanced glycation end-products, Invitrogen occludin antibody (Zymed, 71-1500) was used in western blot on human samples (fig 3). Neurobiol Aging (2013) ncbi
rabbit polyclonal
  • immunohistochemistry; rat; fig 4
In order to test if the stable permeability state of individually perfused microvessels is characteristic of flow conditioning, Invitrogen occludin antibody (Zymed Laboratories, 71-1500) was used in immunohistochemistry on rat samples (fig 4). Am J Physiol Heart Circ Physiol (2013) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; fig 8
In order to test the efficacy of internal and external biliary drainage during experimental biliary obstruction, Invitrogen occludin antibody (Invitrogen, 40-4700) was used in immunohistochemistry - paraffin section on rat samples (fig 8). Scand J Gastroenterol (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 8a
In order to assess in vitro the effects of several S. Typhi strains and the licensed Ty21a typhoid vaccine on intestinal barrier function and immune response, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on human samples (fig 8a). Front Immunol (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 2
  • western blot; human; 1:3000; fig 2
In order to examine the contribution of various tight junction proteins in keratinocytes, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples at 1:3000 (fig 2). J Invest Dermatol (2013) ncbi
rabbit polyclonal
  • western blot; rat; 1:500; fig 2
In order to develop an organotypic brain slice culture as a model to study the role of the neurovascular unit in epilepsy and other neurological disorders, Invitrogen occludin antibody (Life Technologies, 71-1500) was used in western blot on rat samples at 1:500 (fig 2). Fluids Barriers CNS (2013) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:80; fig 3
  • western blot; human; 1:2000; fig 5
In order to observe changes in tight junction proteins in various epithelial tumors, Invitrogen occludin antibody (Zymed, OC-3F1071-1500) was used in immunocytochemistry on human samples at 1:80 (fig 3) and in western blot on human samples at 1:2000 (fig 5). PLoS ONE (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; loading ...; fig s2
In order to study regulatory mechanisms that modulate Snail and claudin-1 via a PKCalpha during the epithelial-mesenchymal transition of pancreatic cancer cells, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig s2). Carcinogenesis (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1, 2
In order to study the roles of MAPK-related kinase and MKNK-1 in HCV replication and cellular entry, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in western blot on human samples (fig 1, 2). J Virol (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; fig 3
In order to examine innate responses to Entamoeba histolytica in wild-type and MUC-2-deficient mice, Invitrogen occludin antibody (Invitrogen, 331500) was used in immunohistochemistry - frozen section on mouse samples (fig 3). Am J Pathol (2013) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig S4
In order to identify elements of intestinal polarity regulated by Rab25, Invitrogen occludin antibody (Zymed, 71-1500) was used in western blot on human samples at 1:1000 (fig S4). Mol Biol Cell (2013) ncbi
rabbit polyclonal
  • western blot; rat; 1:200
In order to examine the effects of TNFalpha on Sertoli cell barrier function, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:200. Spermatogenesis (2012) ncbi
rabbit polyclonal
  • western blot; human; 2 ug/ml; fig 6
In order to study changes in the blood retinal barrier in diabetic macular edema, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on human samples at 2 ug/ml (fig 6). Peptides (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:100; fig 4
In order to elucidate role of bile acids in fat-induced barrier dysfunction, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry on mouse samples at 1:100 (fig 4). Am J Physiol Gastrointest Liver Physiol (2013) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 4
In order to show that miR-199a-5p regulates intercellular junctions in the bladder, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 4). Am J Pathol (2013) ncbi
rabbit polyclonal
  • western blot; rat; 1:250
In order to assess the role of intercellular adhesion molecule-2 in the testis, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:250. J Endocrinol (2013) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000
In order to elucidate the protective effect and mechanism of Lycium barbarum polysaccharides in acute ocular hypertension, Invitrogen occludin antibody (Invitrogen, 40-4700) was used in western blot on mouse samples at 1:1000. PLoS ONE (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 1
In order to investigate the assembly and disassembly of tricellular in tight junctions by altering the calcium concentration, Invitrogen occludin antibody (Zymed Laboratories, OC-3F10) was used in immunocytochemistry on human samples (fig 1). Cell Tissue Res (2013) ncbi
rabbit polyclonal
  • western blot; human; fig 4
In order to use a novel cell-based model system to study phenotypic plasticity in triple-negative breast cancer, Invitrogen occludin antibody (Invitrogen, 40-4700) was used in western blot on human samples (fig 4). PLoS ONE (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:250; fig 7
  • western blot; human; 1:2000; fig 7
In order to study permeability and tight junctions in endothelial cells derived from human cord blood, Invitrogen occludin antibody (Invitrogen, clone OC-3F10) was used in immunocytochemistry on human samples at 1:250 (fig 7) and in western blot on human samples at 1:2000 (fig 7). Am J Physiol Heart Circ Physiol (2012) ncbi
rabbit polyclonal
  • immunohistochemistry; human; 1:50; fig 2
In order to determine the expression pattern of selected components involved in the formation of tight junctions in relation to gastroesophageal reflux disease, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry on human samples at 1:50 (fig 2). BMC Gastroenterol (2012) ncbi
rabbit polyclonal
  • immunohistochemistry - free floating section; rat; fig 1
In order to examine the effect of cholestasis to the localization of occludin in brain capillary endothelium, Invitrogen occludin antibody (Zymed, 711500) was used in immunohistochemistry - free floating section on rat samples (fig 1). Neurosci Lett (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 1
In order to develop a solid model of polarized epithelium for human pancreatic ducts to study ion transport, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples (fig 1). Pancreas (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 5
In order to characterize salivary gland epithelial cells cultured on poly(lactic-co-glycolic acid) nanofiber scaffolds, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples (fig 5). Biomaterials (2012) ncbi
mouse monoclonal (OC-3F10)
In order to evaluate the isolation and culture of adult salivary gland-derived stem/progenitor cells, Invitrogen occludin antibody (Invitrogen, 33-1500) was used . J Tissue Eng Regen Med (2014) ncbi
rabbit polyclonal
  • western blot; human; 1:170
In order to study the role of caspases in cytokine-induced barrier breakdown during neuroinflammation, Invitrogen occludin antibody (Zymed, 40-4700) was used in western blot on human samples at 1:170. J Immunol (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to test if drugs used in highly active antiretroviral therapy increase susceptibility to HCV infection, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 2). Antiviral Res (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; 1:500; fig 2
In order to assess the role of neuroinflammation in mediating the effects of chronic stress exposure and/or methamphetamine on blood brain barrier structure and function, Invitrogen occludin antibody (Invitrogen, 331500) was used in western blot on rat samples at 1:500 (fig 2). J Neuroimmune Pharmacol (2012) ncbi
rabbit polyclonal
  • western blot; human; fig 2
In order to test if GLP-2 regulates tight junctions, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on human samples (fig 2). Regul Pept (2012) ncbi
rabbit polyclonal
  • western blot; mouse; fig 7
In order to study the function of dysferlin and myoferlin in airway epithelial homeostasis, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples (fig 7). PLoS ONE (2012) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; fig 4
In order to determine the contribution of neutrophils to central nervous system vascular permeability, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on mouse samples (fig 4). J Immunol (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:250; fig 3
In order to study the role of COX-2 in the upregulation of CNS laminin in a murine model of ischemic injury, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunohistochemistry on mouse samples at 1:250 (fig 3). J Neuroinflammation (2012) ncbi
rabbit polyclonal
  • western blot; rat; 1:500; fig 4
In order to use Phoneutria nigriventer spider venom to study the blood brain barrier, Invitrogen occludin antibody (Zymed, 711500) was used in western blot on rat samples at 1:500 (fig 4). Neurochem Res (2012) ncbi
rabbit polyclonal
  • western blot; rat; 1:250
In order to examine the role of actin and tubulin in ectoplasmic specialization, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:250. Spermatogenesis (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human
In order to report the consequences of modulating PP2A phosphatase activity in human mammary epithelial cells, Invitrogen occludin antibody (Zymed Laboratories, OC-3F10) was used in western blot on human samples . PLoS Genet (2012) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 2
In order to develop and characterize a model for Hailey-Hailey disease using normal keratinocytes, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 2). Exp Dermatol (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:250; fig 4a
In order to study the role of mucins in apical endocytic trafficking using RNAi-mediated knockdown of core 1 beta-1,3-galactosyltransferase in human corneal keratinocytes, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in western blot on human samples at 1:250 (fig 4a). PLoS ONE (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; rat; 1:50; fig 4a
In order to assess the effects of opioids on tight junction proteins, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunohistochemistry - paraffin section on rat samples at 1:50 (fig 4a). Anesthesiology (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1
In order to assess the effect of 9-cis-retinoic acid and all-trans retinoic acid on the formation and degradation of gap junctions and junctional communication in cancer cells, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 1). PLoS ONE (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; rat; fig 6
In order to study the junctional complexes of liver sinusoidal endothelial cells, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry on rat samples (fig 6). PLoS ONE (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; rabbit; 1:200; fig 2
In order to test if simvastatin blocks disruption of the blood brain barrier induced by cholesterol in vivo and in vitro, Invitrogen occludin antibody (Zymed, clone OC-3F10) was used in immunohistochemistry - frozen section on rabbit samples at 1:200 (fig 2). Int J Alzheimers Dis (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 3
In order to study non-small cell lung carcinoma cell lines treated with cisplatin, doxorubicin, and gemcitabine, Invitrogen occludin antibody (Invitrogen, clone OC-3F10) was used in western blot on human samples (fig 3). Cancer Lett (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; rabbit; 1:200; fig 4
In order to characterize infant rabbits infected with Vibrio parahaemolyticus, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry - paraffin section on rabbit samples at 1:200 (fig 4). PLoS Pathog (2012) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to characterize two new alleles of Pax2, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Dev Biol (2012) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; human; 1:200; fig 3
  • western blot; human; 1:1000; fig 2
In order to assess the role of tight junctions and gap proteins in cervical remodeling, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 3) and in western blot on human samples at 1:1000 (fig 2). J Transl Med (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dog; fig 1
  • western blot; dog; fig 2, 4
In order to examine the effect of treating epithelial cells with an inhibitor of the lipid kinase PIKfyve, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on dog samples (fig 1) and in western blot on dog samples (fig 2, 4). PLoS ONE (2012) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; fig 1
  • western blot; dog; fig 2, 4
In order to examine the effect of treating epithelial cells with an inhibitor of the lipid kinase PIKfyve, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on dog samples (fig 1) and in western blot on dog samples (fig 2, 4). PLoS ONE (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:100; fig 1
In order to examine the expression of tricellulin in normal human pancreas, and in primary exocrine and endocrine pancreatic tumors, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunohistochemistry on human samples at 1:100 (fig 1). Histopathology (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 2
In order to describe an in vitro model of the gastric barrier using moderately differentiated adenocarcinoma stomach cells, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on human samples (fig 2). Food Funct (2012) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 2.5 ug/ml; fig 2
In order to elucidate the role of CDH1 in the mouse uterus, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry on mouse samples at 2.5 ug/ml (fig 2). Biol Reprod (2012) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; human; 1:50; fig 1
In order to study epidermal tight junction-related structures in humans and in mice, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 1). PLoS ONE (2012) ncbi
rabbit polyclonal
  • western blot; dog; fig 1
In order to analyze the role of paracingulin domains, Invitrogen occludin antibody (BioSource International, 71-1500) was used in western blot on dog samples (fig 1). J Biol Chem (2012) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 2
In order to report that hepatocyte-like cells derived from iPSCs support the entire life cycle of hepatitis C virus, Invitrogen occludin antibody (Invitrogen, 40-4700) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 2). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1
In order to assess the changes in claudins function via PKCalpha activation in pancreatic cancer cells, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 1). Cell Tissue Res (2011) ncbi
rabbit polyclonal
  • western blot; mouse; fig 3
In order to report that commensal colonization induces intestinal barrier function maturation by promoting claudin 3 expression, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on mouse samples (fig 3). Am J Pathol (2012) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; loading ...; fig s1a
In order to investigate the effect of ouabain on cilia development in epithelial cells, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on dog samples (fig s1a). Proc Natl Acad Sci U S A (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; 2.5 ug/ml; fig 3
In order to establish and characterize a three-dimensional organotypic model of the human airway mucosa, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunohistochemistry - frozen section on human samples at 2.5 ug/ml (fig 3). Am J Physiol Lung Cell Mol Physiol (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to report that Honokiol inhibits hepatitis C virus infection in vitro, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 2). Liver Int (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; rat; 1:200; fig 1
  • western blot; rat; 1:1000; fig 6
In order to determine the effects of ischemia-reperfusion injury on expression and distribution of the tight junction proteins in rat kidney, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 1) and in western blot on rat samples at 1:1000 (fig 6). Histochem Cell Biol (2011) ncbi
rabbit polyclonal
  • western blot; mouse; 1:100; fig 2
In order to assess the effect of NOX2 derived from immune cells in the brain and in blood cells in experimental stroke, Invitrogen occludin antibody (Zymed, 71-1500) was used in western blot on mouse samples at 1:100 (fig 2). Ann Neurol (2011) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; tbl 1
In order to assess the effects of stabilizing the blood brain barrier function by therapeutic targeting tight junction proteins for experimental autoimmune encephalomyelitis, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunohistochemistry - frozen section on mouse samples (tbl 1). Acta Neuropathol (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; fig 6
In order to investigate the contribution of the alpha7 nicotinic acetylcholine receptor to bacterial meningitis, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on mouse samples (fig 6). PLoS ONE (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; mouse; fig 5
In order to show that adenosine receptor signaling modulates blood brain barrier permeability in vivo, Invitrogen occludin antibody (Invitrogen, 3F10) was used in immunocytochemistry on mouse samples (fig 5). J Neurosci (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; fig 9
In order to determine the effects of FXYD5 on the paracellular permeability using a mouse kidney collecting duct cell line, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on mouse samples (fig 9). Am J Physiol Renal Physiol (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to examine the effect of the accessory HIV-1 Nef protein on a human epithelial cell line, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 2). PLoS ONE (2011) ncbi
rabbit polyclonal
  • immunohistochemistry; rat; 10 ug/ml; fig 2
  • western blot; rat; 2.5 ug/ml; fig 4
In order to report that HGF reduces the amount of actin present in the BTB region, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunohistochemistry on rat samples at 10 ug/ml (fig 2) and in western blot on rat samples at 2.5 ug/ml (fig 4). Mol Cell Endocrinol (2012) ncbi
rabbit polyclonal
  • immunohistochemistry; rat; fig 7
In order to characterize P-glycoprotein and endothelial barrier antigen in the rat brain, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry on rat samples (fig 7). J Cereb Blood Flow Metab (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; fig 9a
In order to determine the mechanisms by which Gardia intestinalis induces host intestinal epithelium alterations, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig 9a). Cell Microbiol (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; fig 2
  • western blot; human; 1:1000; fig 1
In order to elucidate the role and regulation of marvelD3 in normal epithelial cells and cancer cells, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig 2) and in western blot on human samples at 1:1000 (fig 1). Exp Cell Res (2011) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; 1:25; fig 1
  • western blot; human; 1:1000; fig 4
In order to demonstrate that ESCRT proteins are required to maintain polarity in mammalian epithelial cells, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on dog samples at 1:25 (fig 1) and in western blot on human samples at 1:1000 (fig 4). Mol Biol Cell (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:1000; fig 4
  • immunocytochemistry; dog; 1:25; fig 1
In order to demonstrate that ESCRT proteins are required to maintain polarity in mammalian epithelial cells, Invitrogen occludin antibody (Zymed, 33-1500) was used in western blot on human samples at 1:1000 (fig 4) and in immunocytochemistry on dog samples at 1:25 (fig 1). Mol Biol Cell (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 4
In order to investigate neoplastic transformation of telomerase in immortalized human fibroblasts, Invitrogen occludin antibody (Zymed, 33-1500) was used in western blot on human samples (fig 4). Int J Oncol (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 6
In order to characterize distinct, flat and island-forming Caco-2 cells, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on human samples (fig 6). J Pharm Sci (2011) ncbi
rabbit polyclonal
  • immunohistochemistry; rat; 1:200; fig 2
In order to study microglia/macrophages trafficking and the role of protein kinase Czeta in diabetic retinopathy, Invitrogen occludin antibody (Zymed, 71?C1500) was used in immunohistochemistry on rat samples at 1:200 (fig 2). Am J Pathol (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to investigate how the differences between human and murine occludin contribute to hepatitis C virus spread, Invitrogen occludin antibody (Zymed/Invitrogen, clone OC-3F10) was used in western blot on human samples (fig 2). J Virol (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; fig 3
In order to determine the role of hypoxia-inducible factor-1 in high glucose-induced endothelial permeability of the blood brain barrier, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on mouse samples (fig 3). Cell Mol Life Sci (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; sheep; 1:5000; fig 1
In order to compare the tight junction proteins in the choroid plexus of ewes exposed to short or long days, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in western blot on sheep samples at 1:5000 (fig 1). Brain Res (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to study the role of adhesion mlecules and proteases in the penetration/invasion of ovarian tumor cells into extracellular matrices, Invitrogen occludin antibody (NeoMarkers, clone OC-3F10) was used in western blot on human samples (fig 2). PLoS ONE (2011) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:200; fig 7
In order to study the role of filaggrin mutations to epidermal permeability barrier dysfunction, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 7). Am J Pathol (2011) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to examine the relationship between invasion of ulcerative colitis-associated carcinoma and its prognosis, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Diagn Pathol (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; pig; fig 1
In order to use a guinea pig exchange transfusion model to study the effects of cell-free hemoglobin, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in western blot on pig samples (fig 1). Am J Pathol (2011) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; fig 4
In order to discuss the mechanisms by which the blood brain barrier and the blood-cerebrospinal fluid barrier are dysregulated during inflammation, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunohistochemistry on mouse samples (fig 4). Antioxid Redox Signal (2011) ncbi
rabbit polyclonal
  • immunoprecipitation; mouse; fig 4
  • immunocytochemistry; mouse; fig 4
  • western blot; mouse; fig 4
In order to describe methods to study the protein components in the blood-labyrinth barrier of the ear, Invitrogen occludin antibody (Invitrogen, 40-4700) was used in immunoprecipitation on mouse samples (fig 4), in immunocytochemistry on mouse samples (fig 4) and in western blot on mouse samples (fig 4). PLoS ONE (2011) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:200; fig s2
In order to investigate the role of Cdc42 in polarization of epithelial cells, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on human samples at 1:200 (fig s2). J Biol Chem (2011) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:500; fig 3
In order to test if the epithelial-mesenchymal transition impacts airway remodeling in asthma, Invitrogen occludin antibody (Zymed/Invitrogen, 71-1500) was used in immunohistochemistry on mouse samples at 1:500 (fig 3). PLoS ONE (2011) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; rat; 1:100; tbl 1
  • western blot; rat; 1:250; tbl 1
In order to elucidate how c-Yes regulates the blood-testis barrier and apical ectoplasmic specialization integrity, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunohistochemistry - frozen section on rat samples at 1:100 (tbl 1) and in western blot on rat samples at 1:250 (tbl 1). Int J Biochem Cell Biol (2011) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; 1:50; fig 2
In order to investigate the impact of Wnt signaling on nephrogenesis, Invitrogen occludin antibody (Invitrogen, 711500) was used in immunocytochemistry on mouse samples at 1:50 (fig 2). Dev Biol (2011) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 2
In order to assess the effects of ethanol or ice on transepithelial resistance and microparticle uptake using Caco-2 cells, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on human samples (fig 2). Int J Pharm (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; fig 4
  • western blot; mouse; fig 4
In order to study the role of CD44 in tight-junction assembly and barrier function, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunohistochemistry on mouse samples (fig 4) and in western blot on mouse samples (fig 4). J Invest Dermatol (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 2.5 ug/ml; loading ...; fig 5a
  • western blot; human; loading ...; fig 6a
In order to discuss the role of tight junctions to the development of atopic dermatitis, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 2.5 ug/ml (fig 5a) and in western blot on human samples (fig 6a). J Allergy Clin Immunol (2011) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 10 ug/ml; tbl 1
In order to characterize an invitro human outer blood-retinal barrier model, Invitrogen occludin antibody (Zymed, ZMD.467) was used in immunocytochemistry on human samples at 10 ug/ml (tbl 1). Methods Mol Biol (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 1
In order to determine the regulation of JAM-A expression in brain endothelial cells and evaluate sJAM-A as a biomarker of blood-brain barrier function, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig 1). PLoS ONE (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig s2
  • western blot; human; fig 2
In order to elucidate the role of PDZK1 in scavenger receptor class B type I-mediate hepatitis C virus entry, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig s2) and in western blot on human samples (fig 2). PLoS Pathog (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; fig 1a
In order to investigate the regulation of the Cx43 assembly by E-cadherin and N-cadherin, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on rat samples (fig 1a). Mol Biol Cell (2010) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1 ng/ul; fig 2
In order to study transepithelial resistance and microparticle uptake using epithelial and macrophage co-cultures, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunocytochemistry on human samples at 1 ng/ul (fig 2). J Anat (2010) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 3
  • immunohistochemistry; human; fig 5
  • western blot; human; fig 3
In order to elucidate the contribution of occludin to human breast cancer, Invitrogen occludin antibody (Zymed, 71:1,500) was used in immunocytochemistry on human samples (fig 3), in immunohistochemistry on human samples (fig 5) and in western blot on human samples (fig 3). Int J Mol Med (2010) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:80; fig 2
  • western blot; human; fig 4
In order to investigate occludin-mediated hepatitis C virus entry, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on human samples at 1:80 (fig 2) and in western blot on human samples (fig 4). Virology (2010) ncbi
rabbit polyclonal
  • immunocytochemistry; rat; 1:50; tbl 1
  • western blot; rat; 1:400; tbl 1
In order to test if the function of the blood-testis barrier in affected by adjudin, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on rat samples at 1:50 (tbl 1) and in western blot on rat samples at 1:400 (tbl 1). Int J Biochem Cell Biol (2010) ncbi
rabbit polyclonal
  • immunoprecipitation; rat; 1:40; tbl 1
  • immunocytochemistry; rat; 1:50; tbl 1
  • western blot; rat; 1:250; tbl 1
In order to study protein trafficking in Sertoli cells, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunoprecipitation on rat samples at 1:40 (tbl 1), in immunocytochemistry on rat samples at 1:50 (tbl 1) and in western blot on rat samples at 1:250 (tbl 1). Exp Cell Res (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:50; tbl 1
  • western blot; rat; 1:250; tbl 1
In order to study protein trafficking in Sertoli cells, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunocytochemistry on rat samples at 1:50 (tbl 1) and in western blot on rat samples at 1:250 (tbl 1). Exp Cell Res (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 2
In order to investigate the regulatory mechanisms of the PAR complex, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig 2). Curr Biol (2010) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1
In order to test if cells originating from the brain or central nervous system are permissive for HCV cell entry, RNA replication, and virus assembly, Invitrogen occludin antibody (Zymed, clone OC-3F10) was used in western blot on human samples (fig 1). J Viral Hepat (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; loading ...; fig 3a
In order to examine the expression of tight junction proteins in normal human pancreatic duct epithelial cells, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig 3a). Am J Pathol (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dog; 1:50; fig 2
In order to investigate the role of CRTAM in epithelial cell adhesion, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on dog samples at 1:50 (fig 2). J Cell Biochem (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; fig 2
  • western blot; human; 1:1000; fig 2
In order to test if the c-Jun N-terminal kinase pathway regulates tricellulin, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig 2) and in western blot on human samples at 1:1000 (fig 2). J Cell Physiol (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; rat; 1:200; fig 5
In order to use rats to test if changes in gut epithelial function and microbiota are diet- or obesity-associated, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry on rat samples at 1:200 (fig 5). Am J Physiol Gastrointest Liver Physiol (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; loading ...; fig 2a
  • western blot; human; loading ...; fig 3a
In order to report that MMP-8 activity contributes to disassembly of cell junction components and cell adhesion during meningococcal infection, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig 2a) and in western blot on human samples (fig 3a). PLoS Pathog (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 2
In order to determine the localization of TGFbeta receptors and ligand secretion in polarizing colonic cells, Invitrogen occludin antibody (Zymed, 33-1,500) was used in immunocytochemistry on human samples (fig 2). J Cell Physiol (2010) ncbi
rabbit polyclonal
  • western blot; human; fig 1
In order to perform a proteomic study of Snail1-regulated events during epithelial-to-mesenchymal transition, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on human samples (fig 1). PLoS ONE (2010) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 2
In order to use mice to study the impact of mMCP-1 in intestinal barrier disruption and egg excretion, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2). Parasite Immunol (2010) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:50; fig 7
In order to study barrier integrity and tight junction protein expression using in vitro lung epithelial barrier model, Invitrogen occludin antibody (Invitrogen, Z-T22) was used in immunocytochemistry on human samples at 1:50 (fig 7). Immunobiology (2011) ncbi
rabbit polyclonal
  • immunohistochemistry; rat; 2.5 ug/ml; fig 2
In order to examine the role of gonadotropins in the maintenance of Sertoli cell tight junctions, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunohistochemistry on rat samples at 2.5 ug/ml (fig 2). Endocrinology (2010) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 8
In order to generate and characterize 2 human epidermis-derived cell lines, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunocytochemistry on human samples (fig 8). Biol Reprod (2010) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 9
In order to elucidate the role of cystic fibrosis transmembrane conductance regulator in epithelial tightness, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on human samples at 1:1000 (fig 9). J Physiol (2010) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:500; fig 3
In order to discuss the impact of corticosteroid treatment on hepatitis C virus recurrence after liver transplantation, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples at 1:500 (fig 3). Gastroenterology (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 1
In order to show that the entire hepatitis C virus life cycle is recapitulated in micropatterned cocultures of primary human hepatocytes, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on human samples at 1:200 (fig 1). Proc Natl Acad Sci U S A (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; cat; 1:50; fig 2c
  • immunohistochemistry; human; 1:50; fig 2a
In order to investigate if the expression pattern of tight junction proteins in mice, rabbits, and cats resemble those of humans, Invitrogen occludin antibody (Invitrogen, 33-1500) was used in immunohistochemistry on cat samples at 1:50 (fig 2c) and in immunohistochemistry on human samples at 1:50 (fig 2a). Biotech Histochem (2011) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:50; fig 2d
In order to investigate if the expression pattern of tight junction proteins in mice, rabbits, and cats resemble those of humans, Invitrogen occludin antibody (Invitrogen, 711500) was used in immunohistochemistry on mouse samples at 1:50 (fig 2d). Biotech Histochem (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1c
In order to investigate the effect of E-cadherin on gap junction formation in cancer cells, Invitrogen occludin antibody (Zymed Laboratories Inc, OC-3F10) was used in western blot on human samples (fig 1c). J Biol Chem (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:100; fig 2
In order to determine the expression and localization of tricellulin, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunohistochemistry on human samples at 1:100 (fig 2). Med Mol Morphol (2009) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; fig 2
  • western blot; mouse; 1:250-1:500; fig 1
In order to examine the effect of prolonged hypoxia on blood-brain barrier integrity in vivo, Invitrogen occludin antibody (Zymed, 71-1500) was used in immunohistochemistry on mouse samples at 1:100 (fig 2) and in western blot on mouse samples at 1:250-1:500 (fig 1). J Cereb Blood Flow Metab (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:25; fig 3
  • western blot; human; 1:1000; fig 3
In order to examine the role of Fhit during tumor cell invasion, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:25 (fig 3) and in western blot on human samples at 1:1000 (fig 3). Oncogene (2010) ncbi
rabbit polyclonal
  • western blot; rat; fig 4
In order to examine the inflammatory and molecular changes that occur within the bladder uroepithelium using a spinal contusion injury model, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in western blot on rat samples (fig 4). J Neurotrauma (2010) ncbi
mouse monoclonal (OC-3F10)
  • western blot; sheep; 1:5000; fig 3a
In order to measure the expression of tight junction proteins in the cerebral cortex, cerebellum, and spinal cord of fetuses after maternal treatment with dexamethasone, Invitrogen occludin antibody (Zymed, 33-1500) was used in western blot on sheep samples at 1:5000 (fig 3a). Am J Physiol Heart Circ Physiol (2010) ncbi
rabbit polyclonal
  • immunoprecipitation; mouse
  • immunocytochemistry; mouse
In order to test if increasing ascorbate protects the endothelial barrier from septic insult by inhibiting protein phosphatase type 2A, Invitrogen occludin antibody (Invitrogen, 71-1500) was used in immunoprecipitation on mouse samples and in immunocytochemistry on mouse samples . Free Radic Biol Med (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 5h
  • western blot; human; fig 4a
In order to clarify the role of epithelial-derived thymic stromal lymphopoietin in allergic rhinitis, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig 5h) and in western blot on human samples (fig 4a). Cell Tissue Res (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; 1:50; fig 1
In order to observe the barrier function of cultivated limbal and oral mucosal epithelial sheets, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 1). Invest Ophthalmol Vis Sci (2009) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 5
In order to measure tyrosine-phosphorylated proteins abundance in T cell, B cells, and nonlymphoid cells, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 5). Proteomics (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; rat; 2 ug/ml
  • western blot; rat; 2.5 ug/ml
In order to examine the cellular distributions of tight junction components during early pregnancy and under various hormonal regimens, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunohistochemistry - frozen section on rat samples at 2 ug/ml and in western blot on rat samples at 2.5 ug/ml. Acta Histochem (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; rat; 1:5; fig 4
  • western blot; rat; 1:300; fig 7
In order to test if di(2-ethylhexyl) phthalate alters the expression of testicular gap and tight junction proteins, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunohistochemistry - frozen section on rat samples at 1:5 (fig 4) and in western blot on rat samples at 1:300 (fig 7). Microsc Res Tech (2009) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; 1:1000
In order to test if pre-treatment with nitric oxide before ischemia and reperfusion injury affects cell junction proteins and vascular endothelial growth factor, Invitrogen occludin antibody (Zymed, 33-1500) was used in western blot on rat samples at 1:1000. J Surg Res (2009) ncbi
mouse monoclonal (OC-3F10)
  • western blot; cow; fig 3
In order to report a novel mechanism of VEGF-induced occludin phosphorylation and ubiquitination that contributes to tight junction trafficking, Invitrogen occludin antibody (Zymed, 33-1500) was used in western blot on cow samples (fig 3). J Biol Chem (2009) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; fig 3
In order to test the effect of hypoxia and reoxygenation on oligomeric assemblies of occludin, Invitrogen occludin antibody (Zymed, 33-1500) was used in western blot on rat samples (fig 3). J Neurochem (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; 1:100; fig 1
In order to study the expression of adherens junction and tight junction components in human peripheral nerve endoneurium, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 1). J Histochem Cytochem (2009) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; 1:500
In order to assess the effects of dietary glutamine or oral antibiotics on the gut barrier function in a rat model of short bowel syndrome, Invitrogen occludin antibody (Zymed, 33-1500) was used in western blot on rat samples at 1:500. Am J Physiol Gastrointest Liver Physiol (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:100; tbl 3
In order to study the role of claudin-2 in bile canalicular formation, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on rat samples at 1:100 (tbl 3). Histochem Cell Biol (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:50; loading ...; fig 4
  • western blot; human; loading ...; fig 2a
In order to test if patulin alters the barrier function of intestinal cells, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:50 (fig 4) and in western blot on human samples (fig 2a). Toxicol In Vitro (2009) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to elucidate how the keratin intermediate filament network is involved in the establishment and maintenance of cell polarity, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in western blot on human samples (fig 2). J Cell Biol (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dog; 1:250; loading ...; fig 4b
In order to develop a canine duodenal epithelial cell culture model to study Neospora caninum infection, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on dog samples at 1:250 (fig 4b). J Parasitol (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 3b
In order to study tight junction proteins in ECV304 cells, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on human samples (fig 3b). Neurosci Lett (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; fig 6
  • western blot; mouse; 1:1000; fig 6
In order to study the effect of caffeine on the blood brain barrier, Invitrogen occludin antibody (Zymed, clone OC-3F10) was used in immunohistochemistry - frozen section on mouse samples (fig 6) and in western blot on mouse samples at 1:1000 (fig 6). J Neurochem (2008) ncbi
rabbit polyclonal
In order to suggest that aPKC regulates tight junction formation through the phosphorylation of claudin-4, Invitrogen occludin antibody (Zymed, 71-1500) was used . Exp Cell Res (2008) ncbi
rabbit polyclonal
In order to test if altered expression of intestinal epithelial tight junction proteins contributes to neoplastic progression, Invitrogen occludin antibody (Invitrogen, 71-1500) was used . Lab Invest (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200
In order to use mass spectroscopy to identify proteins that contribute to adhesion of human embryonic stem cells, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples at 1:200. Stem Cells (2008) ncbi
rabbit polyclonal
In order to test the effect of lambda-carrageenan-induced peripheral inflammatory pain on occludin, Invitrogen occludin antibody (Zymed, 71-1500) was used . J Neurochem (2008) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; fig 6
In order to test the effect of lambda-carrageenan-induced peripheral inflammatory pain on occludin, Invitrogen occludin antibody (Zymed, 33-1500) was used in western blot on rat samples (fig 6). J Neurochem (2008) ncbi
rabbit polyclonal
In order to examine the architecture of cellular junctions present in blood and lymphatic vessel endothelium in peripheral lymph nodes, Invitrogen occludin antibody (Zymed, 71-1500) was used . Eur J Immunol (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2a
In order to study translocation of HIV across the vaginal pluristratified epithelium, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunohistochemistry - paraffin section on human samples (fig 2a). AIDS (2008) ncbi
rabbit polyclonal
In order to investigate the role of beta1-integrin in hemidesmosome, Invitrogen occludin antibody (Zymed, 71-1500) was used . Proc Natl Acad Sci U S A (2008) ncbi
rabbit polyclonal
In order to determine the composition of the apical junctional complex present in lens epithelial cells, Invitrogen occludin antibody (Zymed, 71-1500) was used . Exp Eye Res (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:100
In order to characterize two cell lines to study the blood-brain barrier, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on rat samples at 1:100. J Pharm Sci (2008) ncbi
rabbit polyclonal
In order to elucidate the roles of Dmrt1 in testicular development, Invitrogen occludin antibody (Zymed, 71-1500) was used . Sex Dev (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; rabbit; fig 5
  • western blot; rabbit; fig 4
In order to use rabbits to test if chronic ingestion of caffeine protects against high cholesterol diet-induced disruptions of the blood brain barrier, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunohistochemistry - frozen section on rabbit samples (fig 5) and in western blot on rabbit samples (fig 4). J Neuroinflammation (2008) ncbi
rabbit polyclonal
In order to discover differences between occludin and ZO-1 expression in normal liver samples, HCCs, and colorectal liver metastases, Invitrogen occludin antibody (Zymed, 71-1500) was used . Pathol Oncol Res (2008) ncbi
rabbit polyclonal
In order to develop an ex vivo mouse lung vibratome slice model for confocal live cell imaging of neuroepithelial bodies and surrounding epithelial cells, Invitrogen occludin antibody (Zymed, 71-1500) was used . Am J Respir Cell Mol Biol (2008) ncbi
rabbit polyclonal
In order to study the effect of hepatocyte growth factor on Sertoli cell tight junctions, Invitrogen occludin antibody (Zymed, 71-1500) was used . J Cell Physiol (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1d
In order to study M cells in the epithelial barrier of the human adenoid, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunohistochemistry - frozen section on mouse samples (fig 1d). J Mol Histol (2008) ncbi
rabbit polyclonal
In order to describe a role for beta-catenin in kidney development, Invitrogen occludin antibody (zymed, 71-1500) was used . Dev Biol (2008) ncbi
rabbit polyclonal
In order to study the effects of cingulin overexpression, Invitrogen occludin antibody (Zymed, 71-1500) was used . Mol Membr Biol (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dog; fig 5
  • western blot; dog; fig 3
In order to study the effects of cingulin overexpression, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on dog samples (fig 5) and in western blot on dog samples (fig 3). Mol Membr Biol (2008) ncbi
rabbit polyclonal
In order to develop and characterize a mesenchymal-epithelial coculture system to identify transcriptional regulators of intestinal epithelial cell differentiation, Invitrogen occludin antibody (Zymed Laboratories (Invitrogen), 71-1500) was used . Am J Physiol Gastrointest Liver Physiol (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; fig 2c
In order to develop and characterize a mesenchymal-epithelial coculture system to identify transcriptional regulators of intestinal epithelial cell differentiation, Invitrogen occludin antibody (Zymed Laboratories, 33-1500) was used in immunocytochemistry on rat samples (fig 2c). Am J Physiol Gastrointest Liver Physiol (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:100; fig 7A
In order to determine whether transforming growth factor-beta down-regulates claudin-1 expression to induce epithelial to mesenchymal transition, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on rat samples at 1:100 (fig 7A). Liver Int (2008) ncbi
rabbit polyclonal
In order to analyze tight junction protein expression during follicular and luteal development in the primate ovary and after inhibition of vascular endothelial growth factor, Invitrogen occludin antibody (Zymed, 71-1500) was used . Mol Hum Reprod (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:100; fig 1
  • western blot; rat; 1:1000; fig 1
In order to test if trafficking of occludin and claudin-5 is essential for forming the tight junction seal between microvascular endothelial cells, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on rat samples at 1:100 (fig 1) and in western blot on rat samples at 1:1000 (fig 1). J Neurochem (2007) ncbi
rabbit polyclonal
In order to test if trafficking of occludin and claudin-5 is essential for forming the tight junction seal between microvascular endothelial cells, Invitrogen occludin antibody (Zymed, 71-1500) was used . J Neurochem (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; loading ...; fig 7c
  • immunocytochemistry; human; loading ...; fig 1d-f
  • western blot; human; loading ...; fig 2b
In order to determine the fate of tight junction proteins in the skin during bacterial colonization and infection, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunohistochemistry - frozen section on human samples (fig 7c), in immunocytochemistry on human samples (fig 1d-f) and in western blot on human samples (fig 2b). J Invest Dermatol (2008) ncbi
rabbit polyclonal
In order to describe the novel junctions between endothelial cells of initial lymphatics, Invitrogen occludin antibody (Zymed Laboratories, 71-1500) was used . J Exp Med (2007) ncbi
rabbit polyclonal
In order to find phospho-p38 MAPK level significantly increases in poorly differentiated gastric cancers compared to differentiated cancers and normal gastric mucosa, Invitrogen occludin antibody (Zymed, 71-1500) was used . Pathol Int (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 4
In order to elucidate the role of Snail in the epithelial to mesenchymal transition, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 4). Mol Endocrinol (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 5
In order to quantify junctional adhesion molecule-A expression in human corneal endothelium and retinal pigment epithelium and examine the impact of a junctional adhesion molecule-A function-blocking antibody on the permeability of cultured retinal pigment ep, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples (fig 5). Invest Ophthalmol Vis Sci (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100
In order to report that capsid contributes to astrovirus infection-induced diarrhea, Invitrogen occludin antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples at 1:100. J Virol (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dog; 1:250; tbl 1
In order to establish and characterize a primary canine duodenal epithelial cell culture, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on dog samples at 1:250 (tbl 1). In Vitro Cell Dev Biol Anim (2007) ncbi
rabbit polyclonal
In order to discuss how menopause affects estrogen regulation of epithelial permeability, Invitrogen occludin antibody (Zymed Laboratory, 71-1500) was used . Menopause (2007) ncbi
rabbit polyclonal
In order to analyze lumbar spinal cord proteins present in naive and experimental autoimmune encephalomyelitis rats, Invitrogen occludin antibody (Zymed, 71-1500) was used . Neuroscience (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; rat; 1:100; fig 6
In order to analyze lumbar spinal cord proteins present in naive and experimental autoimmune encephalomyelitis rats, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunohistochemistry - frozen section on rat samples at 1:100 (fig 6). Neuroscience (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 1
  • western blot; human; 1:500; fig 3
In order to examine occludin expression and localization in Caco-2 cells infected with rhesus monkey rotavirus, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:200 (fig 1) and in western blot on human samples at 1:500 (fig 3). J Virol (2007) ncbi
rabbit polyclonal
In order to ask if urothelial differentiation failure contributes to the aetiopathology of interstitial cystitis, Invitrogen occludin antibody (Zymed, 71-1500) was used . BJU Int (2007) ncbi
rabbit polyclonal
In order to characterize Dlgh1 knockout mice, Invitrogen occludin antibody (Zymed, 71-1500) was used . Development (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dog; 1:100
In order to ascertain the role of ZO-2 in epithelial cells, Invitrogen occludin antibody (Zymed Laboratories, 33-1500) was used in immunocytochemistry on dog samples at 1:100. Exp Cell Res (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 6D
In order to report that the hDlg1-MPP7 complex promotes epithelial cell polarity and tight junction formation, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:200 (fig 6D). Mol Biol Cell (2007) ncbi
rabbit polyclonal
In order to report that the hDlg1-MPP7 complex promotes epithelial cell polarity and tight junction formation, Invitrogen occludin antibody (Zymed, 71-1500) was used . Mol Biol Cell (2007) ncbi
rabbit polyclonal
In order to review structural proteins of epidermal tight junctions, Invitrogen occludin antibody (Zymed, 71-1500) was used . Br J Dermatol (2007) ncbi
rabbit polyclonal
In order to examine the origin and development of Aire positive medullary thymic epithelial cells, Invitrogen occludin antibody (Zymed, 71-1500) was used . Nat Immunol (2007) ncbi
rabbit polyclonal
In order to review mechanisms and applications of heat-induced antigen retrieval, Invitrogen occludin antibody (Zymed, 71-1500) was used . Prog Histochem Cytochem (2007) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to show that androgens control the expression level of connexin32 in prostate cancer cells, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 2). Mol Biol Cell (2006) ncbi
rabbit polyclonal
In order to develop an in vitro model of the respiratory tract wall, Invitrogen occludin antibody (Zymed, 71-1500) was used . J Aerosol Med (2006) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:50; fig 2
In order to test if the expression of tight junction proteins increases in vessels of germinal matrix and cortex with gestational age, Invitrogen occludin antibody (Zymed, 33-1,500) was used in immunohistochemistry on human samples at 1:50 (fig 2). Histochem Cell Biol (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; rabbit; 10 mg/ml; loading ...; fig 3d
In order to develop and assess artificial cornea materials for in vivo use, Invitrogen occludin antibody (ZYMED, OC- 3F10) was used in immunohistochemistry - paraffin section on rabbit samples at 10 mg/ml (fig 3d). J Biomed Mater Res B Appl Biomater (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dog
In order to study ouabain-sensitive and -resistant MDCK cells, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on dog samples . Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; loading ...; fig 4
In order to measure tight junction mRNA and protein levels in patients with edema, venous leg ulcers, and healthy controls, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 4). Int J Mol Med (2006) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; rabbit; 2 ug/ml; fig 8
In order to determine the distribution of claudins-7 and -8 in rabbit Henle's loops and collecting ducts, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunohistochemistry on rabbit samples at 2 ug/ml (fig 8). Nephrol Dial Transplant (2006) ncbi
rabbit polyclonal
In order to test if claudin-1 regulates invasion of oral squamous cell carcinoma cells, Invitrogen occludin antibody (Zymed, 71-1500) was used . Cancer Res (2006) ncbi
rabbit polyclonal
In order to determine the role of soluble guanylate cyclase in junction restructuring of the seminiferous epithelium of rat testis, Invitrogen occludin antibody (Invitrogen, 71-1500) was used . J Cell Physiol (2006) ncbi
rabbit polyclonal
In order to discuss how endothelial cells from different tissues regulate barrier function, Invitrogen occludin antibody (Zymed, zy-71-1500) was used . J Physiol (2006) ncbi
rabbit polyclonal
In order to examine the molecular composition of the tight junction present in human term placenta from normal women and from those with preeclampsia, Invitrogen occludin antibody (Zymed, 71-1500) was used . Cell Tissue Res (2006) ncbi
rabbit polyclonal
In order to characterize cell lines that mimic the characteristics of the proximal tubule, Invitrogen occludin antibody (Zymed, 71-1500) was used . Toxicol In Vitro (2006) ncbi
rabbit polyclonal
In order to report a reliable technique for the harvest, cultivation and expansion of monoculture of NMU and characterize the isolated cells, Invitrogen occludin antibody (Zymed, 71-1500) was used . Folia Biol (Praha) (2005) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:1000; loading ...; fig 2
In order to elucidate how IFN-gamma alters macromolecular permeability, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples at 1:1000 (fig 2). J Cell Sci (2005) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to study tight junctions in CaSki cells treated with ATP or diacylglyceride sn-1,2-dioctanoyl diglyceride, Invitrogen occludin antibody (Zymed, 33-1500) was used in western blot on human samples (fig 2). Endocrinology (2006) ncbi
rabbit polyclonal
In order to study tight junctions in CaSki cells treated with ATP or diacylglyceride sn-1,2-dioctanoyl diglyceride, Invitrogen occludin antibody (Zymed, 71-1500) was used . Endocrinology (2006) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; pig; 1:100
In order to characterize a permanent porcine intestinal epithelial cell line to use as an in vitro infection model, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on pig samples at 1:100. Histochem Cell Biol (2006) ncbi
rabbit polyclonal
In order to determine the distribution and role of perineurial cells in neurofibromas, Invitrogen occludin antibody (ZYMED, 71-1500) was used . J Histochem Cytochem (2006) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; loading ...; fig 4d
In order to evaluate a new biocompatible artificial cornea scaffold, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig 4d). J Biomed Mater Res B Appl Biomater (2006) ncbi
rabbit polyclonal
In order to study the blood-CSF barrier in neuroinfectious and inflammatory diseases using a differentiated cellular model of the choroidal epithelium, Invitrogen occludin antibody (Zymed Laboratories, 71-1500) was used . J Neurochem (2005) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 4c
In order to show that irradiated progeny of enterocytic precursor cells proliferate and differentiate, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:200 (fig 4c). Int J Radiat Biol (2005) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:250; loading ...; fig 4b
  • western blot; human; 1:1000; loading ...; fig 4a
In order to elucidate the mechanisms of interferon gamma-mediated bacterial translocation across human colonic epithelial monolayers, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:250 (fig 4b) and in western blot on human samples at 1:1000 (fig 4a). Gastroenterology (2005) ncbi
rabbit polyclonal
In order to study regulation of the blood-testis barrier, Invitrogen occludin antibody (Zymed, 71-1500) was used . J Cell Physiol (2005) ncbi
rabbit polyclonal
In order to examine the early response of the urothelium after superficial and full-thickness injuries, Invitrogen occludin antibody (Zymed, 71-1500) was used . Histochem Cell Biol (2005) ncbi
rabbit polyclonal
In order to observe the expression of occludin and syndecan-1 in the early phases of cervical carcinogenesis, Invitrogen occludin antibody (Zymed, 71-1500) was used . Pathol Oncol Res (2005) ncbi
rabbit polyclonal
In order to develop and characterize a triple co-culture model of the human airway barrier, Invitrogen occludin antibody (Zymed, 71-1,500) was used . Am J Respir Cell Mol Biol (2005) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 4
  • immunocytochemistry; rat; 1:100; fig 1
  • western blot; hamsters; fig 4
  • western blot; dog; fig 1
  • western blot; African green monkey; fig 4
In order to test if HDAC inhibitors affect the expression of tight junction proteins, Invitrogen occludin antibody (Zymed, 33-1500) was used in western blot on human samples (fig 4), in immunocytochemistry on rat samples at 1:100 (fig 1), in western blot on hamsters samples (fig 4), in western blot on dog samples (fig 1) and in western blot on African green monkey samples (fig 4). Mol Cancer Res (2004) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; 1:100; fig 3
In order to examine the expression and function of tight junctions in the epithelium of human palatine tonsils from patients with tonsillar hypertrophy or recurrent tonsillitis, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 3). J Histochem Cytochem (2004) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; dog; loading ...; fig 1
In order to assess the effect of 50-Hz magnetic field exposures on the subcellular distribution of proteins found in adherens and tight junctions, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunohistochemistry on dog samples (fig 1). ScientificWorldJournal (2004) ncbi
rabbit polyclonal
In order to test if the rotavirus outer capsid proteins are capable of opening the paracellular space sealed by the tight junctions, Invitrogen occludin antibody (Zymed, 71-1500) was used . J Cell Sci (2004) ncbi
mouse monoclonal (OC-3F10)
  • immunoprecipitation; human; fig 9
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 7
In order to investigate the effects of estrogen on transcervical tight-junctional resistance, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunoprecipitation on human samples (fig 9), in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 7). J Clin Endocrinol Metab (2004) ncbi
rabbit polyclonal
In order to use a reversible unilateral renal ischemia-reperfusion model to study the expression and distribution of cytoskeletal components and Rho GTPases in proximal tubule fractions, Invitrogen occludin antibody (Zymed, 71-1500) was used . Arch Biochem Biophys (2004) ncbi
rabbit polyclonal
In order to test if lack of junctional cingulin affects tight-junction organization and function, Invitrogen occludin antibody (Zymed, 71-1500) was used . J Cell Sci (2004) ncbi
rabbit polyclonal
In order to elucidate how NC-1059 treatment alters tight junction proteins, Invitrogen occludin antibody (Zymed, 71-1500) was used . Am J Physiol Cell Physiol (2004) ncbi
rabbit polyclonal
In order to use canine testis and epididymis to study occludin expression, Invitrogen occludin antibody (Zymed, 71-1500) was used . Reprod Domest Anim (2004) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dog; fig 8
In order to elucidate the localization of CEACAM1 isoforms, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunocytochemistry on dog samples (fig 8). J Cell Sci (2004) ncbi
rabbit polyclonal
In order to examine the effect of oxidative stress on stress protein induction and junctional integrity, Invitrogen occludin antibody (Zymed, 71-1500) was used . Invest Ophthalmol Vis Sci (2004) ncbi
rabbit polyclonal
In order to examine the role of nuclear ZO-2, Invitrogen occludin antibody (Zymed, 71-1500) was used . Exp Cell Res (2004) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1b
In order to discuss the effects on tight junctions due to compression therapy, Invitrogen occludin antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 1b). J Invest Dermatol (2003) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2c
In order to examine tight junction protein expression and localization in synovial sarcoma samples, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2c). Mod Pathol (2004) ncbi
rabbit polyclonal
In order to investigate the effects of Src tyrosine kinase activation in temperature sensitive-Src-transformed Madin-Darby canine kidney cells, Invitrogen occludin antibody (Zymed, 71?C1500) was used . Lab Invest (2003) ncbi
rabbit polyclonal
In order to discuss methods to study tight junctions, Invitrogen occludin antibody (Zymed, 71-1500) was used . Br J Dermatol (2003) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; fig 1
In order to discuss methods to study tight junctions, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunohistochemistry on human samples (fig 1). Br J Dermatol (2003) ncbi
rabbit polyclonal
In order to elucidate the role of Rab8B in germ cell movement, Invitrogen occludin antibody (Zymed, 71-1500) was used . Endocrinology (2003) ncbi
rabbit polyclonal
In order to study tight junction proteins in the cerebrum of aging rats, Invitrogen occludin antibody (Zymed, 71-1500) was used . Mech Ageing Dev (2003) ncbi
rabbit polyclonal
In order to investigate the role of myosin in vectorial transport, Invitrogen occludin antibody (Zymed, 711500) was used . J Muscle Res Cell Motil (2002) ncbi
rabbit polyclonal
In order to examine the role of the extracellular matrix in Sertoli cell tight junction dynamics, Invitrogen occludin antibody (Zymed, 71-1500) was used . Endocrinology (2003) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:1600
In order to determine the distribution of airway junctional complex proteins after antigen or lipopolysaccharide challenge, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunohistochemistry - frozen section on mouse samples at 1:1600. Am J Respir Cell Mol Biol (2002) ncbi
rabbit polyclonal
In order to investigate tight junctions and E-cadherin in heterotypic borders, Invitrogen occludin antibody (Zymed, 71-1500) was used . Pflugers Arch (2002) ncbi
rabbit polyclonal
In order to examine the differential expression of occludin and several claudins in isolated renal tubules from newborn and adult rabbits, Invitrogen occludin antibody (Zymed, 71-1500) was used . Kidney Int (2002) ncbi
rabbit polyclonal
In order to review applications of epithelial cell culture in studies of drug transport, Invitrogen occludin antibody (Zymed, 71-1500) was used . Methods Mol Biol (2002) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human
In order to review applications of epithelial cell culture in studies of drug transport, Invitrogen occludin antibody (Zymed, 33-1500) was used in immunocytochemistry on human samples . Methods Mol Biol (2002) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:100; fig 1
In order to study CEACAM1 in prostate cancer samples, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunohistochemistry on human samples at 1:100 (fig 1). Hum Pathol (2002) ncbi
rabbit polyclonal
In order to test if diabetes alters tight junction proteins, Invitrogen occludin antibody (Zymed, 71-1500) was used . Neurochem Res (2002) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; loading ...
In order to isolate and characterize a human breast epithelial cell line with stem cell properties, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunohistochemistry - frozen section on human samples . Genes Dev (2002) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human
In order to test if myoepithelial cells are required for the correct polarity of breast epithelial structures, Invitrogen occludin antibody (Zymed, OC-3F10) was used in immunohistochemistry - frozen section on human samples . J Cell Sci (2002) ncbi
rabbit polyclonal
In order to establish and characterize an in vitro culture model of whole mouse urothelial tissue, Invitrogen occludin antibody (Zymed, 71-1500) was used . Cell Biol Int (2002) ncbi
rabbit polyclonal
In order to test if tight junction antigens are present in adult and developing human epidermis, Invitrogen occludin antibody (Zymed, 71?C1500) was used . J Invest Dermatol (2001) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; human; fig 2
  • western blot; human; fig 1
In order to test if tight junction antigens are present in adult and developing human epidermis, Invitrogen occludin antibody (Zymed, 33?C1500) was used in immunohistochemistry - paraffin section on human samples (fig 2) and in western blot on human samples (fig 1). J Invest Dermatol (2001) ncbi
rabbit polyclonal
In order to investigate the use of vitamin D analogues to treat colon cancer, Invitrogen occludin antibody (Zymed, 71-1500) was used . J Cell Biol (2001) ncbi
rabbit polyclonal
In order to study the effect of ouabain treatment on cell attachment, Invitrogen occludin antibody (Zymed, 71-1500) was used . J Cell Sci (1999) ncbi
rabbit polyclonal
In order to study hair cell development using a new cell line, Invitrogen occludin antibody (Zymed, 71?C1500) was used . J Neurosci (1999) ncbi
Abcam
rabbit monoclonal (EPR20992)
  • western blot; mouse; loading ...; fig 2c
Abcam occludin antibody (Abcam, ab216327) was used in western blot on mouse samples (fig 2c). Cell Mol Gastroenterol Hepatol (2019) ncbi
rabbit polyclonal
  • western blot; mouse; loading ...; fig 5d
Abcam occludin antibody (Abcam, ab31721) was used in western blot on mouse samples (fig 5d). Dis Model Mech (2018) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 6c
In order to characterize the differentiation of RPE cells, Abcam occludin antibody (Abcam, ab31721) was used in immunocytochemistry on human samples (fig 6c). Stem Cell Res Ther (2017) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3d
Abcam occludin antibody (Abcam, ab31721) was used in immunohistochemistry - paraffin section on mouse samples (fig 3d). Histochem Cell Biol (2017) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; 1:50; fig 8c
In order to develop a novel method for obtaining perivascular-resident macrophage-like melanocytes, pericytes, and endothelial cells primary cells to study the vestibular blood-labyrinth barrier, Abcam occludin antibody (Abcam, Ab31721) was used in immunocytochemistry on mouse samples at 1:50 (fig 8c). Hear Res (2017) ncbi
rabbit polyclonal
  • western blot; human; 1:250; loading ...; fig 3e
In order to test if D1-like receptors regulate duodenal permeability, Abcam occludin antibody (Abcam, ab31721) was used in western blot on human samples at 1:250 (fig 3e). Acta Physiol (Oxf) (2017) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 8a
In order to investigate the effects of tetrahydrocannabinol on bronchial epithelial cell permeability after exposure to TNF-alpha, Abcam occludin antibody (Abcam, ab31721) was used in western blot on human samples (fig 8a). Biochem Pharmacol (2016) ncbi
rabbit polyclonal
  • western blot; mouse; 1:250; loading ...; fig 7a
In order to assess the effects of dietary protein using a model of colitis, Abcam occludin antibody (Abcam, ab31721) was used in western blot on mouse samples at 1:250 (fig 7a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:100; loading ...; fig 4
In order to investigate puerarin transport in a nasal mucosa model, Abcam occludin antibody (Abcam, ab31721) was used in immunocytochemistry on human samples at 1:100 (fig 4). Drug Des Devel Ther (2016) ncbi
rabbit polyclonal
  • western blot; mouse; fig 6
Abcam occludin antibody (Abcam, ab31721) was used in western blot on mouse samples (fig 6). Oncotarget (2016) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; fig 3
In order to study prevention of allergic skin disease by epidermal RAF, Abcam occludin antibody (Abcam, ab31721) was used in western blot on mouse samples at 1:1000 (fig 3). elife (2016) ncbi
rabbit polyclonal
  • western blot; pig; 1:250; fig 6b
Abcam occludin antibody (Abcam, ab31721) was used in western blot on pig samples at 1:250 (fig 6b). Vet Res (2016) ncbi
rabbit polyclonal
  • immunohistochemistry; rat; 1:50; loading ...; fig 1c
  • western blot; rat; 1:500; loading ...; fig 3b
In order to elucidate how miR-21-5p alleviates traumatic brain injury in rats, Abcam occludin antibody (Abcam, ab31721) was used in immunohistochemistry on rat samples at 1:50 (fig 1c) and in western blot on rat samples at 1:500 (fig 3b). Brain Res (2016) ncbi
rabbit monoclonal (EPR8208)
  • ELISA; mouse; 1:1000; fig 4
Abcam occludin antibody (abcam, ab167161) was used in ELISA on mouse samples at 1:1000 (fig 4). Front Neurosci (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:100; fig 6
Abcam occludin antibody (abcam, ab31721) was used in immunocytochemistry on human samples at 1:100 (fig 6). Virol J (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:100; fig 4
  • western blot; human; 1:500; fig 4
In order to study the prevention of amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1 by MicroRNA-107, Abcam occludin antibody (Abcam, Ab31721) was used in immunocytochemistry on human samples at 1:100 (fig 4) and in western blot on human samples at 1:500 (fig 4). Exp Cell Res (2016) ncbi
rabbit monoclonal (EPR8208)
  • western blot; mouse; loading ...; fig 5k
In order to determine the effects of an altered intestinal microbiota and microbial metabolites on graft-versus-host disease, Abcam occludin antibody (abcam, EPR8208) was used in western blot on mouse samples (fig 5k). Nat Immunol (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; fig s2
Abcam occludin antibody (Abcam, ab31721) was used in immunocytochemistry on mouse samples (fig s2). Nat Med (2016) ncbi
rabbit polyclonal
  • western blot; rat; 1:1000; fig 3
In order to assess regulation of blood-brain barrier permeability via Tie-2 after permanent middle cerebral artery occlusion in rats due to MicroRNA-150, Abcam occludin antibody (Abcam, ab31721) was used in western blot on rat samples at 1:1000 (fig 3). FASEB J (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 7
In order to research an increase in human airway epithelial cell permeability through an arachidonic acid metabolite caused by the endogenous cannabinoid anandamide, Abcam occludin antibody (Abcam, ab31721) was used in western blot on human samples at 1:1000 (fig 7). Pharmacol Res (2016) ncbi
rabbit monoclonal (EPR8208)
  • western blot; rat; 1:1000; fig 7
In order to analyze EP1 prostanoid receptor in blood-brain barrier damage and their role in ischemic stroke, Abcam occludin antibody (Abcam, ab167161) was used in western blot on rat samples at 1:1000 (fig 7). Sci Rep (2015) ncbi
rabbit polyclonal
  • western blot; mouse; fig 6
Abcam occludin antibody (Abcam, ab168986) was used in western blot on mouse samples (fig 6). PLoS ONE (2015) ncbi
rabbit monoclonal (EPR8208)
  • immunohistochemistry; mouse; 1:50; fig 1d
  • western blot; mouse; 1:1000; fig 5f
Abcam occludin antibody (Epitomics (now Abcam), ab167161) was used in immunohistochemistry on mouse samples at 1:50 (fig 1d) and in western blot on mouse samples at 1:1000 (fig 5f). Endocrinology (2015) ncbi
rabbit polyclonal
  • immunohistochemistry; rat; 1:100
  • western blot; rat; 1:250
In order to investigate the molecular and physiological involved in vasogenic edema formation, Abcam occludin antibody (Abcam, ab31721) was used in immunohistochemistry on rat samples at 1:100 and in western blot on rat samples at 1:250. Neuroscience (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; human
In order to study OGR1-mediated, pH-dependent signaling pathways in intestinal epithelial cells, Abcam occludin antibody (Abcam, 31721) was used in immunocytochemistry on human samples . Am J Physiol Gastrointest Liver Physiol (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:50
  • western blot; human; 1:250
In order to determine the role of lncRNAs in blood tumor barrier permeability, Abcam occludin antibody (Abcam, Ab31721) was used in immunocytochemistry on human samples at 1:50 and in western blot on human samples at 1:250. Oncotarget (2015) ncbi
rabbit polyclonal
  • western blot; human; 1:1000
Abcam occludin antibody (Abcam, ab31721) was used in western blot on human samples at 1:1000. Am J Pathol (2015) ncbi
rabbit polyclonal
  • western blot; pig; loading ...; fig 7a
Abcam occludin antibody (Abcam, ab31721) was used in western blot on pig samples (fig 7a). PLoS ONE (2015) ncbi
rabbit polyclonal
  • In-Cell Western; mouse; 1:50; fig 4
  • immunocytochemistry; mouse; 1:50; fig 4
  • western blot; mouse; 1:100; fig 4
In order to characterize disruption of the cochlear intra-strail fluid-blood barrier through tight junction proteins down-regulation due to lipopolysaccharide-induced middle ear inflammation, Abcam occludin antibody (Abcam, Ab31721) was used in In-Cell Western on mouse samples at 1:50 (fig 4), in immunocytochemistry on mouse samples at 1:50 (fig 4) and in western blot on mouse samples at 1:100 (fig 4). PLoS ONE (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; 6:1000
In order to study the modulatory effect of TLR4/EGF signaling pathways on TPN-associated intestinal epithelial cell atrophy, Abcam occludin antibody (Abcam, ab31721) was used in immunocytochemistry on mouse samples at 6:1000. FASEB J (2015) ncbi
rabbit polyclonal
  • western blot; mouse
Abcam occludin antibody (Abcam, ab31721) was used in western blot on mouse samples . Free Radic Res (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:50
  • western blot; human; 1:250
In order to study how knockdown of Robo4 alters the blood-tumor barrier, Abcam occludin antibody (Abcam, Ab31721) was used in immunocytochemistry on human samples at 1:50 and in western blot on human samples at 1:250. J Neuropathol Exp Neurol (2015) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 5
Abcam occludin antibody (Abcam, ab31721) was used in western blot on human samples at 1:1000 (fig 5). Mol Med Rep (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; rat
  • western blot; rat; 1:100
In order to examine the effects of long-term ketamine abuse on the inducement of cystitis in rats, Abcam occludin antibody (Abcam, ab31721) was used in immunocytochemistry on rat samples and in western blot on rat samples at 1:100. Mol Biol Rep (2014) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:200
  • western blot; mouse; 1:100
In order to evaluate the cystathionine-beta-synthase heterozygous mice as a model of mild to moderate hyperhomocysteinemia, Abcam occludin antibody (Abcam, AB 31721) was used in immunohistochemistry on mouse samples at 1:200 and in western blot on mouse samples at 1:100. Am J Pathol (2014) ncbi
rabbit polyclonal
  • western blot; rat; 1:200; fig 3
In order to assess the effect of enteral bovine lactoferrin supplementation on intestinal adaptation and barrier function in a rat model of short bowel syndrome, Abcam occludin antibody (Abcam, Ab31721) was used in western blot on rat samples at 1:200 (fig 3). Br J Nutr (2014) ncbi
rabbit polyclonal
  • western blot; rat; 1:500
Abcam occludin antibody (Abcam, ab31721) was used in western blot on rat samples at 1:500. Evid Based Complement Alternat Med (2013) ncbi
rabbit polyclonal
  • western blot; mouse
Abcam occludin antibody (Abcam, ab31721) was used in western blot on mouse samples . Reproduction (2014) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:200
Abcam occludin antibody (Abcam, ab31721) was used in immunohistochemistry on mouse samples at 1:200. Nat Med (2013) ncbi
rabbit polyclonal
  • immunocytochemistry; human
Abcam occludin antibody (Abcam, ab31721) was used in immunocytochemistry on human samples . Fertil Steril (2013) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200
  • western blot; mouse; 1:1000
Abcam occludin antibody (occludin, ab31721) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 and in western blot on mouse samples at 1:1000. Biol Reprod (2013) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 4 ug/ml; tbl 1
In order to characterize an invitro human outer blood-retinal barrier model, Abcam occludin antibody (Affinity Bioreagents, ab31721) was used in immunocytochemistry on human samples at 4 ug/ml (tbl 1). Methods Mol Biol (2011) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-7)
  • western blot; rat; 1:500; loading ...; fig 5b
Santa Cruz Biotechnology occludin antibody (Santa Cruz Biotechnology, sc-271842) was used in western blot on rat samples at 1:500 (fig 5b). Mol Med Rep (2017) ncbi
mouse monoclonal (E-5)
  • western blot; human; 1:200; loading ...; fig 4c
Santa Cruz Biotechnology occludin antibody (SantaCruz, sc-133256) was used in western blot on human samples at 1:200 (fig 4c). Oncotarget (2016) ncbi
mouse monoclonal (E-5)
  • immunohistochemistry - paraffin section; mouse; 1:100
Santa Cruz Biotechnology occludin antibody (Santa Cruz Biotechnology, sc-133256) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Exp Ther Med (2015) ncbi
mouse monoclonal (E-5)
  • western blot; mouse; 1:500; fig 5
In order to test if increasing dietary lipid consumption results in increased endotoxemia, low-grade inflammation, and metabolic and intestinal alterations, Santa Cruz Biotechnology occludin antibody (santa cruz, sc- 133256) was used in western blot on mouse samples at 1:500 (fig 5). Nutr Res (2015) ncbi
mouse monoclonal (E-5)
  • western blot; mouse; 1:1000
In order to determine the metabolic outcomes of cows fed high fat diet, Santa Cruz Biotechnology occludin antibody (Santa Cruz, sc-133256) was used in western blot on mouse samples at 1:1000. Br J Nutr (2014) ncbi
Articles Reviewed
  1. Kiyohara H, Sujino T, Teratani T, Miyamoto K, Arai M, Nomura E, et al. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells. Cell Mol Gastroenterol Hepatol. 2019;7:135-156 pubmed publisher
  2. Kim Y, Lee M, Gu H, Kim J, Jeong S, Yeo S, et al. HIF-1α activation in myeloid cells accelerates dextran sodium sulfate-induced colitis progression in mice. Dis Model Mech. 2018;11: pubmed publisher
  3. Rempe R, Hartz A, Soldner E, Sokola B, Alluri S, Abner E, et al. Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy. J Neurosci. 2018;38:4301-4315 pubmed publisher
  4. Hazim R, Karumbayaram S, Jiang M, Dimashkie A, Lopes V, Li D, et al. Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization. Stem Cell Res Ther. 2017;8:217 pubmed publisher
  5. Katsumata O, Mori M, Sawane Y, Niimura T, Ito A, Okamoto H, et al. Cellular and subcellular localization of ADP-ribosylation factor 6 in mouse peripheral tissues. Histochem Cell Biol. 2017;148:577-596 pubmed publisher
  6. Yang A, Inamine T, Hochrath K, Chen P, Wang L, Llorente C, et al. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest. 2017;127:2829-2841 pubmed publisher
  7. Benedicto I, Lehmann G, Ginsberg M, Nolan D, Bareja R, Elemento O, et al. Concerted regulation of retinal pigment epithelium basement membrane and barrier function by angiocrine factors. Nat Commun. 2017;8:15374 pubmed publisher
  8. Yanagida K, Liu C, Faraco G, Galvani S, Smith H, Burg N, et al. Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. Proc Natl Acad Sci U S A. 2017;114:4531-4536 pubmed publisher
  9. Lapierre L, Manning E, Mitchell K, Caldwell C, Goldenring J. Interaction of phosphorylated Rab11-FIP2 with Eps15 regulates apical junction composition. Mol Biol Cell. 2017;28:1088-1100 pubmed publisher
  10. Tung K, Harakal J, Qiao H, Rival C, Li J, Paul A, et al. Egress of sperm autoantigen from seminiferous tubules maintains systemic tolerance. J Clin Invest. 2017;127:1046-1060 pubmed publisher
  11. Prasad S, Sajja R, Kaisar M, Park J, Villalba H, Liles T, et al. Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity. Redox Biol. 2017;12:58-69 pubmed publisher
  12. Ni Y, Teng T, Li R, Simonyi A, Sun G, Lee J. TNFα alters occludin and cerebral endothelial permeability: Role of p38MAPK. PLoS ONE. 2017;12:e0170346 pubmed publisher
  13. Zhang J, Chen S, Cai J, Hou Z, Wang X, Kachelmeier A, et al. Culture media-based selection of endothelial cells, pericytes, and perivascular-resident macrophage-like melanocytes from the young mouse vestibular system. Hear Res. 2017;345:10-22 pubmed publisher
  14. Kraya R, Komin A, Searson P. On Chip Bioelectric Impedance Spectroscopy Reveals the Effect of P-Glycoprotein Efflux Pumps on the Paracellular Impedance of Tight Junctions at the Blood-Brain Barrier. IEEE Trans Nanobioscience. 2016;15:697-703 pubmed publisher
  15. Sivagurunathan S, Palanisamy K, Arunachalam J, Chidambaram S. Possible role of HIWI2 in modulating tight junction proteins in retinal pigment epithelial cells through Akt signaling pathway. Mol Cell Biochem. 2017;427:145-156 pubmed publisher
  16. Cao X, Shen L, Wu S, Yan C, Zhou Y, Xiong G, et al. Urban fine particulate matter exposure causes male reproductive injury through destroying blood-testis barrier (BTB) integrity. Toxicol Lett. 2017;266:1-12 pubmed publisher
  17. Zhang H, Zhang P, Gao Y, Li C, Wang H, Chen L, et al. Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs. Mol Med Rep. 2017;15:57-64 pubmed publisher
  18. Capra J, Eskelinen S. MDCK cells are capable of water secretion and reabsorption in response to changes in the ionic environment. Can J Physiol Pharmacol. 2017;95:72-83 pubmed publisher
  19. Hurtado Alvarado G, Dominguez Salazar E, Velazquez Moctezuma J, Gómez González B. A2A Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction. PLoS ONE. 2016;11:e0167236 pubmed publisher
  20. Lin Z, Zhang Y, Xia Y, Xu X, Jiao X, Sun J. Salmonella enteritidis Effector AvrA Stabilizes Intestinal Tight Junctions via the JNK Pathway. J Biol Chem. 2016;291:26837-26849 pubmed publisher
  21. Martínez Rendón J, Sánchez Guzmán E, Rueda A, González J, Gulias Cañizo R, Aquino Jarquin G, et al. TRPV4 Regulates Tight Junctions and Affects Differentiation in a Cell Culture Model of the Corneal Epithelium. J Cell Physiol. 2017;232:1794-1807 pubmed publisher
  22. Chehaibi K, le Maire L, Bradoni S, Escolà J, Blanco Vaca F, Slimane M. Effect of PPAR-β/δ agonist GW0742 treatment in the acute phase response and blood-brain barrier permeability following brain injury. Transl Res. 2017;182:27-48 pubmed publisher
  23. Majka G, Wiecek G, Sróttek M, Spiewak K, Brindell M, Koziel J, et al. The impact of lactoferrin with different levels of metal saturation on the intestinal epithelial barrier function and mucosal inflammation. Biometals. 2016;29:1019-1033 pubmed
  24. Keppner A, Malsure S, Nobile A, Auberson M, Bonny O, Hummler E. Altered Prostasin (CAP1/Prss8) Expression Favors Inflammation and Tissue Remodeling in DSS-induced Colitis. Inflamm Bowel Dis. 2016;22:2824-2839 pubmed
  25. Mendonça M, Soares E, de Jesus M, Ceragioli H, Batista Ã, Nyúl Tóth Ã, et al. PEGylation of Reduced Graphene Oxide Induces Toxicity in Cells of the Blood-Brain Barrier: An in Vitro and in Vivo Study. Mol Pharm. 2016;13:3913-3924 pubmed
  26. Feng X, Zhang D, Wang Y, Fan R, Hong F, Zhang Y, et al. Dopamine enhances duodenal epithelial permeability via the dopamine D5 receptor in rodent. Acta Physiol (Oxf). 2017;220:113-123 pubmed publisher
  27. Shang V, Kendall D, Roberts R. ?9-Tetrahydrocannabinol reverses TNF?-induced increase in airway epithelial cell permeability through CB2 receptors. Biochem Pharmacol. 2016;120:63-71 pubmed publisher
  28. Qian Y, Li C, Jiang A, Ge S, Gu P, Fan X, et al. HIV-1 gp120 Glycoprotein Interacting with Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN) Down-Regulates Tight Junction Proteins to Disrupt the Blood Retinal Barrier and Increase Its Permeability. J Biol Chem. 2016;291:22977-22987 pubmed
  29. Ahn C, Shin D, Lee D, Kang S, Seok J, Kang H, et al. Expression of claudins, occludin, junction adhesion molecule A and zona occludens 1 in canine organs. Mol Med Rep. 2016;14:3697-703 pubmed publisher
  30. de Sousa Rodrigues M, Bekhbat M, Houser M, Chang J, Walker D, Jones D, et al. Chronic psychological stress and high-fat high-fructose diet disrupt metabolic and inflammatory gene networks in the brain, liver, and gut and promote behavioral deficits in mice. Brain Behav Immun. 2017;59:158-172 pubmed publisher
  31. Lan A, Blais A, Coelho D, Capron J, Maarouf M, Benamouzig R, et al. Dual effects of a high-protein diet on DSS-treated mice during colitis resolution phase. Am J Physiol Gastrointest Liver Physiol. 2016;311:G624-G633 pubmed publisher
  32. Li N, Lee W, Cheng C. Overexpression of plastin 3 in Sertoli cells disrupts actin microfilament bundle homeostasis and perturbs the tight junction barrier. Spermatogenesis. 2016;6:e1206353 pubmed publisher
  33. Wardill H, Bowen J, Van Sebille Y, Secombe K, Coller J, Ball I, et al. TLR4-Dependent Claudin-1 Internalization and Secretagogue-Mediated Chloride Secretion Regulate Irinotecan-Induced Diarrhea. Mol Cancer Ther. 2016;15:2767-2779 pubmed
  34. Ronaghan N, Shang J, Iablokov V, Zaheer R, Colarusso P, Dion S, et al. The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction. Am J Physiol Gastrointest Liver Physiol. 2016;311:G466-79 pubmed publisher
  35. Stammler A, Lüftner B, Kliesch S, Weidner W, Bergmann M, Middendorff R, et al. Highly Conserved Testicular Localization of Claudin-11 in Normal and Impaired Spermatogenesis. PLoS ONE. 2016;11:e0160349 pubmed publisher
  36. Zhang L, Du S, Lu Y, Liu C, Tian Z, Yang C, et al. Puerarin transport across a Calu-3 cell monolayer - an in vitro model of nasal mucosa permeability and the influence of paeoniflorin and menthol. Drug Des Devel Ther. 2016;10:2227-37 pubmed publisher
  37. Pang J, Wu Y, Peng J, Yang P, Kuai L, Qin X, et al. Potential implications of Apolipoprotein E in early brain injury after experimental subarachnoid hemorrhage: Involvement in the modulation of blood-brain barrier integrity. Oncotarget. 2016;7:56030-56044 pubmed publisher
  38. Zeller P, Legendre A, Jacques S, Fleury M, Gilard F, Tcherkez G, et al. Hepatocytes cocultured with Sertoli cells in bioreactor favors Sertoli barrier tightness in rat. J Appl Toxicol. 2017;37:287-295 pubmed publisher
  39. Li N, Mruk D, Chen H, Wong C, Lee W, Cheng C. Rescue of perfluorooctanesulfonate (PFOS)-mediated Sertoli cell injury by overexpression of gap junction protein connexin 43. Sci Rep. 2016;6:29667 pubmed publisher
  40. Raguz J, Jerić I, Niault T, Nowacka J, Kuzet S, Rupp C, et al. Epidermal RAF prevents allergic skin disease. elife. 2016;5: pubmed publisher
  41. Zhang Z, Yan J, Shi H. Role of Hypoxia Inducible Factor 1 in Hyperglycemia-Exacerbated Blood-Brain Barrier Disruption in Ischemic Stroke. Neurobiol Dis. 2016;95:82-92 pubmed publisher
  42. Yang G, Zhu Y, Zhang W, Zhou D, Zhai C, Wang J. Influence of orally fed a select mixture of Bacillus probiotics on intestinal T-cell migration in weaned MUC4 resistant pigs following Escherichia coli challenge. Vet Res. 2016;47:71 pubmed publisher
  43. Clark P, Al Ahmad A, Qian T, Zhang R, Wilson H, Weichert J, et al. Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model. Mol Pharm. 2016;13:3341-9 pubmed publisher
  44. Ge X, Huang S, Gao H, Han Z, Chen F, Zhang S, et al. miR-21-5p alleviates leakage of injured brain microvascular endothelial barrier in vitro through suppressing inflammation and apoptosis. Brain Res. 2016;1650:31-40 pubmed publisher
  45. Gao Y, Lui W, Lee W, Cheng C. Polarity protein Crumbs homolog-3 (CRB3) regulates ectoplasmic specialization dynamics through its action on F-actin organization in Sertoli cells. Sci Rep. 2016;6:28589 pubmed publisher
  46. Campos Y, Qiu X, Gomero E, Wakefield R, Horner L, Brutkowski W, et al. Alix-mediated assembly of the actomyosin-tight junction polarity complex preserves epithelial polarity and epithelial barrier. Nat Commun. 2016;7:11876 pubmed publisher
  47. Löffler T, Flunkert S, Temmel M, Hutter Paier B. Decreased Plasma A? in Hyperlipidemic APPSL Transgenic Mice Is Associated with BBB Dysfunction. Front Neurosci. 2016;10:232 pubmed publisher
  48. Rodriguez M, Kaushik A, Lapierre J, Dever S, El Hage N, Nair M. Electro-Magnetic Nano-Particle Bound Beclin1 siRNA Crosses the Blood-Brain Barrier to Attenuate the Inflammatory Effects of HIV-1 Infection in Vitro. J Neuroimmune Pharmacol. 2017;12:120-132 pubmed publisher
  49. Lee S, Kim H, Kim K, Lee H, Lee S, Lee D. Arhgap17, a RhoGTPase activating protein, regulates mucosal and epithelial barrier function in the mouse colon. Sci Rep. 2016;6:26923 pubmed publisher
  50. Lehner C, Gehwolf R, Ek J, Korntner S, Bauer H, Bauer H, et al. The blood-tendon barrier: identification and characterisation of a novel tissue barrier in tendon blood vessels. Eur Cell Mater. 2016;31:296-311 pubmed
  51. Poon C, Madawala R, Dowland S, Murphy C. Nectin-3 Is Increased in the Cell Junctions of the Uterine Epithelium at Implantation. Reprod Sci. 2016;23:1580-1592 pubmed
  52. Xu S, Xue X, You K, Fu J. Caveolin-1 regulates the expression of tight junction proteins during hyperoxia-induced pulmonary epithelial barrier breakdown. Respir Res. 2016;17:50 pubmed publisher
  53. Teo W, Merino V, Cho S, Korangath P, Liang X, Wu R, et al. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24. Oncogene. 2016;35:5539-5551 pubmed publisher
  54. Vorvis C, Hatziapostolou M, Mahurkar Joshi S, Koutsioumpa M, Williams J, Donahue T, et al. Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. Am J Physiol Gastrointest Liver Physiol. 2016;310:G1124-37 pubmed publisher
  55. Kobayashi K, Tsugami Y, Matsunaga K, Oyama S, Kuki C, Kumura H. Prolactin and glucocorticoid signaling induces lactation-specific tight junctions concurrent with ?-casein expression in mammary epithelial cells. Biochim Biophys Acta. 2016;1863:2006-16 pubmed publisher
  56. Inada M, Izawa G, Kobayashi W, Ozawa M. 293 cells express both epithelial as well as mesenchymal cell adhesion molecules. Int J Mol Med. 2016;37:1521-7 pubmed publisher
  57. Liu S, Zhou F, Shen Y, Zhang Y, Yin H, Zeng Y, et al. Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells. Oncotarget. 2016;7:32876-92 pubmed publisher
  58. Guerrera D, Shah J, Vasileva E, Sluysmans S, Méan I, Jond L, et al. PLEKHA7 Recruits PDZD11 to Adherens Junctions to Stabilize Nectins. J Biol Chem. 2016;291:11016-29 pubmed publisher
  59. Sa Ngiamsuntorn K, Wongkajornsilp A, Phanthong P, Borwornpinyo S, Kitiyanant N, Chantratita W, et al. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host. Virol J. 2016;13:59 pubmed publisher
  60. Kwon J, Jeong S, Choi I, Kim N. ADAM10 Is Involved in Cell Junction Assembly in Early Porcine Embryo Development. PLoS ONE. 2016;11:e0152921 pubmed publisher
  61. Liu W, Cai H, Lin M, Zhu L, Gao L, Zhong R, et al. MicroRNA-107 prevents amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1. Exp Cell Res. 2016;343:248-257 pubmed publisher
  62. Wardill H, Gibson R, Van Sebille Y, Secombe K, Logan R, Bowen J. A novel in vitro platform for the study of SN38-induced mucosal damage and the development of Toll-like receptor 4-targeted therapeutic options. Exp Biol Med (Maywood). 2016;241:1386-94 pubmed publisher
  63. Yang C, Demars K, Hawkins K, Candelario Jalil E. Adropin reduces paracellular permeability of rat brain endothelial cells exposed to ischemia-like conditions. Peptides. 2016;81:29-37 pubmed publisher
  64. Mathewson N, Jenq R, Mathew A, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17:505-513 pubmed publisher
  65. Chen H, Mruk D, Lee W, Cheng C. Planar Cell Polarity (PCP) Protein Vangl2 Regulates Ectoplasmic Specialization Dynamics via Its Effects on Actin Microfilaments in the Testes of Male Rats. Endocrinology. 2016;157:2140-59 pubmed publisher
  66. Kacem M, Agili F, Tounsi H, Zribi H, Zaraa I, Mokni M, et al. Immunohistological study of tight junction protein expression in mal de Meleda. Ultrastruct Pathol. 2016;40:176-80 pubmed publisher
  67. Kuehn A, Kletting S, de Souza Carvalho Wodarz C, Repnik U, Griffiths G, Fischer U, et al. Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier. ALTEX. 2016;33:251-60 pubmed publisher
  68. Ji X, Liu Y, Hurd R, Wang J, Fitzmaurice B, Nishina P, et al. Retinal Pigment Epithelium Atrophy 1 (rpea1): A New Mouse Model With Retinal Detachment Caused by a Disruption of Protein Kinase C, θ. Invest Ophthalmol Vis Sci. 2016;57:877-88 pubmed publisher
  69. Shukla P, Chaudhry K, Mir H, Gangwar R, Yadav N, Manda B, et al. Chronic ethanol feeding promotes azoxymethane and dextran sulfate sodium-induced colonic tumorigenesis potentially by enhancing mucosal inflammation. BMC Cancer. 2016;16:189 pubmed publisher
  70. Jang C, Oh S, Wada S, Rowe G, Liu L, Chan M, et al. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat Med. 2016;22:421-6 pubmed publisher
  71. Strazielle N, Creidy R, Malcus C, Boucraut J, Ghersi Egea J. T-Lymphocytes Traffic into the Brain across the Blood-CSF Barrier: Evidence Using a Reconstituted Choroid Plexus Epithelium. PLoS ONE. 2016;11:e0150945 pubmed publisher
  72. Liu H, Garzoni L, Herry C, Durosier L, Cao M, Burns P, et al. Can Monitoring Fetal Intestinal Inflammation Using Heart Rate Variability Analysis Signal Incipient Necrotizing Enterocolitis of the Neonate?. Pediatr Crit Care Med. 2016;17:e165-76 pubmed publisher
  73. Fang Z, He Q, Li Q, Chen X, Baral S, Jin H, et al. MicroRNA-150 regulates blood-brain barrier permeability via Tie-2 after permanent middle cerebral artery occlusion in rats. FASEB J. 2016;30:2097-107 pubmed publisher
  74. Shirasago Y, Shimizu Y, Tanida I, Suzuki T, Suzuki R, Sugiyama K, et al. Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection. Biol Pharm Bull. 2016;39:839-48 pubmed publisher
  75. Ibrahim A, Mander S, Hussein K, Elsherbiny N, Smith S, Al Shabrawey M, et al. Hyperhomocysteinemia disrupts retinal pigment epithelial structure and function with features of age-related macular degeneration. Oncotarget. 2016;7:8532-45 pubmed publisher
  76. Sántha P, Veszelka S, Hoyk Z, Mészáros M, Walter F, Tóth A, et al. Restraint Stress-Induced Morphological Changes at the Blood-Brain Barrier in Adult Rats. Front Mol Neurosci. 2015;8:88 pubmed publisher
  77. Shang V, O Sullivan S, Kendall D, Roberts R. The endogenous cannabinoid anandamide increases human airway epithelial cell permeability through an arachidonic acid metabolite. Pharmacol Res. 2016;105:152-63 pubmed publisher
  78. Villarroel Espíndola F, Tapia C, González Stegmaier R, Concha I, Slebe J. Polyglucosan Molecules Induce Mitochondrial Impairment and Apoptosis in Germ Cells Without Affecting the Integrity and Functionality of Sertoli Cells. J Cell Physiol. 2016;231:2142-52 pubmed publisher
  79. Miquel S, Martín R, Lashermes A, Gillet M, Meleine M, Gelot A, et al. Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models. Sci Rep. 2016;6:19399 pubmed publisher
  80. Lou N, Takano T, Pei Y, Xavier A, Goldman S, Nedergaard M. Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier. Proc Natl Acad Sci U S A. 2016;113:1074-9 pubmed publisher
  81. Li N, Mruk D, Mok K, Li M, Wong C, Lee W, et al. Connexin 43 reboots meiosis and reseals blood-testis barrier following toxicant-mediated aspermatogenesis and barrier disruption. FASEB J. 2016;30:1436-52 pubmed publisher
  82. Shi Y, Liu T, Fu J, Xu W, Wu L, Hou A, et al. Vitamin D/VDR signaling attenuates lipopolysaccharide‑induced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier. Mol Med Rep. 2016;13:1186-94 pubmed publisher
  83. Kim H, Cronin M, Ahrens K, Papastavros V, Santoro D, Marsella R. A comparative study of epidermal tight junction proteins in a dog model of atopic dermatitis. Vet Dermatol. 2016;27:40-e11 pubmed publisher
  84. Arévalo Turrubiarte M, Perruchot M, Finot L, Mayeur F, Dessauge F. Phenotypic and functional characterization of two bovine mammary epithelial cell lines in 2D and 3D models. Am J Physiol Cell Physiol. 2016;310:C348-56 pubmed publisher
  85. Frankowski J, Demars K, Ahmad A, Hawkins K, Yang C, Leclerc J, et al. Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke. Sci Rep. 2015;5:17956 pubmed publisher
  86. Kessler M, Hoffmann K, Brinkmann V, Thieck O, Jackisch S, Toelle B, et al. The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids. Nat Commun. 2015;6:8989 pubmed publisher
  87. Nadeem A, Thomas P, Ulf M, Elena N, Anggakusuma A, Mohamed B, et al. Cell culture-derived HCV cannot infect synovial fibroblasts. Sci Rep. 2015;5:18043 pubmed publisher
  88. Castro V, Bertrand L, Luethen M, Dabrowski S, Lombardi J, Morgan L, et al. Occludin controls HIV transcription in brain pericytes via regulation of SIRT-1 activation. FASEB J. 2016;30:1234-46 pubmed publisher
  89. McCabe M, Foo C, Dinger M, Smooker P, Stanton P. Claudin-11 and occludin are major contributors to Sertoli cell tight junction function, in vitro. Asian J Androl. 2016;18:620-6 pubmed publisher
  90. Rodrigo Albors A, Tazaki A, Rost F, Nowoshilow S, Chara O, Tanaka E. Planar cell polarity-mediated induction of neural stem cell expansion during axolotl spinal cord regeneration. elife. 2015;4:e10230 pubmed publisher
  91. Stebbins M, Wilson H, Canfield S, Qian T, Palecek S, Shusta E. Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells. Methods. 2016;101:93-102 pubmed publisher
  92. Vandenhaute E, Stump Guthier C, Losada M, Tenenbaum T, Rudolph H, Ishikawa H, et al. The choroid plexus may be an underestimated site of tumor invasion to the brain: an in vitro study using neuroblastoma cell lines. Cancer Cell Int. 2015;15:102 pubmed publisher
  93. Freedman B, Brooks C, Lam A, Fu H, Morizane R, Agrawal V, et al. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun. 2015;6:8715 pubmed publisher
  94. Kim C, Kim J, Jo K, Lee Y, Sohn E, Yoo N, et al. OSSC1E-K19, a novel phytochemical component of Osteomeles schwerinae, prevents glycated albumin-induced retinal vascular injury in rats. Mol Med Rep. 2015;12:7279-84 pubmed publisher
  95. Barbáchano A, Fernández Barral A, Pereira F, Segura M, Ordóñez Morán P, Carrillo de Santa Pau E, et al. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150. Oncogene. 2016;35:2991-3003 pubmed publisher
  96. Martínez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed publisher
  97. Cravo A, Carter E, Erkan M, Harvey E, Furutani Seiki M, MRSNY R. Hippo pathway elements Co-localize with Occludin: A possible sensor system in pancreatic epithelial cells. Tissue Barriers. 2015;3:e1037948 pubmed publisher
  98. Wardill H, Logan R, Bowen J, Van Sebille Y, Gibson R. Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer. Support Care Cancer. 2016;24:1779-88 pubmed publisher
  99. Blume C, Reale R, Held M, Millar T, Collins J, Davies D, et al. Temporal Monitoring of Differentiated Human Airway Epithelial Cells Using Microfluidics. PLoS ONE. 2015;10:e0139872 pubmed publisher
  100. Lee J, Tato C, Joyce Shaikh B, Gulen M, Gulan F, Cayatte C, et al. Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability. Immunity. 2015;43:727-38 pubmed publisher
  101. Bauskar A, Mack W, Mauris J, Argüeso P, Heur M, Nagel B, et al. Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye. PLoS ONE. 2015;10:e0138958 pubmed publisher
  102. Valere K, Rapista A, Eugenin E, Lu W, Chang T. Human Alpha-Defensin HNP1 Increases HIV Traversal of the Epithelial Barrier: A Potential Role in STI-Mediated Enhancement of HIV Transmission. Viral Immunol. 2015;28:609-15 pubmed publisher
  103. Brkic M, Balusu S, Van Wonterghem E, Gorlé N, Benilova I, Kremer A, et al. Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases. J Neurosci. 2015;35:12766-78 pubmed publisher
  104. Dong H, Chen Z, Wang C, Xiong Z, Zhao W, Jia C, et al. Rictor Regulates Spermatogenesis by Controlling Sertoli Cell Cytoskeletal Organization and Cell Polarity in the Mouse Testis. Endocrinology. 2015;156:4244-56 pubmed publisher
  105. Zhao Y, Zhao L, Wang P, Miao Y, Liu Y, Wang Z, et al. Overexpression of miR-18a negatively regulates myocyte enhancer factor 2D to increase the permeability of the blood-tumor barrier via Krüppel-like factor 4-mediated downregulation of zonula occluden-1, claudin-5, and occludin. J Neurosci Res. 2015;93:1891-902 pubmed publisher
  106. Janosevic D, Axis J, Bacallao R, Amsler K. Occludin Content Modulates Hydrogen Peroxide-Induced Increase in Renal Epithelial Paracellular Permeability. J Cell Biochem. 2016;117:769-79 pubmed publisher
  107. Liu S, Zhao J, Fan X, Liu G, Jiao H, Wang X, et al. Rapamycin, a specific inhibitor of the target of rapamycin complex 1, disrupts intestinal barrier integrity in broiler chicks. J Anim Physiol Anim Nutr (Berl). 2016;100:323-30 pubmed publisher
  108. Kim J, Ko A, Hyun H, Kang T. ETB receptor-mediated MMP-9 activation induces vasogenic edema via ZO-1 protein degradation following status epilepticus. Neuroscience. 2015;304:355-67 pubmed publisher
  109. de Vallière C, Vidal S, Clay I, Jurisic G, Tcymbarevich I, Lang S, et al. The pH-sensing receptor OGR1 improves barrier function of epithelial cells and inhibits migration in an acidic environment. Am J Physiol Gastrointest Liver Physiol. 2015;309:G475-90 pubmed publisher
  110. Yuksel H, Yilmaz O, Karaman M, Fırıncı F, Turkeli A, Kanik E, et al. Vascular endothelial growth factor antagonism restores epithelial barrier dysfunction via affecting zonula occludens proteins. Exp Ther Med. 2015;10:362-368 pubmed
  111. Tan F, Fu W, Cheng N, Meng D, Gu Y. Ligustrazine reduces blood-brain barrier permeability in a rat model of focal cerebral ischemia and reperfusion. Exp Ther Med. 2015;9:1757-1762 pubmed
  112. Goichon A, Bertrand J, Chan P, Lecleire S, Coquard A, Cailleux A, et al. Enteral delivery of proteins enhances the expression of proteins involved in the cytoskeleton and protein biosynthesis in human duodenal mucosa. Am J Clin Nutr. 2015;102:359-67 pubmed publisher
  113. Chang C, Lin C, Lu C, Martel J, Ko Y, Ojcius D, et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun. 2015;6:7489 pubmed publisher
  114. Ek C, D Angelo B, Lehner C, Nathanielsz P, Li C, Mallard C. Expression of tight junction proteins and transporters for xenobiotic metabolism at the blood-CSF barrier during development in the nonhuman primate (P. hamadryas). Reprod Toxicol. 2015;56:32-44 pubmed publisher
  115. Cai H, Xue Y, Wang P, Wang Z, Li Z, Hu Y, et al. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget. 2015;6:19759-79 pubmed
  116. Li N, Mruk D, Wong C, Lee W, Han D, Cheng C. Actin-bundling protein plastin 3 is a regulator of ectoplasmic specialization dynamics during spermatogenesis in the rat testis. FASEB J. 2015;29:3788-805 pubmed publisher
  117. Suárez Causado A, Caballero Díaz D, Bertrán E, Roncero C, Addante A, García Álvaro M, et al. HGF/c-Met signaling promotes liver progenitor cell migration and invasion by an epithelial-mesenchymal transition-independent, phosphatidyl inositol-3 kinase-dependent pathway in an in vitro model. Biochim Biophys Acta. 2015;1853:2453-63 pubmed publisher
  118. Good R, Gilbane A, Trinder S, Denton C, Coghlan G, Abraham D, et al. Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension. Am J Pathol. 2015;185:1850-8 pubmed publisher
  119. Abdayem R, Callejon S, Portes P, Kirilov P, Demarne F, Pirot F, et al. Modulation of transepithelial electric resistance (TEER) in reconstructed human epidermis by excipients known to permeate intestinal tight junctions. Exp Dermatol. 2015;24:686-91 pubmed publisher
  120. Son Y, Heo K, Bae M, Lee C, Cho W, Kim S, et al. Injury to the blood-testis barrier after low-dose-rate chronic radiation exposure in mice. Radiat Prot Dosimetry. 2015;167:316-20 pubmed publisher
  121. Cong X, Zhang Y, Li J, Mei M, Ding C, Xiang R, et al. Claudin-4 is required for modulation of paracellular permeability by muscarinic acetylcholine receptor in epithelial cells. J Cell Sci. 2015;128:2271-86 pubmed publisher
  122. Zhang W, Zhu Y, Yang J, Yang G, Zhou D, Wang J. A Selected Lactobacillus rhamnosus Strain Promotes EGFR-Independent Akt Activation in an Enterotoxigenic Escherichia coli K88-Infected IPEC-J2 Cell Model. PLoS ONE. 2015;10:e0125717 pubmed publisher
  123. Staat C, Coisne C, Dabrowski S, Stamatovic S, Andjelkovic A, Wolburg H, et al. Mode of action of claudin peptidomimetics in the transient opening of cellular tight junction barriers. Biomaterials. 2015;54:9-20 pubmed publisher
  124. Wu S, Yi J, Zhang Y, Zhou J, Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol Rep. 2015;3: pubmed publisher
  125. Pothoven K, Norton J, Hulse K, Suh L, Carter R, Rocci E, et al. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease. J Allergy Clin Immunol. 2015;136:737-746.e4 pubmed publisher
  126. Scull M, Shi C, De Jong Y, Gerold G, Ries M, von Schaewen M, et al. Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice. Hepatology. 2015;62:57-67 pubmed publisher
  127. Zhang J, Chen S, Hou Z, Cai J, Dong M, Shi X. Lipopolysaccharide-induced middle ear inflammation disrupts the cochlear intra-strial fluid-blood barrier through down-regulation of tight junction proteins. PLoS ONE. 2015;10:e0122572 pubmed publisher
  128. Haarmann A, Nowak E, Deiß A, van der Pol S, Monoranu C, Kooij G, et al. Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling. Acta Neuropathol. 2015;129:639-52 pubmed publisher
  129. Bazellières E, Conte V, Elosegui Artola A, Serra Picamal X, Bintanel Morcillo M, Roca Cusachs P, et al. Control of cell-cell forces and collective cell dynamics by the intercellular adhesome. Nat Cell Biol. 2015;17:409-20 pubmed publisher
  130. Muramatsu R, Kuroda M, Matoba K, Lin H, Takahashi C, Koyama Y, et al. Prostacyclin prevents pericyte loss and demyelination induced by lysophosphatidylcholine in the central nervous system. J Biol Chem. 2015;290:11515-25 pubmed publisher
  131. Fredriksson K, Van Itallie C, Aponte A, Gucek M, Tietgens A, Anderson J. Proteomic analysis of proteins surrounding occludin and claudin-4 reveals their proximity to signaling and trafficking networks. PLoS ONE. 2015;10:e0117074 pubmed publisher
  132. Freeman J, Feng Y, Demehri F, Dempsey P, Teitelbaum D. TPN-associated intestinal epithelial cell atrophy is modulated by TLR4/EGF signaling pathways. FASEB J. 2015;29:2943-58 pubmed publisher
  133. Strick Marchand H, Dusséaux M, Darche S, Huntington N, Legrand N, Masse Ranson G, et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE. 2015;10:e0119820 pubmed publisher
  134. Lee J, Choi H, Na W, Ju B, Yune T. 17β-estradiol inhibits MMP-9 and SUR1/TrpM4 expression and activation and thereby attenuates BSCB disruption/hemorrhage after spinal cord injury in male rats. Endocrinology. 2015;156:1838-50 pubmed publisher
  135. Furihata T, Kawamatsu S, Ito R, Saito K, Suzuki S, Kishida S, et al. Hydrocortisone enhances the barrier properties of HBMEC/ciβ, a brain microvascular endothelial cell line, through mesenchymal-to-endothelial transition-like effects. Fluids Barriers CNS. 2015;12:7 pubmed publisher
  136. Boulay A, Mazeraud A, Cisternino S, Saubaméa B, Mailly P, Jourdren L, et al. Immune quiescence of the brain is set by astroglial connexin 43. J Neurosci. 2015;35:4427-39 pubmed publisher
  137. Sohet F, Lin C, Munji R, Lee S, Ruderisch N, Soung A, et al. LSR/angulin-1 is a tricellular tight junction protein involved in blood-brain barrier formation. J Cell Biol. 2015;208:703-11 pubmed publisher
  138. ErLin S, WenJie W, LiNing W, BingXin L, MingDe L, Yan S, et al. Musashi-1 maintains blood-testis barrier structure during spermatogenesis and regulates stress granule formation upon heat stress. Mol Biol Cell. 2015;26:1947-56 pubmed publisher
  139. Röhl M, Tjernlund A, Mehta S, Pettersson P, Bailey R, Broliden K. Comparable mRNA expression of inflammatory markers but lower claudin-1 mRNA levels in foreskin tissue of HSV-2 seropositive versus seronegative asymptomatic Kenyan young men. BMJ Open. 2015;5:e006627 pubmed publisher
  140. Benoit B, Laugerette F, Plaisancié P, Géloën A, Bodennec J, Estienne M, et al. Increasing fat content from 20 to 45 wt% in a complex diet induces lower endotoxemia in parallel with an increased number of intestinal goblet cells in mice. Nutr Res. 2015;35:346-56 pubmed publisher
  141. Momeny M, Saunus J, Marturana F, McCart Reed A, Black D, Sala G, et al. Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines. Oncotarget. 2015;6:3932-46 pubmed
  142. Chajra H, Amstutz B, Schweikert K, Auriol D, Redziniak G, Lefèvre F. Opioid receptor delta as a global modulator of skin differentiation and barrier function repair. Int J Cosmet Sci. 2015;37:386-94 pubmed publisher
  143. Ek C, D Angelo B, Baburamani A, Lehner C, Leverin A, Smith P, et al. Brain barrier properties and cerebral blood flow in neonatal mice exposed to cerebral hypoxia-ischemia. J Cereb Blood Flow Metab. 2015;35:818-27 pubmed publisher
  144. Peng H, Li C, Kadow S, Henry B, Steinmann J, Becker K, et al. Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis. J Mol Med (Berl). 2015;93:675-89 pubmed publisher
  145. Chen M, Yang T, Meng X, Sun T. Azithromycin attenuates cigarette smoke extract-induced oxidative stress injury in human alveolar epithelial cells. Mol Med Rep. 2015;11:3414-22 pubmed publisher
  146. Li Z, Liu Y, Liu X, Xue Y, Wang P, Liu L. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism. Exp Cell Res. 2015;331:257-66 pubmed publisher
  147. Lee S, Kwon J, Choi I, Kim N. Expression and function of transcription factor AP-2? in early embryonic development of porcine parthenotes. Reprod Fertil Dev. 2015;: pubmed publisher
  148. Kreft M, Jerman U, Lasič E, Hevir Kene N, Rižner T, Peternel L, et al. The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function. Eur J Pharm Sci. 2015;69:1-9 pubmed publisher
  149. Nicolas V, Liévin Le Moal V. Antisecretory factor peptide AF-16 inhibits the secreted autotransporter toxin-stimulated transcellular and paracellular passages of fluid in cultured human enterocyte-like cells. Infect Immun. 2015;83:907-22 pubmed publisher
  150. Vitiello E, Ferreira J, Maiato H, Balda M, Matter K. The tumour suppressor DLC2 ensures mitotic fidelity by coordinating spindle positioning and cell-cell adhesion. Nat Commun. 2014;5:5826 pubmed publisher
  151. Watari A, Hashegawa M, Yagi K, Kondoh M. Homoharringtonine increases intestinal epithelial permeability by modulating specific claudin isoforms in Caco-2 cell monolayers. Eur J Pharm Biopharm. 2015;89:232-8 pubmed publisher
  152. Cunningham M, Wirth J, Freeman L, Boger H, Granholm A, Gilkeson G. Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus. J Neuroinflammation. 2014;11:171 pubmed publisher
  153. Qiao X, Roth I, Féraille E, Hasler U. Different effects of ZO-1, ZO-2 and ZO-3 silencing on kidney collecting duct principal cell proliferation and adhesion. Cell Cycle. 2014;13:3059-75 pubmed publisher
  154. Nacer A, Movila A, Sohet F, Girgis N, Gundra U, Loke P, et al. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier. PLoS Pathog. 2014;10:e1004528 pubmed publisher
  155. Duan J, Yin J, Ren W, Wu M, Chen S, Cui Z, et al. Pyrrolidine dithiocarbamate restores gastric damages and suppressive autophagy induced by hydrogen peroxide. Free Radic Res. 2015;49:210-8 pubmed publisher
  156. Cai H, Liu W, Xue Y, Shang X, Liu J, Li Z, et al. Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, Occludin, and Claudin-5 expression. J Neuropathol Exp Neurol. 2015;74:25-37 pubmed publisher
  157. Fernandes S, Salta S, Bravo J, Silva A, Summavielle T. Acetyl-L-Carnitine Prevents Methamphetamine-Induced Structural Damage on Endothelial Cells via ILK-Related MMP-9 Activity. Mol Neurobiol. 2016;53:408-422 pubmed publisher
  158. Tang E, Mok K, Lee W, Cheng C. EB1 regulates tubulin and actin cytoskeletal networks at the sertoli cell blood-testis barrier in male rats: an in vitro study. Endocrinology. 2015;156:680-93 pubmed publisher
  159. Shirasago Y, Sekizuka T, Saito K, Suzuki T, Wakita T, Hanada K, et al. Isolation and characterization of an Huh.7.5.1-derived cell clone highly permissive to hepatitis C virus. Jpn J Infect Dis. 2015;68:81-8 pubmed publisher
  160. Wiechmann A, Ceresa B, Howard E. Diurnal variation of tight junction integrity associates inversely with matrix metalloproteinase expression in Xenopus laevis corneal epithelium: implications for circadian regulation of homeostatic surface cell desquamation. PLoS ONE. 2014;9:e113810 pubmed publisher
  161. Braniste V, Al Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6:263ra158 pubmed publisher
  162. Zhang F, Man X, Yu H, Liu L, Li Y. Synergistic protective effects of escin and low‑dose glucocorticoids against vascular endothelial growth factor‑induced blood‑retinal barrier breakdown in retinal pigment epithelial and umbilical vein endothelial cells. Mol Med Rep. 2015;11:1372-7 pubmed publisher
  163. Johnson H, Willenbring R, Jin F, Manhart W, Lafrance S, Pirko I, et al. Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption. PLoS ONE. 2014;9:e111401 pubmed publisher
  164. Lei Q, Qiang F, Chao D, Di W, Guoqian Z, Bo Y, et al. Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways. Int J Mol Med. 2014;34:1629-39 pubmed publisher
  165. Cai X, Dai Z, Reeves R, Caballero Benítez A, Duran K, Delrow J, et al. Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. PLoS ONE. 2014;9:e108942 pubmed publisher
  166. Casselbrant A, Elias E, Fändriks L, Wallenius V. Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2015;11:45-53 pubmed publisher
  167. Tao S, Duanmu Y, Dong H, Tian J, Ni Y, Zhao R. A high-concentrate diet induced colonic epithelial barrier disruption is associated with the activating of cell apoptosis in lactating goats. BMC Vet Res. 2014;10:235 pubmed publisher
  168. Wögenstein K, Szabo S, Lunova M, Wiche G, Haybaeck J, Strnad P, et al. Epiplakin deficiency aggravates murine caerulein-induced acute pancreatitis and favors the formation of acinar keratin granules. PLoS ONE. 2014;9:e108323 pubmed publisher
  169. Mok K, Mruk D, Cheng C. rpS6 regulates blood-testis barrier dynamics through Akt-mediated effects on MMP-9. J Cell Sci. 2014;127:4870-82 pubmed publisher
  170. Kelsey L, Katoch P, Ray A, Mitra S, Chakraborty S, Lin M, et al. Vitamin D3 regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. PLoS ONE. 2014;9:e106437 pubmed publisher
  171. Gumber S, Nusrat A, Villinger F. Immunohistological characterization of intercellular junction proteins in rhesus macaque intestine. Exp Toxicol Pathol. 2014;66:437-44 pubmed publisher
  172. Scotti L, Abramovich D, Pascuali N, Irusta G, Meresman G, Tesone M, et al. Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome. J Steroid Biochem Mol Biol. 2014;144 Pt B:392-401 pubmed publisher
  173. Liu X, Zhou X, Yuan W. The angiopoietin1-Akt pathway regulates barrier function of the cultured spinal cord microvascular endothelial cells through Eps8. Exp Cell Res. 2014;328:118-31 pubmed publisher
  174. Kreft M, Jerman U, Lasič E, Lanišnik Rižner T, Hevir Kene N, Peternel L, et al. The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model. Pharm Res. 2015;32:665-79 pubmed publisher
  175. Bankwitz D, Vieyres G, Hueging K, Bitzegeio J, Doepke M, Chhatwal P, et al. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins. J Virol. 2014;88:12644-55 pubmed publisher
  176. Steiner E, Enzmann G, Lyck R, Lin S, Ruegg M, Kroger S, et al. The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain endothelial cells by stabilizing adherens junctions. Cell Tissue Res. 2014;358:465-79 pubmed publisher
  177. Ragupathy S, Esmaeili F, Paschoud S, Sublet E, Citi S, Borchard G. Toll-like receptor 2 regulates the barrier function of human bronchial epithelial monolayers through atypical protein kinase C zeta, and an increase in expression of claudin-1. Tissue Barriers. 2014;2:e29166 pubmed publisher
  178. Matsuda M, Suzuki R, Kataoka C, Watashi K, Aizaki H, Kato N, et al. Alternative endocytosis pathway for productive entry of hepatitis C virus. J Gen Virol. 2014;95:2658-67 pubmed publisher
  179. Gu D, Huang J, Yin Y, Shan Z, Zheng S, Wu P. Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier. Mol Biol Rep. 2014;41:7313-22 pubmed publisher
  180. Crespi A, Bertoni A, Ferrari I, Padovano V, Della Mina P, Berti E, et al. POF1B localizes to desmosomes and regulates cell adhesion in human intestinal and keratinocyte cell lines. J Invest Dermatol. 2015;135:192-201 pubmed publisher
  181. Tawfik A, Markand S, Al Shabrawey M, Mayo J, Reynolds J, Bearden S, et al. Alterations of retinal vasculature in cystathionine-?-synthase heterozygous mice: a model of mild to moderate hyperhomocysteinemia. Am J Pathol. 2014;184:2573-85 pubmed publisher
  182. Jakimovski D, Schneider H, Frei K, Kennes L, Bertalanffy H. Bleeding propensity of cavernous malformations: impact of tight junction alterations on the occurrence of overt hematoma. J Neurosurg. 2014;121:613-20 pubmed publisher
  183. Spadaro D, Tapia R, Jond L, Sudol M, Fanning A, Citi S. ZO proteins redundantly regulate the transcription factor DbpA/ZONAB. J Biol Chem. 2014;289:22500-11 pubmed publisher
  184. Grassme H, Carpinteiro A, Edwards M, Gulbins E, Becker K. Regulation of the inflammasome by ceramide in cystic fibrosis lungs. Cell Physiol Biochem. 2014;34:45-55 pubmed publisher
  185. Xiao X, Mruk D, Tang E, Massarwa R, Mok K, Li N, et al. N-wasp is required for structural integrity of the blood-testis barrier. PLoS Genet. 2014;10:e1004447 pubmed publisher
  186. Friis S, Sales K, Schafer J, Vogel L, Kataoka H, Bugge T. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin. J Biol Chem. 2014;289:22319-32 pubmed publisher
  187. Glotfelty L, Zahs A, Hodges K, Shan K, Alto N, Hecht G. Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration. Cell Microbiol. 2014;16:1767-83 pubmed publisher
  188. Benoit B, Plaisancie P, Geloen A, Estienne M, Debard C, Meugnier E, et al. Pasture v. standard dairy cream in high-fat diet-fed mice: improved metabolic outcomes and stronger intestinal barrier. Br J Nutr. 2014;112:520-35 pubmed publisher
  189. Price D, Ackland M, Burks W, Knight M, Suphioglu C. Peanut allergens alter intestinal barrier permeability and tight junction localisation in Caco-2 cell cultures. Cell Physiol Biochem. 2014;33:1758-77 pubmed publisher
  190. Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol. 2014;15:676-86 pubmed publisher
  191. Ruan Z, Liu S, Zhou Y, Mi S, Liu G, Wu X, et al. Chlorogenic acid decreases intestinal permeability and increases expression of intestinal tight junction proteins in weaned rats challenged with LPS. PLoS ONE. 2014;9:e97815 pubmed publisher
  192. Koda R, Yoshino A, Imanishi Y, Kawamoto S, Ueda Y, Yaoita E, et al. Expression of tight junction protein claudin-1 in human crescentic glomerulonephritis. Int J Nephrol. 2014;2014:598670 pubmed publisher
  193. Takeshita Y, Obermeier B, Cotleur A, Sano Y, Kanda T, Ransohoff R. An in vitro blood-brain barrier model combining shear stress and endothelial cell/astrocyte co-culture. J Neurosci Methods. 2014;232:165-72 pubmed publisher
  194. Martin T, Mason M, Jiang W. HGF and the regulation of tight junctions in human prostate cancer cells. Oncol Rep. 2014;32:213-24 pubmed publisher
  195. Kyoko O, Kono H, Ishimaru K, Miyake K, Kubota T, Ogawa H, et al. Expressions of tight junction proteins Occludin and Claudin-1 are under the circadian control in the mouse large intestine: implications in intestinal permeability and susceptibility to colitis. PLoS ONE. 2014;9:e98016 pubmed publisher
  196. Paschoud S, Jond L, Guerrera D, Citi S. PLEKHA7 modulates epithelial tight junction barrier function. Tissue Barriers. 2014;2:e28755 pubmed publisher
  197. Wu J, Chen J, Wu W, Shi J, Zhong Y, van Tol E, et al. Enteral supplementation of bovine lactoferrin improves gut barrier function in rats after massive bowel resection. Br J Nutr. 2014;112:486-92 pubmed publisher
  198. Altshuler A, Lamadrid I, Li D, Ma S, Kurre L, Schmid Schonbein G, et al. Transmural intestinal wall permeability in severe ischemia after enteral protease inhibition. PLoS ONE. 2014;9:e96655 pubmed publisher
  199. Tossetta G, Paolinelli F, Avellini C, Salvolini E, Ciarmela P, Lorenzi T, et al. IL-1? and TGF-? weaken the placental barrier through destruction of tight junctions: an in vivo and in vitro study. Placenta. 2014;35:509-16 pubmed publisher
  200. Grosse B, Degrouard J, Jaillard D, Cassio D. Build them up and break them down: Tight junctions of cell lines expressing typical hepatocyte polarity with a varied repertoire of claudins. Tissue Barriers. 2013;1:e25210 pubmed publisher
  201. Reaves D, Fagan Solis K, Dunphy K, Oliver S, Scott D, Fleming J. The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior. PLoS ONE. 2014;9:e91747 pubmed publisher
  202. Yang D, Zuo C, Wang X, Meng X, Xue B, Liu N, et al. Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line. Proc Natl Acad Sci U S A. 2014;111:E1264-73 pubmed publisher
  203. Retana C, Sanchez E, Perez Lopez A, Cruz A, Lagunas J, Cruz C, et al. Alterations of intercellular junctions in peritoneal mesothelial cells from patients undergoing dialysis: effect of retinoic Acid. Perit Dial Int. 2015;35:275-87 pubmed publisher
  204. Yao Y, Chen Z, Norris E, Strickland S. Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. Nat Commun. 2014;5:3413 pubmed publisher
  205. Wang S, Liu S, Mao J, Wen D. Effect of retinoic acid on the tight junctions of the retinal pigment epithelium-choroid complex of guinea pigs with lens-induced myopia in vivo. Int J Mol Med. 2014;33:825-32 pubmed publisher
  206. Xiao W, Feng Y, Holst J, Hartmann B, Yang H, Teitelbaum D. Glutamate prevents intestinal atrophy via luminal nutrient sensing in a mouse model of total parenteral nutrition. FASEB J. 2014;28:2073-87 pubmed publisher
  207. Lee J, Lee M. Decreased expression of zonula occludens-1 and occludin in the bladder urothelium of patients with interstitial cystitis/painful bladder syndrome. J Formos Med Assoc. 2014;113:17-22 pubmed publisher
  208. Fiorentino M, Levine M, Sztein M, Fasano A. Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release. PLoS ONE. 2014;9:e85211 pubmed publisher
  209. Boyer Di Ponio J, El Ayoubi F, Glacial F, Ganeshamoorthy K, Driancourt C, Godet M, et al. Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes. PLoS ONE. 2014;9:e84179 pubmed publisher
  210. Paul C, Robaire B. Impaired function of the blood-testis barrier during aging is preceded by a decline in cell adhesion proteins and GTPases. PLoS ONE. 2013;8:e84354 pubmed publisher
  211. Wang Q, Schultz B. Cholera toxin enhances Na(+) absorption across MCF10A human mammary epithelia. Am J Physiol Cell Physiol. 2014;306:C471-84 pubmed publisher
  212. Omri S, Behar Cohen F, Rothschild P, Gélizé E, Jonet L, Jeanny J, et al. PKC? mediates breakdown of outer blood-retinal barriers in diabetic retinopathy. PLoS ONE. 2013;8:e81600 pubmed publisher
  213. Altshuler A, Richter M, Modestino A, Penn A, Heller M, Schmid Schonbein G. Removal of luminal content protects the small intestine during hemorrhagic shock but is not sufficient to prevent lung injury. Physiol Rep. 2013;1:e00109 pubmed publisher
  214. Jesus P, Ouelaa W, François M, Riachy L, Guérin C, Aziz M, et al. Alteration of intestinal barrier function during activity-based anorexia in mice. Clin Nutr. 2014;33:1046-53 pubmed publisher
  215. Zhang S, Liu Z, Heldsinger A, Owyang C, Yu S. Intraluminal acid activates esophageal nodose C fibers after mast cell activation. Am J Physiol Gastrointest Liver Physiol. 2014;306:G200-7 pubmed publisher
  216. Shiobara T, Usui T, Han J, Isoda H, Nagumo Y. The reversible increase in tight junction permeability induced by capsaicin is mediated via cofilin-actin cytoskeletal dynamics and decreased level of occludin. PLoS ONE. 2013;8:e79954 pubmed publisher
  217. Hawkins K, Demars K, Singh J, Yang C, Cho H, Frankowski J, et al. Neurovascular protection by post-ischemic intravenous injections of the lipoxin A4 receptor agonist, BML-111, in a rat model of ischemic stroke. J Neurochem. 2014;129:130-42 pubmed publisher
  218. Duan H, Huang J, Li W, Tang M. Protective effects of fufang xueshuantong on diabetic retinopathy in rats. Evid Based Complement Alternat Med. 2013;2013:408268 pubmed publisher
  219. De Lisle R. Disrupted tight junctions in the small intestine of cystic fibrosis mice. Cell Tissue Res. 2014;355:131-42 pubmed publisher
  220. Whiteman E, Fan S, Harder J, Walton K, Liu C, Soofi A, et al. Crumbs3 is essential for proper epithelial development and viability. Mol Cell Biol. 2014;34:43-56 pubmed publisher
  221. Castelli M, Boca M, Chiaravalli M, Ramalingam H, Rowe I, Distefano G, et al. Polycystin-1 binds Par3/aPKC and controls convergent extension during renal tubular morphogenesis. Nat Commun. 2013;4:2658 pubmed publisher
  222. Rincon Heredia R, Flores Benitez D, Flores Maldonado C, Bonilla Delgado J, García Hernández V, Verdejo Torres O, et al. Ouabain induces endocytosis and degradation of tight junction proteins through ERK1/2-dependent pathways. Exp Cell Res. 2014;320:108-18 pubmed publisher
  223. Elamin E, Masclee A, Dekker J, Pieters H, Jonkers D. Short-chain fatty acids activate AMP-activated protein kinase and ameliorate ethanol-induced intestinal barrier dysfunction in Caco-2 cell monolayers. J Nutr. 2013;143:1872-81 pubmed publisher
  224. Zheng Q, Wang X, Wen Q, Zhang Y, Chen S, Zhang J, et al. Wt1 deficiency causes undifferentiated spermatogonia accumulation and meiotic progression disruption in neonatal mice. Reproduction. 2014;147:45-52 pubmed publisher
  225. Sugimoto K, Ichikawa Tomikawa N, Satohisa S, Akashi Y, Kanai R, Saito T, et al. The tight-junction protein claudin-6 induces epithelial differentiation from mouse F9 and embryonic stem cells. PLoS ONE. 2013;8:e75106 pubmed publisher
  226. Beaufort N, Corvazier E, Mlanaoindrou S, de Bentzmann S, Pidard D. Disruption of the endothelial barrier by proteases from the bacterial pathogen Pseudomonas aeruginosa: implication of matrilysis and receptor cleavage. PLoS ONE. 2013;8:e75708 pubmed publisher
  227. Guichard A, Cruz Moreno B, Cruz Moreno B, Aguilar B, van Sorge N, Kuang J, et al. Cholera toxin disrupts barrier function by inhibiting exocyst-mediated trafficking of host proteins to intestinal cell junctions. Cell Host Microbe. 2013;14:294-305 pubmed publisher
  228. Nighot P, Young K, Nighot M, Rawat M, Sung E, Maharshak N, et al. Chloride channel ClC-2 is a key factor in the development of DSS-induced murine colitis. Inflamm Bowel Dis. 2013;19:2867-77 pubmed publisher
  229. Hernández Monge J, Garay E, Raya Sandino A, Vargas Sierra O, Diaz Chavez J, Popoca Cuaya M, et al. Papillomavirus E6 oncoprotein up-regulates occludin and ZO-2 expression in ovariectomized mice epidermis. Exp Cell Res. 2013;319:2588-603 pubmed publisher
  230. Bittner S, Ruck T, Schuhmann M, Herrmann A, Moha Ou Maati H, Bobak N, et al. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161-5 pubmed publisher
  231. Chastre A, Belanger M, Nguyen B, Butterworth R. Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure. Liver Int. 2014;34:353-61 pubmed publisher
  232. Wong E, Cheng C. NC1 domain of collagen ?3(IV) derived from the basement membrane regulates Sertoli cell blood-testis barrier dynamics. Spermatogenesis. 2013;3:e25465 pubmed
  233. Teng F, Beray Berthat V, Coqueran B, Lesbats C, Kuntz M, Palmier B, et al. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice. Exp Neurol. 2013;248:416-28 pubmed publisher
  234. Hirashima T, Hosokawa Y, Iino T, Nagayama M. On fundamental cellular processes for emergence of collective epithelial movement. Biol Open. 2013;2:660-6 pubmed publisher
  235. Siljamäki E, Raiko L, Toriseva M, Nissinen L, Näreoja T, Peltonen J, et al. p38? mitogen-activated protein kinase regulates the expression of tight junction protein ZO-1 in differentiating human epidermal keratinocytes. Arch Dermatol Res. 2014;306:131-41 pubmed publisher
  236. Chen J, Erikson D, Piltonen T, Meyer M, Barragan F, McIntire R, et al. Coculturing human endometrial epithelial cells and stromal fibroblasts alters cell-specific gene expression and cytokine production. Fertil Steril. 2013;100:1132-43 pubmed publisher
  237. Nicholls P, Harrison C, Rainczuk K, Wayne Vogl A, Stanton P. Retinoic acid promotes Sertoli cell differentiation and antagonises activin-induced proliferation. Mol Cell Endocrinol. 2013;377:33-43 pubmed publisher
  238. Someya M, Kojima T, Ogawa M, Ninomiya T, Nomura K, Takasawa A, et al. Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano. Cell Tissue Res. 2013;354:481-94 pubmed publisher
  239. Elsum I, Martin C, Humbert P. Scribble regulates an EMT polarity pathway through modulation of MAPK-ERK signaling to mediate junction formation. J Cell Sci. 2013;126:3990-9 pubmed publisher
  240. Soscia D, Sequeira S, Schramm R, Jayarathanam K, Cantara S, Larsen M, et al. Salivary gland cell differentiation and organization on micropatterned PLGA nanofiber craters. Biomaterials. 2013;34:6773-84 pubmed publisher
  241. Watson P, Paterson J, Thom G, Ginman U, Lundquist S, Webster C. Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier. BMC Neurosci. 2013;14:59 pubmed publisher
  242. Stridh L, Ek C, Wang X, Nilsson H, Mallard C. Regulation of Toll-like receptors in the choroid plexus in the immature brain after systemic inflammatory stimuli. Transl Stroke Res. 2013;4:220-7 pubmed publisher
  243. Liu Z, He J. Cell-cell contact-mediated hepatitis C virus (HCV) transfer, productive infection, and replication and their requirement for HCV receptors. J Virol. 2013;87:8545-58 pubmed publisher
  244. Yoshida K, Yokouchi M, Nagao K, Ishii K, Amagai M, Kubo A. Functional tight junction barrier localizes in the second layer of the stratum granulosum of human epidermis. J Dermatol Sci. 2013;71:89-99 pubmed publisher
  245. Cheng Y, Lan K, Lee W, Tseng S, Hung L, Lin H, et al. Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle. Clin Sci (Lond). 2013;125:439-48 pubmed publisher
  246. Díaz Coránguez M, Segovia J, López Ornelas A, Puerta Guardo H, Ludert J, Chávez B, et al. Transmigration of neural stem cells across the blood brain barrier induced by glioma cells. PLoS ONE. 2013;8:e60655 pubmed publisher
  247. Puerta Guardo H, Raya Sandino A, Gonzalez Mariscal L, Rosales V, Ayala Davila J, Chávez Mungía B, et al. The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability. J Virol. 2013;87:7486-501 pubmed publisher
  248. Singh A, Cummings C, Mishina Y, Archer T. SOX8 regulates permeability of the blood-testes barrier that affects adult male fertility in the mouse. Biol Reprod. 2013;88:133 pubmed publisher
  249. Szczepkowska A, Lagaraine C, Robert V, Dufourny L, Thiery J, Skipor J. Effect of a two-week treatment with a low dose of 2,2'4,4',5,5'-hexachlorobiphenyl (PCB153) on tight junction protein expression in ovine choroid plexus during long and short photoperiods. Neurotoxicol Teratol. 2013;37:63-7 pubmed publisher
  250. Qian X, Mruk D, Cheng C. Rai14 (retinoic acid induced protein 14) is involved in regulating f-actin dynamics at the ectoplasmic specialization in the rat testis*. PLoS ONE. 2013;8:e60656 pubmed publisher
  251. Sourisseau M, Michta M, Zony C, Israelow B, Hopcraft S, Narbus C, et al. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies. PLoS Pathog. 2013;9:e1003244 pubmed publisher
  252. Mishra R, Singh S. HIV-1 Tat C modulates expression of miRNA-101 to suppress VE-cadherin in human brain microvascular endothelial cells. J Neurosci. 2013;33:5992-6000 pubmed publisher
  253. Wang Q, Ma C, Kemmner W. Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma. BMC Cancer. 2013;13:137 pubmed publisher
  254. Ngan E, Northey J, Brown C, Ursini Siegel J, Siegel P. A complex containing LPP and ?-actinin mediates TGF?-induced migration and invasion of ErbB2-expressing breast cancer cells. J Cell Sci. 2013;126:1981-91 pubmed publisher
  255. Shimizu F, Sano Y, Tominaga O, Maeda T, Abe M, Kanda T. Advanced glycation end-products disrupt the blood-brain barrier by stimulating the release of transforming growth factor-? by pericytes and vascular endothelial growth factor and matrix metalloproteinase-2 by endothelial cells in vitro. Neurobiol Aging. 2013;34:1902-12 pubmed publisher
  256. Adamson R, Sarai R, Altangerel A, Clark J, Weinbaum S, Curry F. Microvascular permeability to water is independent of shear stress, but dependent on flow direction. Am J Physiol Heart Circ Physiol. 2013;304:H1077-84 pubmed publisher
  257. Wu L, Li W, Wang Z, Yuan Z, Hyder Q. Bile acid-induced expression of farnesoid X receptor as the basis for superiority of internal biliary drainage in experimental biliary obstruction. Scand J Gastroenterol. 2013;48:496-503 pubmed publisher
  258. Fiorentino M, Lammers K, Levine M, Sztein M, Fasano A. In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines. Front Immunol. 2013;4:17 pubmed publisher
  259. Kirschner N, Rosenthal R, Furuse M, Moll I, Fromm M, Brandner J. Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes. J Invest Dermatol. 2013;133:1161-9 pubmed publisher
  260. Morin Brureau M, de Bock F, Lerner Natoli M. Organotypic brain slices: a model to study the neurovascular unit micro-environment in epilepsies. Fluids Barriers CNS. 2013;10:11 pubmed publisher
  261. Rachow S, Zorn Kruppa M, Ohnemus U, Kirschner N, Vidal Y Sy S, von den Driesch P, et al. Occludin is involved in adhesion, apoptosis, differentiation and Ca2+-homeostasis of human keratinocytes: implications for tumorigenesis. PLoS ONE. 2013;8:e55116 pubmed publisher
  262. Kyuno D, Kojima T, Yamaguchi H, Ito T, Kimura Y, Imamura M, et al. Protein kinase C? inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pancreatic cancer. Carcinogenesis. 2013;34:1232-43 pubmed publisher
  263. Kim S, Ishida H, Yamane D, Yi M, Swinney D, Foung S, et al. Contrasting roles of mitogen-activated protein kinases in cellular entry and replication of hepatitis C virus: MKNK1 facilitates cell entry. J Virol. 2013;87:4214-24 pubmed publisher
  264. Kissoon Singh V, Moreau F, Trusevych E, Chadee K. Entamoeba histolytica exacerbates epithelial tight junction permeability and proinflammatory responses in Muc2(-/-) mice. Am J Pathol. 2013;182:852-65 pubmed publisher
  265. Krishnan M, Lapierre L, Knowles B, Goldenring J. Rab25 regulates integrin expression in polarized colonic epithelial cells. Mol Biol Cell. 2013;24:818-31 pubmed publisher
  266. Chen S, Chen M, Wang X, Zhang J, Wen Q, Ji S, et al. The Wilms tumor gene, Wt1, maintains testicular cord integrity by regulating the expression of Col4a1 and Col4a2. Biol Reprod. 2013;88:56 pubmed publisher
  267. Lydka M, Bilinska B, Cheng C, Mruk D. Tumor necrosis factor ?-mediated restructuring of the Sertoli cell barrier in vitro involves matrix metalloprotease 9 (MMP9), membrane-bound intercellular adhesion molecule-1 (ICAM-1) and the actin cytoskeleton. Spermatogenesis. 2012;2:294-303 pubmed
  268. Scuderi S, D Amico A, Castorina A, Imbesi R, Carnazza M, D Agata V. Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction. Peptides. 2013;39:119-24 pubmed publisher
  269. Stenman L, Holma R, Eggert A, Korpela R. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. Am J Physiol Gastrointest Liver Physiol. 2013;304:G227-34 pubmed publisher
  270. Monastyrskaya K, Sanchez Freire V, Hashemi Gheinani A, Klumpp D, Babiychuk E, Draeger A, et al. miR-199a-5p regulates urothelial permeability and may play a role in bladder pain syndrome. Am J Pathol. 2013;182:431-48 pubmed publisher
  271. Xiao X, Cheng C, Mruk D. Intercellular adhesion molecule-2 is involved in apical ectoplasmic specialization dynamics during spermatogenesis in the rat. J Endocrinol. 2013;216:73-86 pubmed publisher
  272. Mi X, Feng Q, Lo A, Chang R, Lin B, Chung S, et al. Protection of retinal ganglion cells and retinal vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular hypertension. PLoS ONE. 2012;7:e45469 pubmed publisher
  273. Takasawa A, Kojima T, Ninomiya T, Tsujiwaki M, Murata M, Tanaka S, et al. Behavior of tricellulin during destruction and formation of tight junctions under various extracellular calcium conditions. Cell Tissue Res. 2013;351:73-84 pubmed publisher
  274. D Amato N, OSTRANDER J, Bowie M, Sistrunk C, Borowsky A, Cardiff R, et al. Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system. PLoS ONE. 2012;7:e45684 pubmed publisher
  275. Cheung T, Ganatra M, Peters E, Truskey G. Effect of cellular senescence on the albumin permeability of blood-derived endothelial cells. Am J Physiol Heart Circ Physiol. 2012;303:H1374-83 pubmed publisher
  276. Monkemuller K, Wex T, Kuester D, Fry L, Kandulski A, Kropf S, et al. Role of tight junction proteins in gastroesophageal reflux disease. BMC Gastroenterol. 2012;12:128 pubmed publisher
  277. Mavrakis A, Havaki S, Marinos E, Chroni E, Konstantinou D. Occludin dislocation in brain capillary endothelium of rats with bile duct ligation induced cholestasis. Neurosci Lett. 2012;528:180-4 pubmed publisher
  278. Wang J, Novak I. Ion transport in human pancreatic duct epithelium, Capan-1 cells, is regulated by secretin, VIP, acetylcholine, and purinergic receptors. Pancreas. 2013;42:452-60 pubmed publisher
  279. Cantara S, Soscia D, Sequeira S, Jean Gilles R, Castracane J, Larsen M. Selective functionalization of nanofiber scaffolds to regulate salivary gland epithelial cell proliferation and polarity. Biomaterials. 2012;33:8372-82 pubmed publisher
  280. Baek H, Noh Y, Lee J, Yeon S, Jeong J, Kwon H. Autonomous isolation, long-term culture and differentiation potential of adult salivary gland-derived stem/progenitor cells. J Tissue Eng Regen Med. 2014;8:717-27 pubmed publisher
  281. Lopez Ramirez M, Fischer R, Torres Badillo C, Davies H, Logan K, Pfizenmaier K, et al. Role of caspases in cytokine-induced barrier breakdown in human brain endothelial cells. J Immunol. 2012;189:3130-9 pubmed publisher
  282. Sandmann L, Wilson M, Back D, Wedemeyer H, Manns M, Steinmann E, et al. Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro. Antiviral Res. 2012;96:51-8 pubmed publisher
  283. Northrop N, Yamamoto B. Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier. J Neuroimmune Pharmacol. 2012;7:951-68 pubmed publisher
  284. Moran G, O NEILL C, McLaughlin J. GLP-2 enhances barrier formation and attenuates TNF?-induced changes in a Caco-2 cell model of the intestinal barrier. Regul Pept. 2012;178:95-101 pubmed publisher
  285. Leung C, Shaheen F, Bernatchez P, Hackett T. Expression of myoferlin in human airway epithelium and its role in cell adhesion and zonula occludens-1 expression. PLoS ONE. 2012;7:e40478 pubmed publisher
  286. Johnson H, Chen Y, Jin F, Hanson L, Gamez J, Pirko I, et al. CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support. J Immunol. 2012;189:1937-45 pubmed publisher
  287. Ji K, Tsirka S. Inflammation modulates expression of laminin in the central nervous system following ischemic injury. J Neuroinflammation. 2012;9:159 pubmed publisher
  288. Raposo C, Odorissi P, Oliveira A, Aoyama H, Ferreira C, Verinaud L, et al. Effect of Phoneutria nigriventer venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain barrier. Neurochem Res. 2012;37:1967-81 pubmed publisher
  289. Tang E, Xiao X, Mruk D, Qian X, Mok K, Jenardhanan P, et al. Microtubule affinity-regulating kinase 4 (MARK4) is a component of the ectoplasmic specialization in the rat testis. Spermatogenesis. 2012;2:117-126 pubmed
  290. Morel A, Hinkal G, Thomas C, Fauvet F, Courtois Cox S, Wierinckx A, et al. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet. 2012;8:e1002723 pubmed publisher
  291. Raiko L, Siljamäki E, Mahoney M, Putaala H, Suominen E, Peltonen J, et al. Hailey-Hailey disease and tight junctions: Claudins 1 and 4 are regulated by ATP2C1 gene encoding Ca(2+) /Mn(2+) ATPase SPCA1 in cultured keratinocytes. Exp Dermatol. 2012;21:586-91 pubmed publisher
  292. Guzman Aranguez A, Woodward A, Pintor J, ARGUESO P. Targeted disruption of core 1 ?1,3-galactosyltransferase (C1galt1) induces apical endocytic trafficking in human corneal keratinocytes. PLoS ONE. 2012;7:e36628 pubmed publisher
  293. Rittner H, Amasheh S, Moshourab R, Hackel D, Yamdeu R, Mousa S, et al. Modulation of tight junction proteins in the perineurium to facilitate peripheral opioid analgesia. Anesthesiology. 2012;116:1323-34 pubmed publisher
  294. Kelsey L, Katoch P, Johnson K, Batra S, Mehta P. Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. PLoS ONE. 2012;7:e32846 pubmed publisher
  295. Géraud C, Evdokimov K, Straub B, Peitsch W, Demory A, Dörflinger Y, et al. Unique cell type-specific junctional complexes in vascular endothelium of human and rat liver sinusoids. PLoS ONE. 2012;7:e34206 pubmed publisher
  296. Jiang X, Guo M, Su J, Lu B, Ma D, Zhang R, et al. Simvastatin blocks blood-brain barrier disruptions induced by elevated cholesterol both in vivo and in vitro. Int J Alzheimers Dis. 2012;2012:109324 pubmed publisher
  297. Hsieh J, Lu C, Huang C, Shieh G, Su B, Su Y, et al. Acquisition of an enhanced aggressive phenotype in human lung cancer cells selected by suboptimal doses of cisplatin following cell deattachment and reattachment. Cancer Lett. 2012;321:36-44 pubmed publisher
  298. Ritchie J, Rui H, Zhou X, Iida T, Kodoma T, Ito S, et al. Inflammation and disintegration of intestinal villi in an experimental model for Vibrio parahaemolyticus-induced diarrhea. PLoS Pathog. 2012;8:e1002593 pubmed publisher
  299. Soofi A, Levitan I, Dressler G. Two novel EGFP insertion alleles reveal unique aspects of Pax2 function in embryonic and adult kidneys. Dev Biol. 2012;365:241-50 pubmed publisher
  300. Ghule V, Gray C, Galimberti A, Anumba D. Prostaglandin-induced cervical remodelling in humans in the first trimester is associated with increased expression of specific tight junction, but not gap junction proteins. J Transl Med. 2012;10:40 pubmed publisher
  301. Dukes J, Whitley P, Chalmers A. The PIKfyve inhibitor YM201636 blocks the continuous recycling of the tight junction proteins claudin-1 and claudin-2 in MDCK cells. PLoS ONE. 2012;7:e28659 pubmed publisher
  302. Korompay A, Borka K, Lotz G, Somorácz A, Törzsök P, Erdélyi Belle B, et al. Tricellulin expression in normal and neoplastic human pancreas. Histopathology. 2012;60:E76-86 pubmed publisher
  303. Fernandes I, de Freitas V, Reis C, Mateus N. A new approach on the gastric absorption of anthocyanins. Food Funct. 2012;3:508-16 pubmed publisher
  304. Reardon S, King M, Maclean J, Mann J, DeMayo F, Lydon J, et al. CDH1 is essential for endometrial differentiation, gland development, and adult function in the mouse uterus. Biol Reprod. 2012;86:141, 1-10 pubmed publisher
  305. Ishida Yamamoto A, Kishibe M, Murakami M, Honma M, Takahashi H, Iizuka H. Lamellar granule secretion starts before the establishment of tight junction barrier for paracellular tracers in mammalian epidermis. PLoS ONE. 2012;7:e31641 pubmed publisher
  306. Paschoud S, Guillemot L, Citi S. Distinct domains of paracingulin are involved in its targeting to the actin cytoskeleton and regulation of apical junction assembly. J Biol Chem. 2012;287:13159-69 pubmed publisher
  307. Schwartz R, Trehan K, Andrus L, Sheahan T, Ploss A, Duncan S, et al. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012;109:2544-8 pubmed publisher
  308. Kyuno D, Kojima T, Ito T, Yamaguchi H, Tsujiwaki M, Takasawa A, et al. Protein kinase C? inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4. Cell Tissue Res. 2011;346:369-81 pubmed publisher
  309. Patel R, Myers L, Kurundkar A, Maheshwari A, Nusrat A, Lin P. Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am J Pathol. 2012;180:626-35 pubmed publisher
  310. Larre I, Castillo A, Flores Maldonado C, Contreras R, Galván I, Muñoz Estrada J, et al. Ouabain modulates ciliogenesis in epithelial cells. Proc Natl Acad Sci U S A. 2011;108:20591-6 pubmed publisher
  311. Nguyen Hoang A, Chen P, Juarez J, Sachamitr P, Billing B, Bosnjak L, et al. Dendritic cell functional properties in a three-dimensional tissue model of human lung mucosa. Am J Physiol Lung Cell Mol Physiol. 2012;302:L226-37 pubmed publisher
  312. Lan K, Wang Y, Lee W, Lan K, Tseng S, Hung L, et al. Multiple effects of Honokiol on the life cycle of hepatitis C virus. Liver Int. 2012;32:989-97 pubmed publisher
  313. Lee S, Shin J, Kwon H, Weiner I, Han K. Renal ischemia-reperfusion injury causes intercalated cell-specific disruption of occludin in the collecting duct. Histochem Cell Biol. 2011;136:637-47 pubmed publisher
  314. Tang X, Zheng Z, Giffard R, Yenari M. Significance of marrow-derived nicotinamide adenine dinucleotide phosphate oxidase in experimental ischemic stroke. Ann Neurol. 2011;70:606-15 pubmed publisher
  315. Pfeiffer F, Schäfer J, Lyck R, Makrides V, Brunner S, Schaeren Wiemers N, et al. Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis. Acta Neuropathol. 2011;122:601-14 pubmed publisher
  316. Chi F, Wang L, Zheng X, Wu C, Jong A, Sheard M, et al. Meningitic Escherichia coli K1 penetration and neutrophil transmigration across the blood-brain barrier are modulated by alpha7 nicotinic receptor. PLoS ONE. 2011;6:e25016 pubmed publisher
  317. Carman A, Mills J, Krenz A, Kim D, Bynoe M. Adenosine receptor signaling modulates permeability of the blood-brain barrier. J Neurosci. 2011;31:13272-80 pubmed publisher
  318. Lubarski I, Asher C, Garty H. FXYD5 (dysadherin) regulates the paracellular permeability in cultured kidney collecting duct cells. Am J Physiol Renal Physiol. 2011;301:F1270-80 pubmed publisher
  319. Quaranta M, Vincentini O, Felli C, Spadaro F, Silano M, Moricoli D, et al. Exogenous HIV-1 Nef upsets the IFN-?-induced impairment of human intestinal epithelial integrity. PLoS ONE. 2011;6:e23442 pubmed publisher
  320. Catizone A, Ricci G, Caruso M, Ferranti F, Canipari R, Galdieri M. Hepatocyte growth factor (HGF) regulates blood-testis barrier (BTB) in adult rats. Mol Cell Endocrinol. 2012;348:135-46 pubmed publisher
  321. Saubamea B, Cochois Guégan V, Cisternino S, Scherrmann J. Heterogeneity in the rat brain vasculature revealed by quantitative confocal analysis of endothelial barrier antigen and P-glycoprotein expression. J Cereb Blood Flow Metab. 2012;32:81-92 pubmed publisher
  322. Humen M, Perez P, Liévin Le Moal V. Lipid raft-dependent adhesion of Giardia intestinalis trophozoites to a cultured human enterocyte-like Caco-2/TC7 cell monolayer leads to cytoskeleton-dependent functional injuries. Cell Microbiol. 2011;13:1683-702 pubmed publisher
  323. Kojima T, Takasawa A, Kyuno D, Ito T, Yamaguchi H, Hirata K, et al. Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells. Exp Cell Res. 2011;317:2288-98 pubmed publisher
  324. Dukes J, Fish L, Richardson J, Blaikley E, Burns S, Caunt C, et al. Functional ESCRT machinery is required for constitutive recycling of claudin-1 and maintenance of polarity in vertebrate epithelial cells. Mol Biol Cell. 2011;22:3192-205 pubmed publisher
  325. Belgiovine C, Chiodi I, Mondello C. Relocalization of cell adhesion molecules during neoplastic transformation of human fibroblasts. Int J Oncol. 2011;39:1199-204 pubmed publisher
  326. Jahn K, Biazik J, Braet F. GM1 expression in caco-2 cells: characterisation of a fundamental passage-dependent transformation of a cell line. J Pharm Sci. 2011;100:3751-62 pubmed publisher
  327. Omri S, Behar Cohen F, de Kozak Y, Sennlaub F, Verissimo L, Jonet L, et al. Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKC? in the Goto Kakizaki rat model. Am J Pathol. 2011;179:942-53 pubmed publisher
  328. Ciesek S, Westhaus S, Wicht M, Wappler I, Henschen S, Sarrazin C, et al. Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles. J Virol. 2011;85:7613-21 pubmed publisher
  329. Yan J, Zhang Z, Shi H. HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells. Cell Mol Life Sci. 2012;69:115-28 pubmed publisher
  330. Lagaraine C, Skipor J, Szczepkowska A, Dufourny L, Thiery J. Tight junction proteins vary in the choroid plexus of ewes according to photoperiod. Brain Res. 2011;1393:44-51 pubmed publisher
  331. Kwon Y, Cukierman E, Godwin A. Differential expressions of adhesive molecules and proteases define mechanisms of ovarian tumor cell matrix penetration/invasion. PLoS ONE. 2011;6:e18872 pubmed publisher
  332. Gruber R, Elias P, Crumrine D, Lin T, Brandner J, Hachem J, et al. Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol. 2011;178:2252-63 pubmed publisher
  333. Mikami T, Yoshida T, Numata Y, Kikuchi M, Araki K, Nakada N, et al. Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma. Diagn Pathol. 2011;6:30 pubmed publisher
  334. Butt O, Buehler P, D Agnillo F. Blood-brain barrier disruption and oxidative stress in guinea pig after systemic exposure to modified cell-free hemoglobin. Am J Pathol. 2011;178:1316-28 pubmed publisher
  335. Coisne C, Engelhardt B. Tight junctions in brain barriers during central nervous system inflammation. Antioxid Redox Signal. 2011;15:1285-303 pubmed publisher
  336. Yang Y, Dai M, Wilson T, Omelchenko I, Klimek J, Wilmarth P, et al. Na+/K+-ATPase α1 identified as an abundant protein in the blood-labyrinth barrier that plays an essential role in the barrier integrity. PLoS ONE. 2011;6:e16547 pubmed publisher
  337. Durgan J, Kaji N, Jin D, Hall A. Par6B and atypical PKC regulate mitotic spindle orientation during epithelial morphogenesis. J Biol Chem. 2011;286:12461-74 pubmed publisher
  338. Johnson J, Roos A, Berg T, Nord M, Fuxe J. Chronic respiratory aeroallergen exposure in mice induces epithelial-mesenchymal transition in the large airways. PLoS ONE. 2011;6:e16175 pubmed publisher
  339. Xiao X, Mruk D, Lee W, Cheng C. c-Yes regulates cell adhesion at the blood-testis barrier and the apical ectoplasmic specialization in the seminiferous epithelium of rat testes. Int J Biochem Cell Biol. 2011;43:651-65 pubmed publisher
  340. Tanigawa S, Wang H, Yang Y, Sharma N, Tarasova N, Ajima R, et al. Wnt4 induces nephronic tubules in metanephric mesenchyme by a non-canonical mechanism. Dev Biol. 2011;352:58-69 pubmed publisher
  341. Moyes S, Morris J, Carr K. Roles of pre-treatment time and junctional proteins in Caco-2 cell microparticle uptake. Int J Pharm. 2011;407:21-30 pubmed publisher
  342. Kirschner N, Haftek M, Niessen C, Behne M, Furuse M, Moll I, et al. CD44 regulates tight-junction assembly and barrier function. J Invest Dermatol. 2011;131:932-43 pubmed publisher
  343. De Benedetto A, Rafaels N, McGirt L, Ivanov A, Georas S, Cheadle C, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127:773-86.e1-7 pubmed publisher
  344. Hamilton R, Leach L. Isolation and properties of an in vitro human outer blood-retinal barrier model. Methods Mol Biol. 2011;686:401-16 pubmed publisher
  345. Haarmann A, Deiss A, Prochaska J, Foerch C, Weksler B, Romero I, et al. Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown. PLoS ONE. 2010;5:e13568 pubmed publisher
  346. Eyre N, Drummer H, Beard M. The SR-BI partner PDZK1 facilitates hepatitis C virus entry. PLoS Pathog. 2010;6:e1001130 pubmed publisher
  347. Govindarajan R, Chakraborty S, Johnson K, Falk M, Wheelock M, Johnson K, et al. Assembly of connexin43 into gap junctions is regulated differentially by E-cadherin and N-cadherin in rat liver epithelial cells. Mol Biol Cell. 2010;21:4089-107 pubmed publisher
  348. Moyes S, Morris J, Carr K. Macrophages increase microparticle uptake by enterocyte-like Caco-2 cell monolayers. J Anat. 2010;217:740-54 pubmed publisher
  349. Martin T, Mansel R, Jiang W. Loss of occludin leads to the progression of human breast cancer. Int J Mol Med. 2010;26:723-34 pubmed
  350. Liu S, Kuo W, Yang W, Liu W, Gibson G, Dorko K, et al. The second extracellular loop dictates Occludin-mediated HCV entry. Virology. 2010;407:160-70 pubmed publisher
  351. Su L, Cheng C, Mruk D. Adjudin-mediated Sertoli-germ cell junction disassembly affects Sertoli cell barrier function in vitro and in vivo. Int J Biochem Cell Biol. 2010;42:1864-75 pubmed publisher
  352. Su L, Mruk D, Lee W, Cheng C. Differential effects of testosterone and TGF-?3 on endocytic vesicle-mediated protein trafficking events at the blood-testis barrier. Exp Cell Res. 2010;316:2945-60 pubmed publisher
  353. Cong W, Hirose T, Harita Y, Yamashita A, Mizuno K, Hirano H, et al. ASPP2 regulates epithelial cell polarity through the PAR complex. Curr Biol. 2010;20:1408-14 pubmed publisher
  354. Burgel B, Friesland M, Koch A, Manns M, Wedemeyer H, Weissenborn K, et al. Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration. J Viral Hepat. 2011;18:562-70 pubmed publisher
  355. Yamaguchi H, Kojima T, Ito T, Kimura Y, Imamura M, Son S, et al. Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells. Am J Pathol. 2010;177:698-712 pubmed publisher
  356. Garay E, Patino Lopez G, Islas S, Alarcón L, Canche Pool E, Valle Rios R, et al. CRTAM: A molecule involved in epithelial cell adhesion. J Cell Biochem. 2010;111:111-22 pubmed publisher
  357. Kojima T, Fuchimoto J, Yamaguchi H, Ito T, Takasawa A, Ninomiya T, et al. c-Jun N-terminal kinase is largely involved in the regulation of tricellular tight junctions via tricellulin in human pancreatic duct epithelial cells. J Cell Physiol. 2010;225:720-33 pubmed publisher
  358. De la Serre C, Ellis C, Lee J, Hartman A, Rutledge J, Raybould H. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 2010;299:G440-8 pubmed publisher
  359. Schubert Unkmeir A, Konrad C, Slanina H, Czapek F, Hebling S, Frosch M. Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog. 2010;6:e1000874 pubmed publisher
  360. Yakovich A, Huang Q, Du J, Jiang B, Barnard J. Vectorial TGFbeta signaling in polarized intestinal epithelial cells. J Cell Physiol. 2010;224:398-404 pubmed publisher
  361. Larriba M, Casado Vela J, Pendás Franco N, Peña R, Garcia de Herreros A, Berciano M, et al. Novel snail1 target proteins in human colon cancer identified by proteomic analysis. PLoS ONE. 2010;5:e10221 pubmed publisher
  362. Rychter J, van Nassauw L, Brown J, Van Marck E, Knight P, Miller H, et al. Impairment of intestinal barrier and secretory function as well as egg excretion during intestinal schistosomiasis occur independently of mouse mast cell protease-1. Parasite Immunol. 2010;32:221-31 pubmed publisher
  363. Blank F, Wehrli M, Lehmann A, Baum O, Gehr P, von Garnier C, et al. Macrophages and dendritic cells express tight junction proteins and exchange particles in an in vitro model of the human airway wall. Immunobiology. 2011;216:86-95 pubmed publisher
  364. McCabe M, Tarulli G, Meachem S, Robertson D, Smooker P, Stanton P. Gonadotropins regulate rat testicular tight junctions in vivo. Endocrinology. 2010;151:2911-22 pubmed publisher
  365. Dube E, Dufresne J, Chan P, Hermo L, Cyr D. Assessing the role of claudins in maintaining the integrity of epididymal tight junctions using novel human epididymal cell lines. Biol Reprod. 2010;82:1119-28 pubmed publisher
  366. Lesimple P, Liao J, Robert R, Gruenert D, Hanrahan J. Cystic fibrosis transmembrane conductance regulator trafficking modulates the barrier function of airway epithelial cell monolayers. J Physiol. 2010;588:1195-209 pubmed publisher
  367. Ciesek S, Steinmann E, Iken M, Ott M, Helfritz F, Wappler I, et al. Glucocorticosteroids increase cell entry by hepatitis C virus. Gastroenterology. 2010;138:1875-84 pubmed publisher
  368. Ploss A, Khetani S, Jones C, Syder A, Trehan K, Gaysinskaya V, et al. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A. 2010;107:3141-5 pubmed publisher
  369. Karim M, Biswas S, Bhattacherjee P, Paterson C. Comparison of tight junction protein expression in the ciliary epithelia of mouse, rabbit, cat and human eyes. Biotech Histochem. 2011;86:161-7 pubmed publisher
  370. Chakraborty S, Mitra S, Falk M, Caplan S, Wheelock M, Johnson K, et al. E-cadherin differentially regulates the assembly of Connexin43 and Connexin32 into gap junctions in human squamous carcinoma cells. J Biol Chem. 2010;285:10761-76 pubmed publisher
  371. Ohkuni T, Kojima T, Ogasawara N, Masaki T, Ninomiya T, Kikuchi S, et al. Expression and localization of tricellulin in human nasal epithelial cells in vivo and in vitro. Med Mol Morphol. 2009;42:204-11 pubmed publisher
  372. Bauer A, Bürgers H, Rabie T, Marti H. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab. 2010;30:837-48 pubmed publisher
  373. Joannes A, Bonnomet A, Bindels S, Polette M, Gilles C, Burlet H, et al. Fhit regulates invasion of lung tumor cells. Oncogene. 2010;29:1203-13 pubmed publisher
  374. HERRERA J, Haywood Watson R, Grill R. Acute and chronic deficits in the urinary bladder after spinal contusion injury in the adult rat. J Neurotrauma. 2010;27:423-31 pubmed publisher
  375. Sadowska G, Malaeb S, Stonestreet B. Maternal glucocorticoid exposure alters tight junction protein expression in the brain of fetal sheep. Am J Physiol Heart Circ Physiol. 2010;298:H179-88 pubmed publisher
  376. Han M, Pendem S, Teh S, Sukumaran D, Wu F, Wilson J. Ascorbate protects endothelial barrier function during septic insult: Role of protein phosphatase type 2A. Free Radic Biol Med. 2010;48:128-35 pubmed publisher
  377. Kamekura R, Kojima T, Koizumi J, Ogasawara N, Kurose M, Go M, et al. Thymic stromal lymphopoietin enhances tight-junction barrier function of human nasal epithelial cells. Cell Tissue Res. 2009;338:283-93 pubmed publisher
  378. Shimazaki J, Higa K, Kato N, Satake Y. Barrier function of cultivated limbal and oral mucosal epithelial cell sheets. Invest Ophthalmol Vis Sci. 2009;50:5672-80 pubmed publisher
  379. Matsumoto M, Oyamada K, Takahashi H, Sato T, Hatakeyama S, Nakayama K. Large-scale proteomic analysis of tyrosine-phosphorylation induced by T-cell receptor or B-cell receptor activation reveals new signaling pathways. Proteomics. 2009;9:3549-63 pubmed publisher
  380. Nicholson M, Lindsay L, Murphy C. Ovarian hormones control the changing expression of claudins and occludin in rat uterine epithelial cells during early pregnancy. Acta Histochem. 2010;112:42-52 pubmed publisher
  381. Sobarzo C, Lustig L, Ponzio R, Suescun M, Denduchis B. Effects of di(2-ethylhexyl) phthalate on gap and tight junction protein expression in the testis of prepubertal rats. Microsc Res Tech. 2009;72:868-77 pubmed publisher
  382. Waldow T, Witt W, Janke A, Ulmer A, Buzin A, Matschke K. Cell-cell junctions and vascular endothelial growth factor in rat lung as affected by ischemia/reperfusion and preconditioning with inhaled nitric oxide. J Surg Res. 2009;157:30-42 pubmed publisher
  383. Murakami T, Felinski E, Antonetti D. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem. 2009;284:21036-46 pubmed publisher
  384. McCaffrey G, Willis C, Staatz W, Nametz N, Quigley C, Hom S, et al. Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. J Neurochem. 2009;110:58-71 pubmed publisher
  385. Alanne M, Pummi K, Heape A, Grenman R, Peltonen J, Peltonen S. Tight junction proteins in human Schwann cell autotypic junctions. J Histochem Cytochem. 2009;57:523-9 pubmed publisher
  386. Tian J, Hao L, Chandra P, Jones D, Willams I, Gewirtz A, et al. Dietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2009;296:G348-55 pubmed publisher
  387. Son S, Kojima T, Decaens C, Yamaguchi H, Ito T, Imamura M, et al. Knockdown of tight junction protein claudin-2 prevents bile canalicular formation in WIF-B9 cells. Histochem Cell Biol. 2009;131:411-24 pubmed publisher
  388. McLaughlin J, Lambert D, Padfield P, Burt J, O Neill C. The mycotoxin patulin, modulates tight junctions in caco-2 cells. Toxicol In Vitro. 2009;23:83-9 pubmed publisher
  389. Sugimoto M, Inoko A, Shiromizu T, Nakayama M, Zou P, Yonemura S, et al. The keratin-binding protein Albatross regulates polarization of epithelial cells. J Cell Biol. 2008;183:19-28 pubmed publisher
  390. Hemphill A, Vonlaufen N, Golaz J, Burgener I. Infection of primary canine duodenal epithelial cell cultures with Neospora caninum. J Parasitol. 2009;95:372-80 pubmed publisher
  391. Neuhaus W, Wirth M, Plattner V, Germann B, Gabor F, Noe C. Expression of Claudin-1, Claudin-3 and Claudin-5 in human blood-brain barrier mimicking cell line ECV304 is inducible by glioma-conditioned media. Neurosci Lett. 2008;446:59-64 pubmed publisher
  392. Chen X, Lan X, Roche I, Liu R, Geiger J. Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J Neurochem. 2008;107:1147-57 pubmed publisher
  393. Aono S, Hirai Y. Phosphorylation of claudin-4 is required for tight junction formation in a human keratinocyte cell line. Exp Cell Res. 2008;314:3326-39 pubmed publisher
  394. Weber C, Nalle S, Tretiakova M, Rubin D, Turner J. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008;88:1110-20 pubmed publisher
  395. Van Hoof D, Braam S, Dormeyer W, Ward van Oostwaard D, Heck A, Krijgsveld J, et al. Feeder-free monolayer cultures of human embryonic stem cells express an epithelial plasma membrane protein profile. Stem Cells. 2008;26:2777-81 pubmed publisher
  396. McCaffrey G, Seelbach M, Staatz W, Nametz N, Quigley C, Campos C, et al. Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. J Neurochem. 2008;106:2395-409 pubmed publisher
  397. Pfeiffer F, Kumar V, Butz S, Vestweber D, Imhof B, Stein J, et al. Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node. Eur J Immunol. 2008;38:2142-55 pubmed publisher
  398. Bouschbacher M, Bomsel M, Verronèse E, Gofflo S, Ganor Y, Dezutter Dambuyant C, et al. Early events in HIV transmission through a human reconstructed vaginal mucosa. AIDS. 2008;22:1257-66 pubmed publisher
  399. Yan H, Mruk D, Wong E, Lee W, Cheng C. An autocrine axis in the testis that coordinates spermiation and blood-testis barrier restructuring during spermatogenesis. Proc Natl Acad Sci U S A. 2008;105:8950-5 pubmed publisher
  400. Sugiyama Y, Prescott A, Tholozan F, Ohno S, Quinlan R. Expression and localisation of apical junctional complex proteins in lens epithelial cells. Exp Eye Res. 2008;87:64-70 pubmed publisher
  401. Neuhaus W, Plattner V, Wirth M, Germann B, Lachmann B, Gabor F, et al. Validation of in vitro cell culture models of the blood-brain barrier: tightness characterization of two promising cell lines. J Pharm Sci. 2008;97:5158-75 pubmed publisher
  402. Fahrioglu U, Murphy M, Zarkower D, Bardwell V. mRNA expression analysis and the molecular basis of neonatal testis defects in Dmrt1 mutant mice. Sex Dev. 2007;1:42-58 pubmed publisher
  403. Chen X, Gawryluk J, Wagener J, Ghribi O, Geiger J. Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation. 2008;5:12 pubmed publisher
  404. Orbán E, Szabó E, Lotz G, Kupcsulik P, Páska C, Schaff Z, et al. Different expression of occludin and ZO-1 in primary and metastatic liver tumors. Pathol Oncol Res. 2008;14:299-306 pubmed publisher
  405. De Proost I, Pintelon I, Brouns I, Kroese A, Riccardi D, Kemp P, et al. Functional live cell imaging of the pulmonary neuroepithelial body microenvironment. Am J Respir Cell Mol Biol. 2008;39:180-9 pubmed publisher
  406. Catizone A, Ricci G, Galdieri M. Hepatocyte growth factor modulates Sertoli-Sertoli tight junction dynamics. J Cell Physiol. 2008;216:253-60 pubmed publisher
  407. Takano K, Kojima T, Ogasawara N, Go M, Kikuchi S, Ninomiya T, et al. Expression of tight junction proteins in epithelium including Ck20-positive M-like cells of human adenoids in vivo and in vitro. J Mol Histol. 2008;39:265-73 pubmed publisher
  408. Marose T, Merkel C, McMahon A, Carroll T. Beta-catenin is necessary to keep cells of ureteric bud/Wolffian duct epithelium in a precursor state. Dev Biol. 2008;314:112-26 pubmed publisher
  409. Paschoud S, Citi S. Inducible overexpression of cingulin in stably transfected MDCK cells does not affect tight junction organization and gene expression. Mol Membr Biol. 2008;25:1-13 pubmed
  410. Lussier C, Babeu J, Auclair B, Perreault N, Boudreau F. Hepatocyte nuclear factor-4alpha promotes differentiation of intestinal epithelial cells in a coculture system. Am J Physiol Gastrointest Liver Physiol. 2008;294:G418-28 pubmed
  411. Kojima T, Takano K, Yamamoto T, Murata M, Son S, Imamura M, et al. Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes. Liver Int. 2008;28:534-45 pubmed
  412. Rodewald M, Herr D, Fraser H, Hack G, Kreienberg R, Wulff C. Regulation of tight junction proteins occludin and claudin 5 in the primate ovary during the ovulatory cycle and after inhibition of vascular endothelial growth factor. Mol Hum Reprod. 2007;13:781-9 pubmed
  413. McCaffrey G, Staatz W, Quigley C, Nametz N, Seelbach M, Campos C, et al. Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J Neurochem. 2007;103:2540-55 pubmed publisher
  414. Ohnemus U, Kohrmeyer K, Houdek P, Rohde H, Wladykowski E, Vidal S, et al. Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains. J Invest Dermatol. 2008;128:906-16 pubmed
  415. Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204:2349-62 pubmed
  416. Atsumi T, Kato K, Uno K, Iijima K, Koike T, Imatani A, et al. Pathophysiological role of the activation of p38 mitogen-activated protein kinases in poorly differentiated gastric cancer. Pathol Int. 2007;57:635-44 pubmed
  417. Dhasarathy A, Kajita M, Wade P. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol Endocrinol. 2007;21:2907-18 pubmed
  418. Mandell K, Berglin L, Severson E, Edelhauser H, Parkos C. Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function. Invest Ophthalmol Vis Sci. 2007;48:3928-36 pubmed
  419. Moser L, Carter M, Schultz Cherry S. Astrovirus increases epithelial barrier permeability independently of viral replication. J Virol. 2007;81:11937-45 pubmed
  420. Golaz J, Vonlaufen N, Hemphill A, Burgener I. Establishment and characterization of a primary canine duodenal epithelial cell culture. In Vitro Cell Dev Biol Anim. 2007;43:176-85 pubmed
  421. Gorodeski G. Estrogen modulation of epithelial permeability in cervical-vaginal cells of premenopausal and postmenopausal women. Menopause. 2007;14:1012-9 pubmed
  422. Morgan L, Shah B, Rivers L, Barden L, Groom A, Chung R, et al. Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis. Neuroscience. 2007;147:664-73 pubmed
  423. Beau I, Cotte Laffitte J, Amsellem R, Servin A. A protein kinase A-dependent mechanism by which rotavirus affects the distribution and mRNA level of the functional tight junction-associated protein, occludin, in human differentiated intestinal Caco-2 cells. J Virol. 2007;81:8579-86 pubmed
  424. Southgate J, Varley C, Garthwaite M, Hinley J, Marsh F, Stahlschmidt J, et al. Differentiation potential of urothelium from patients with benign bladder dysfunction. BJU Int. 2007;99:1506-16 pubmed
  425. Iizuka Kogo A, Ishidao T, Akiyama T, Senda T. Abnormal development of urogenital organs in Dlgh1-deficient mice. Development. 2007;134:1799-807 pubmed
  426. Hernandez S, Chavez Munguia B, Gonzalez Mariscal L. ZO-2 silencing in epithelial cells perturbs the gate and fence function of tight junctions and leads to an atypical monolayer architecture. Exp Cell Res. 2007;313:1533-47 pubmed
  427. Stucke V, Timmerman E, Vandekerckhove J, Gevaert K, Hall A. The MAGUK protein MPP7 binds to the polarity protein hDlg1 and facilitates epithelial tight junction formation. Mol Biol Cell. 2007;18:1744-55 pubmed
  428. Peltonen S, Riehokainen J, Pummi K, Peltonen J. Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis. Br J Dermatol. 2007;156:466-72 pubmed
  429. Hamazaki Y, Fujita H, Kobayashi T, Choi Y, Scott H, Matsumoto M, et al. Medullary thymic epithelial cells expressing Aire represent a unique lineage derived from cells expressing claudin. Nat Immunol. 2007;8:304-11 pubmed
  430. Yamashita S. Heat-induced antigen retrieval: mechanisms and application to histochemistry. Prog Histochem Cytochem. 2007;41:141-200 pubmed
  431. Mitra S, Annamalai L, Chakraborty S, Johnson K, Song X, Batra S, et al. Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. Mol Biol Cell. 2006;17:5400-16 pubmed
  432. Blank F, Rothen Rutishauser B, Schurch S, Gehr P. An optimized in vitro model of the respiratory tract wall to study particle cell interactions. J Aerosol Med. 2006;19:392-405 pubmed
  433. Anstrom J, Thore C, Moody D, Brown W. Immunolocalization of tight junction proteins in blood vessels in human germinal matrix and cortex. Histochem Cell Biol. 2007;127:205-13 pubmed
  434. Uchino Y, Shimmura S, Miyashita H, Taguchi T, Kobayashi H, Shimazaki J, et al. Amniotic membrane immobilized poly(vinyl alcohol) hybrid polymer as an artificial cornea scaffold that supports a stratified and differentiated corneal epithelium. J Biomed Mater Res B Appl Biomater. 2007;81:201-6 pubmed
  435. Larre I, Ponce A, Fiorentino R, Shoshani L, Contreras R, Cereijido M. Contacts and cooperation between cells depend on the hormone ouabain. Proc Natl Acad Sci U S A. 2006;103:10911-6 pubmed
  436. Herouy Y, Kahle B, Idzko M, Eberth I, Norgauer J, Pannier F, et al. Tight junctions and compression therapy in chronic venous insufficiency. Int J Mol Med. 2006;18:215-9 pubmed
  437. Gonzalez Mariscal L, Namorado M, Martin D, Sierra G, Reyes J. The tight junction proteins claudin-7 and -8 display a different subcellular localization at Henle's loops and collecting ducts of rabbit kidney. Nephrol Dial Transplant. 2006;21:2391-8 pubmed
  438. Oku N, Sasabe E, Ueta E, Yamamoto T, Osaki T. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res. 2006;66:5251-7 pubmed
  439. Sarkar O, Xia W, Mruk D. Adjudin-mediated junction restructuring in the seminiferous epithelium leads to displacement of soluble guanylate cyclase from adherens junctions. J Cell Physiol. 2006;208:175-87 pubmed
  440. Förster C, Waschke J, Burek M, Leers J, Drenckhahn D. Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific. J Physiol. 2006;573:413-25 pubmed
  441. Liévano S, Alarcón L, Chavez Munguia B, Gonzalez Mariscal L. Endothelia of term human placentae display diminished expression of tight junction proteins during preeclampsia. Cell Tissue Res. 2006;324:433-48 pubmed
  442. Prozialeck W, Edwards J, Lamar P, Smith C. Epithelial barrier characteristics and expression of cell adhesion molecules in proximal tubule-derived cell lines commonly used for in vitro toxicity studies. Toxicol In Vitro. 2006;20:942-53 pubmed
  443. Kreft M, Hudoklin S, Sterle M. Establishment and characterization of primary and subsequent subcultures of normal mouse urothelial cells. Folia Biol (Praha). 2005;51:126-32 pubmed
  444. Watson C, Hoare C, Garrod D, Carlson G, Warhurst G. Interferon-gamma selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores. J Cell Sci. 2005;118:5221-30 pubmed
  445. Zhu L, Li X, Zeng R, Gorodeski G. Changes in tight junctional resistance of the cervical epithelium are associated with modulation of content and phosphorylation of occludin 65-kilodalton and 50-kilodalton forms. Endocrinology. 2006;147:977-89 pubmed
  446. Schierack P, Nordhoff M, Pollmann M, Weyrauch K, Amasheh S, Lodemann U, et al. Characterization of a porcine intestinal epithelial cell line for in vitro studies of microbial pathogenesis in swine. Histochem Cell Biol. 2006;125:293-305 pubmed
  447. Pummi K, Aho H, Laato M, Peltonen J, Peltonen S. Tight junction proteins and perineurial cells in neurofibromas. J Histochem Cytochem. 2006;54:53-61 pubmed
  448. Miyashita H, Shimmura S, Kobayashi H, Taguchi T, Asano Kato N, Uchino Y, et al. Collagen-immobilized poly(vinyl alcohol) as an artificial cornea scaffold that supports a stratified corneal epithelium. J Biomed Mater Res B Appl Biomater. 2006;76:56-63 pubmed
  449. Khuth S, Strazielle N, Giraudon P, Belin M, Ghersi Egea J. Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2. J Neurochem. 2005;94:1580-93 pubmed
  450. Haton C, Lebrun F, Benderitter M, Griffiths N. Maintenance of differentiation capacity of HT-29 cells after radiation exposure. Int J Radiat Biol. 2005;81:211-20 pubmed
  451. Clark E, Hoare C, Tanianis Hughes J, Carlson G, Warhurst G. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology. 2005;128:1258-67 pubmed
  452. Xia W, Wong C, Lee N, Lee W, Cheng C. Disruption of Sertoli-germ cell adhesion function in the seminiferous epithelium of the rat testis can be limited to adherens junctions without affecting the blood-testis barrier integrity: an in vivo study using an androgen suppression model. J Cell Physiol. 2005;205:141-57 pubmed
  453. Kreft M, Sterle M, Veranic P, Jezernik K. Urothelial injuries and the early wound healing response: tight junctions and urothelial cytodifferentiation. Histochem Cell Biol. 2005;123:529-39 pubmed
  454. Sobel G, Szabo I, Páska C, Kiss A, Kovalszky I, Kadar A, et al. Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia. Pathol Oncol Res. 2005;11:26-31 pubmed
  455. Rothen Rutishauser B, Kiama S, Gehr P. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol. 2005;32:281-9 pubmed
  456. Bordin M, D Atri F, Guillemot L, Citi S. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Mol Cancer Res. 2004;2:692-701 pubmed
  457. Go M, Kojima T, Takano K, Murata M, Ichimiya S, Tsubota H, et al. Expression and function of tight junctions in the crypt epithelium of human palatine tonsils. J Histochem Cytochem. 2004;52:1627-38 pubmed
  458. Somosy Z, Forgacs Z, Bognár G, Horvath K, Horváth G. Alteration of tight and adherens junctions on 50-Hz magnetic field exposure in Madin Darby canine kidney (MDCK) cells. ScientificWorldJournal. 2004;4 Suppl 2:75-82 pubmed
  459. Nava P, Lopez S, Arias C, Islas S, Gonzalez Mariscal L. The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells. J Cell Sci. 2004;117:5509-19 pubmed
  460. Zeng R, Li X, Gorodeski G. Estrogen abrogates transcervical tight junctional resistance by acceleration of occludin modulation. J Clin Endocrinol Metab. 2004;89:5145-55 pubmed
  461. Caron A, Desrosiers R, Beliveau R. Kidney ischemia-reperfusion regulates expression and distribution of tubulin subunits, beta-actin and rho GTPases in proximal tubules. Arch Biochem Biophys. 2004;431:31-46 pubmed
  462. Guillemot L, Hammar E, Kaister C, Ritz J, Caille D, Jond L, et al. Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression. J Cell Sci. 2004;117:5245-56 pubmed
  463. Broughman J, Brandt R, Hastings C, Iwamoto T, Tomich J, Schultz B. Channel-forming peptide modulates transepithelial electrical conductance and solute permeability. Am J Physiol Cell Physiol. 2004;286:C1312-23 pubmed
  464. Gye M. Expression of occludin in canine testis and epididymis. Reprod Domest Anim. 2004;39:43-7 pubmed
  465. Sundberg U, Beauchemin N, Obrink B. The cytoplasmic domain of CEACAM1-L controls its lateral localization and the organization of desmosomes in polarized epithelial cells. J Cell Sci. 2004;117:1091-104 pubmed
  466. Bailey T, Kanuga N, Romero I, Greenwood J, Luthert P, Cheetham M. Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2004;45:675-84 pubmed
  467. Betanzos A, Huerta M, Lopez Bayghen E, Azuara E, Amerena J, Gonzalez Mariscal L. The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. Exp Cell Res. 2004;292:51-66 pubmed
  468. Kahle B, Idzko M, Norgauer J, Rabe E, Herouy Y. Tightening tight junctions with compression therapy. J Invest Dermatol. 2003;121:1228-9 pubmed
  469. Billings S, Walsh S, Fisher C, Nusrat A, Weiss S, Folpe A. Aberrant expression of tight junction-related proteins ZO-1, claudin-1 and occludin in synovial sarcoma: an immunohistochemical study with ultrastructural correlation. Mod Pathol. 2004;17:141-9 pubmed
  470. Palovuori R, Sormunen R, Eskelinen S. SRC-induced disintegration of adherens junctions of madin-darby canine kidney cells is dependent on endocytosis of cadherin and antagonized by Tiam-1. Lab Invest. 2003;83:1901-15 pubmed
  471. Malminen M, Koivukangas V, Peltonen J, Karvonen S, Oikarinen A, Peltonen S. Immunohistological distribution of the tight junction components ZO-1 and occludin in regenerating human epidermis. Br J Dermatol. 2003;149:255-60 pubmed
  472. Lau A, Mruk D. Rab8B GTPase and junction dynamics in the testis. Endocrinology. 2003;144:1549-63 pubmed
  473. Mooradian A, Haas M, Chehade J. Age-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1). Mech Ageing Dev. 2003;124:143-6 pubmed
  474. Castillo A, Reyes J, Sanchez E, Mondragon R, Meza I. 2,3-butanedione monoxime (BDM), a potent inhibitor of actin-myosin interaction, induces ion and fluid transport in MDCK monolayers. J Muscle Res Cell Motil. 2002;23:223-34 pubmed
  475. Siu M, Lee W, Cheng C. The interplay of collagen IV, tumor necrosis factor-alpha, gelatinase B (matrix metalloprotease-9), and tissue inhibitor of metalloproteases-1 in the basal lamina regulates Sertoli cell-tight junction dynamics in the rat testis. Endocrinology. 2003;144:371-87 pubmed
  476. Evans S, Blyth D, Wong T, Sanjar S, West M. Decreased distribution of lung epithelial junction proteins after intratracheal antigen or lipopolysaccharide challenge: correlation with neutrophil influx and levels of BALF sE-cadherin. Am J Respir Cell Mol Biol. 2002;27:446-54 pubmed
  477. Contreras R, Shoshani L, Flores Maldonado C, Lazaro A, Monroy A, Roldán M, et al. E-Cadherin and tight junctions between epithelial cells of different animal species. Pflugers Arch. 2002;444:467-75 pubmed
  478. Reyes J, Lamas M, Martin D, del Carmen Namorado M, Islas S, Luna J, et al. The renal segmental distribution of claudins changes with development. Kidney Int. 2002;62:476-87 pubmed
  479. Tavelin S, Gråsjö J, Taipalensuu J, Ocklind G, Artursson P. Applications of epithelial cell culture in studies of drug transport. Methods Mol Biol. 2002;188:233-72 pubmed
  480. Busch C, Hanssen T, Wagener C, Obrink B. Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum Pathol. 2002;33:290-8 pubmed
  481. Chehade J, Haas M, Mooradian A. Diabetes-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression. Neurochem Res. 2002;27:249-52 pubmed
  482. Gudjonsson T, Villadsen R, Nielsen H, Rønnov Jessen L, Bissell M, Petersen O. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev. 2002;16:693-706 pubmed
  483. Gudjonsson T, Rønnov Jessen L, Villadsen R, Rank F, Bissell M, Petersen O. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci. 2002;115:39-50 pubmed
  484. Kreft M, Romih R, Sterle M. Antigenic and ultrastructural markers associated with urothelial cytodifferentiation in primary explant outgrowths of mouse bladder. Cell Biol Int. 2002;26:63-74 pubmed
  485. Pummi K, Malminen M, Aho H, Karvonen S, Peltonen J, Peltonen S. Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes. J Invest Dermatol. 2001;117:1050-8 pubmed
  486. Pálmer H, González Sancho J, Espada J, Berciano M, Puig I, Baulida J, et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 2001;154:369-87 pubmed
  487. Contreras R, Shoshani L, Flores Maldonado C, Lazaro A, Cereijido M. Relationship between Na(+),K(+)-ATPase and cell attachment. J Cell Sci. 1999;112 ( Pt 23):4223-32 pubmed
  488. Lawlor P, Marcotti W, Rivolta M, Kros C, Holley M. Differentiation of mammalian vestibular hair cells from conditionally immortal, postnatal supporting cells. J Neurosci. 1999;19:9445-58 pubmed